CINXE.COM

<!DOCTYPE html><html lang="en"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width"/><script src="https://cmp.osano.com/6olh2SicG0V81Mlk/1f9d883d-3834-40b9-9a96-6f89a1cda98b/osano.js"></script><title>Product Approvals and Launches</title><meta name="description" content="The AJMC® Product Approvals and Launches page will cover the latest FDA product approvals, as well as product launches in the United States."/><meta property="og:url" content="https://www.ajmc.com/approvals-launches "/><meta property="og:title" content="Product Approvals and Launches"/><meta property="og:image" content="https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png"/><meta property="og:site_name" content="AJMC"/><meta property="og:description" content="The AJMC® Product Approvals and Launches page will cover the latest FDA product approvals, as well as product launches in the United States."/><meta name="twitter:card" content="summary"/><meta name="twitter:title" content="Product Approvals and Launches"/><meta name="twitter:image" content="https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png"/><meta name="twitter:site" content="@@AJMC_Journal"/><meta name="twitter:description" content="The AJMC® Product Approvals and Launches page will cover the latest FDA product approvals, as well as product launches in the United States."/><meta name="robots" content="max-image-preview:large"/><meta name="robots" content="max-video-preview:-1"/><link rel="preconnect dns-prefetch" href="https://cmp.osano.com"/><link rel="preconnect dns-prefetch" href="https://res.lassomarketing.io"/><link rel="preconnect dns-prefetch" href="https://www.lightboxcdn.com"/><link rel="preconnect dns-prefetch" href="https://pub.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.doubleverify.com"/><link rel="preconnect dns-prefetch" href="https://cdn.segment.com"/><link rel="preconnect dns-prefetch" href="https://securepubads.g.doubleclick.net"/><link rel="preconnect dns-prefetch" href="https://pagead2.googlesyndication.com"/><link rel="preconnect dns-prefetch" href="https://cdn.sanity.io"/><link rel="preconnect dns-prefetch" href="https://www.google-analytics.com"/><link rel="preconnect dns-prefetch" href="https://www.googletagmanager.com"/><link rel="preconnect dns-prefetch" href="https://player.vimeo.com"/><link rel="preconnect dns-prefetch" href="https://youtube.com"/><link rel="preconnect dns-prefetch" href="https://connect.facebook.net"/><link rel="preconnect dns-prefetch" href="https://www.facebook.com"/><link rel="preconnect dns-prefetch" href="https://static.ads-twitter.com"/><link rel="preconnect dns-prefetch" href="https://ad.doubleclick.net"/><link rel="preload" href="https://securepubads.g.doubleclick.net/tag/js/gpt.js"/><link rel="preload" href="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&cmp=DV464021"/><link rel="icon" href="/favicon.ico"/><script async="" src="https://securepubads.g.doubleclick.net/tag/js/gpt.js"></script><script src="https://pub.doubleverify.com/signals/pub.js#ctx=20083417&cmp=DV464021"></script><script src="https://one.ajmc.com/tagmanager/scripts/one.js"></script><script>window.dataLayer = window.dataLayer || []; window.dataLayer.push({ event: "page_dimensions", pageTitle: "Product Approvals and Launches", dimension9: "fda-approvals", dimension11: "", dimension12: "", dimension13: "", dimension14: "", dimension15: "approvals-launches", dimension18: "", dimension19: "", dimension20: "", });</script><script type="module"> (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-NK5KQXS'); </script><script type="module"> var ALGOLIA_INSIGHTS_SRC = "https://cdn.jsdelivr.net/npm/search-insights@2.4.0"; !function(e,a,t,n,s,i,c){e.AlgoliaAnalyticsObject=s,e[s]=e[s]||function(){ (e[s].queue=e[s].queue||[]).push(arguments)},i=a.createElement(t),c=a.getElementsByTagName(t)[0], i.async=1,i.src=n,c.parentNode.insertBefore(i,c) }(window,document,"script",ALGOLIA_INSIGHTS_SRC,"aa");</script><link rel="canonical" href="https://www.ajmc.com/approvals-launches"/><meta name="next-head-count" content="10"/><script async="" type="text/javascript" src="https://www.lightboxcdn.com/static/lightbox_mjh.js"></script><script defer="" src="https://res.lassomarketing.io/scripts/lasso-imp-id-min.js" type="text/javascript"></script> <script defer="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script> <script type="module"> !function(){var analytics=window.analytics=window.analytics||[];if(!analytics.initialize)if(analytics.invoked)window.console&&console.error&&console.error("Segment snippet included twice.");else{analytics.invoked=!0;analytics.methods=["trackSubmit","trackClick","trackLink","trackForm","pageview","identify","reset","group","track","ready","alias","debug","page","once","off","on","addSourceMiddleware","addIntegrationMiddleware","setAnonymousId","addDestinationMiddleware"];analytics.factory=function(e){return function(){var t=Array.prototype.slice.call(arguments);t.unshift(e);analytics.push(t);return analytics}};for(var e=0;e<analytics.methods.length;e++){var key=analytics.methods[e];analytics[key]=analytics.factory(key)}analytics.load=function(key,e){var t=document.createElement("script");t.type="text/javascript";t.async=!0;t.src="https://cdn.segment.com/analytics.js/v1/" + key + "/analytics.min.js";var n=document.getElementsByTagName("script")[0];n.parentNode.insertBefore(t,n);analytics._loadOptions=e};analytics.SNIPPET_VERSION="4.13.1"; window.LassoImpressionID = lassoImpID(); analytics.load("BBbKMoOjmhsxPnbd2nO6osz3zq67DzuN"); analytics.page({ 'LassoImpressionID': window.LassoImpressionID }); }}(); </script> <link rel="preload" href="/_next/static/css/a929bdd3e91026fa.css" as="style"/><link rel="stylesheet" href="/_next/static/css/a929bdd3e91026fa.css" data-n-g=""/><link rel="preload" href="/_next/static/css/1fd9d1dcb68b7a42.css" as="style"/><link rel="stylesheet" href="/_next/static/css/1fd9d1dcb68b7a42.css" data-n-p=""/><link rel="preload" href="/_next/static/css/73c00cd95dc66651.css" as="style"/><link rel="stylesheet" href="/_next/static/css/73c00cd95dc66651.css" data-n-p=""/><link rel="preload" href="/_next/static/css/0f1de527bcd6b2b3.css" as="style"/><link rel="stylesheet" href="/_next/static/css/0f1de527bcd6b2b3.css" data-n-p=""/><noscript data-n-css=""></noscript><script defer="" nomodule="" src="/_next/static/chunks/polyfills-c67a75d1b6f99dc8.js"></script><script src="/_next/static/chunks/webpack-961be11aea234f76.js" defer=""></script><script src="/_next/static/chunks/framework-45ce3d09104a2cae.js" defer=""></script><script src="/_next/static/chunks/main-c1ce322a402d266c.js" defer=""></script><script src="/_next/static/chunks/pages/_app-4bfd1e1c0348d790.js" defer=""></script><script src="/_next/static/chunks/8eec4907-bd18a9d50c17fbc1.js" defer=""></script><script src="/_next/static/chunks/065a3ddb-42216585c327b2a5.js" defer=""></script><script src="/_next/static/chunks/9814d858-cb162ab048445baf.js" defer=""></script><script src="/_next/static/chunks/69bd6bf3-c7219ac9ecb38ac9.js" defer=""></script><script src="/_next/static/chunks/f36c6662-e730e1316f9aa347.js" defer=""></script><script src="/_next/static/chunks/72585f70-0d4479e14d41a365.js" defer=""></script><script src="/_next/static/chunks/59b4e022-07228b5f1b83aaf8.js" defer=""></script><script src="/_next/static/chunks/aeb74aa0-4e0b515016d20a9f.js" defer=""></script><script src="/_next/static/chunks/e893f787-08b93252db7fc864.js" defer=""></script><script src="/_next/static/chunks/e1efa4cc-06e900eb45581c19.js" defer=""></script><script src="/_next/static/chunks/c8eae200-9f0c2beb62006a40.js" defer=""></script><script src="/_next/static/chunks/a29ae703-70c961c34719afa8.js" defer=""></script><script src="/_next/static/chunks/4592-37f767f9d2e595fc.js" defer=""></script><script src="/_next/static/chunks/1212-e69ee8c76b24c02a.js" defer=""></script><script src="/_next/static/chunks/4179-91956f2d2c4bf724.js" defer=""></script><script src="/_next/static/chunks/9879-c84885d45ee98d34.js" defer=""></script><script src="/_next/static/chunks/9355-c793747e2dd7fab4.js" defer=""></script><script src="/_next/static/chunks/3499-b4daf1c9382343af.js" defer=""></script><script src="/_next/static/chunks/4386-1eb6319d7e5f2437.js" defer=""></script><script src="/_next/static/chunks/8421-a4cb4c694745bc83.js" defer=""></script><script src="/_next/static/chunks/8412-bd07abe8ce76d08f.js" defer=""></script><script src="/_next/static/chunks/430-ec5773e97694cd78.js" defer=""></script><script src="/_next/static/chunks/173-14593f6d6b9517b7.js" defer=""></script><script src="/_next/static/chunks/7707-0911877d2791a102.js" defer=""></script><script src="/_next/static/chunks/475-8933b8b0e2730387.js" defer=""></script><script src="/_next/static/chunks/9323-fbb62165c37c2d73.js" defer=""></script><script src="/_next/static/chunks/4978-6a483c0f48f7ecb4.js" defer=""></script><script src="/_next/static/chunks/4063-f338377ebed73baf.js" defer=""></script><script src="/_next/static/chunks/pages/%5B...slug%5D-1b8b61a43bc98d83.js" defer=""></script><script src="/_next/static/IRrGcHGbYOSE-7JrEGg8a/_buildManifest.js" defer=""></script><script src="/_next/static/IRrGcHGbYOSE-7JrEGg8a/_ssgManifest.js" defer=""></script><style id="__jsx-1661e6713d4eb9b5">.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:90px;background:#fff}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5{}@media screen and (min-width:768px){.leader-fixed.jsx-1661e6713d4eb9b5{position:fixed;margin-top:1rem;z-index:999999}}.leaderboardAdWrapper.jsx-1661e6713d4eb9b5 .AD728x90.jsx-1661e6713d4eb9b5 div[id*="google_ads_iframe"].jsx-1661e6713d4eb9b5:empty{height:0px!important}@media screen and (max-width:668px){.leaderboardAdWrapper.jsx-1661e6713d4eb9b5{min-height:0px;position:fixed;background:white;left:0;right:0;top:55px;padding-top:.5rem;padding-bottom:.25rem;z-index:9999}}</style><style id="__jsx-ad50481d5ee26850">@media(min-width:980px)and (max-width:1200px){.article-detail.jsx-ad50481d5ee26850{width:47%}}@media(min-width:1201px)and (max-width:1400px){.article-detail.jsx-ad50481d5ee26850{width:55%}}</style></head><body><div id="__next" data-reactroot=""><div class="-mb-6"><div id="frame-nav" class="sticky top-0 z-[999999]"><div class="h-full w-full"><nav role="navigation" class=" w-full mx-auto hidden lg:block bg-white shadow-md relative"><div class="bg-primary" id="topnav"><div class="container px-4 relative justify-between h-16 flex items-center md:items-stretch mx-auto "><div class="h-full flex items-center flex-1 justify-between mr-4"><a role="img" aria-label="logo" class="focus:outline-none relative h-12 w-40 mr-6 flex items-center" href="/"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&w=640&q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&w=750&q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&w=828&q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1080&q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1200&q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1920&q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&w=2048&q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left" loading="lazy"/></noscript></span></a><div class="hidden md:block"><div class="bg-primary py-2 whitespace-nowrap"><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 items-end"><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">News<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/news" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All News</a><a href="/press-release" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Press Releases</a><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Video<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/video-hub" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All Video Types</a><a href="/interviews" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">AJMC TV</a><a href="/guidelines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Guidelines</a><a href="/insights" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insights</a><a href="/onlocation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">OnLocation</a><a href="/payer-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Payer Perspectives</a><a href="/peer-exchange" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Peer Exchange</a><a href="/post-conference-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Post Conference Perspectives</a><a href="/stakeholder-summit" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Stakeholder Summit</a></div></div><a class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center text-sm tracking-normal capitalize text-white" href="/podcasts">Podcasts</a><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Conferences<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/latest-conference" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Conference Coverage</a><a href="/conference" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Conference Listing</a><a href="/post-conference-perspectives" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Post Conference Perspectives</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Journals<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/publications" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">All Journals</a><a href="/publications/issue" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">The American Journal of Managed Care</a><a href="/publications/ajac" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health, Equity & Outcomes</a><a href="/publications/evidence-based-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Evidence-Based Oncology</a><a href="/supplement" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">About Supplements and Featured Publications</a><a href="/publications/supplement" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Supplements and Featured Publications Issues</a><a href="/submit-a-manuscript" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Submit a Manuscript</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Events<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/ivbmevents" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Institute for Value-Based Medicine</a><a href="https://pcoc.ajmc.com/" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Patient-Centered Oncology Care</a></div></div><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">Resources<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/interactive-tools" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Interactive Tools</a><a href="/formulary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Formulary Central</a><a href="/clinical-spotlight" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Clinical Spotlight</a><a href="/custom-email" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Microsites</a><a href="/sponsored" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sponsored Content</a></div></div><a class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center text-sm tracking-normal capitalize text-white" href="/continuing-education">CE</a><div class=" isolate z-[10000] " data-headlessui-state=""><button class="focus:outline-none border-b-2 border-transparent text-[15px] cursor-pointer h-full flex items-center tracking-normal capitalize text-white" type="button" aria-expanded="false" data-headlessui-state="">About AJMC<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><div class="sr-only"><a href="/editorial" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">AJMC Staff</a><a href="/anniversary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Anniversary</a><a href="/about/seema-sonnad-nomination" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Seema Sonnad Award</a><a href="/partners" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Strategic Alliance Partners</a></div></div></div></div></div></div></div><div class="md:flex items-center justify-end hidden"><div class="flex items-center"><div class="md:pr-10 lg:pr-0 h-full flex items-center"><button class="w-6 h-6 relative"><svg xmlns="http://www.w3.org/2000/svg" class="text-white stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></button><div class="hidden bg-secondary p-4 rounded shadow-lg top-16 right-0 overflow-hidden absolute grid place-items-center z-[99999] "><form method="GET" action="/search"><div class="relative"><div class="text-gray-600 absolute ml-3 inset-0 m-auto lg:w-4 lg:h-4 md:w-6 md:h-6"><button aria-label="submit" type="submit" class="absolute block inset-0"><svg xmlns="http://www.w3.org/2000/svg" class="text-gray-600 stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="2" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></button></div><input type="text" required="" name="searchTerm" class="block border border-gray-200 focus:outline-none focus:border-indigo-700 lg:w-48 xl:w-64 rounded text-sm text-gray-800 pl-8 py-2" placeholder="Search"/></div></form></div></div></div><a href="https://one.ajmc.com/subscribe" class="bg-subscribe-btn rounded text-white py-1.5 px-3 text-[14px] ml-4 uppercase font-semibold">Subscribe</a></div></div></div><div class="bg-white" id="bottomnav"><div style="max-height:60px" class="px-4 transition-all container justify-between h-14 flex items-center md:items-stretch mx-auto"><div class="h-full w-full flex items-center justify-between relative"><div class="flex flex-row gap-2 mr-4"><div class="relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Specialty Area<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Specialty Area" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/compendium/cardiorenalmetabolic" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiorenalmetabolic</a><a href="/compendium/cardiovascular" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiovascular</a><a href="/compendium/ckd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Chronic Kidney Disease</a><a href="/compendium/diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Diabetes</a><a href="/compendium/heart-failure" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Heart Failure</a><a href="/compendium/type1diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Type 1 Diabetes</a></div><div><a href="/compendium/dermatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Dermatology</a><a href="/compendium/alopecia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Alopecia</a><a href="/compendium/atopic-dermatitis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Atopic Dermatitis</a><a href="/compendium/psoriasis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Psoriasis</a></div><div><a href="/compendium/gastroenterology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gastroenterology</a></div><div><a href="/compendium/hematology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hematology</a><a href="/compendium/all" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">ALL/AML</a><a href="/compendium/cll" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">CLL/SLL</a><a href="/compendium/gvhd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">GVHD</a><a href="/compendium/hemophilia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hemophilia</a><a href="/compendium/multiple-myeloma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Myeloma</a><a href="/compendium/myelodysplastic-syndromes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myelodysplastic Syndromes</a><a href="/compendium/mpn" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myeloproliferative Neoplasms</a><a href="/compendium/nhl" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non-Hodgkin Lymphoma</a><a href="/compendium/rareblood" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Blood</a></div><div><a href="/compendium/hepatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hepatology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver</a></div><div><a href="/compendium/immunology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immunology</a><a href="/compendium/autoimmune" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Autoimmune</a><a href="/compendium/Inflammation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Inflammation</a><a href="/compendium/lupus" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lupus</a><a href="/compendium/myasthenia-gravis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myasthenia Gravis</a></div><div><a href="/compendium/infectious-disease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Infectious Disease</a><a href="/compendium/covid-19" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COVID-19</a><a href="/compendium/hiv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">HIV</a><a href="/compendium/rsv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">RSV</a><a href="/compendium/vaccines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Vaccines</a></div><div><a href="/compendium/mash" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">MASH</a></div><div><a href="/compendium/mental-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Mental Health</a><a href="/compendium/mdd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Major Depressive Disorder</a><a href="/compendium/sleep" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sleep</a></div><div><a href="/compendium/neurology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Neurology</a><a href="/compendium/dmd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Duchenne Muscular Dystrophy</a><a href="/compendium/epilepsy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Epilepsy</a><a href="/compendium/multiple-sclerosis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Sclerosis</a><a href="/compendium/parkinson" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Parkinson Disease</a></div><div><a href="/compendium/obesity" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Obesity</a></div><div><a href="/compendium/oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Oncology</a><a href="/compendium/breast-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Breast Cancer</a><a href="/compendium/cholangiocarcinoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cholangiocarcinoma</a><a href="/compendium/colorectal-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Colorectal Cancer</a><a href="/compendium/immuno-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immuno-Oncology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver Cancer</a><a href="/compendium/nsclc" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non–Small Cell Lung Cancer</a><a href="/compendium/ovarian-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ovarian Cancer</a><a href="/compendium/prostate-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Prostate Cancer</a><a href="/compendium/skincancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Skin Cancer</a><a href="/compendium/lung-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Small Cell Lung Cancer</a><a href="/compendium/soft-tissue-sarcoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Soft Tissue Sarcoma</a></div><div><a href="/compendium/ophthalmology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ophthalmology</a></div><div><a href="/compendium/pulmonology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonology</a><a href="/compendium/copd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COPD</a><a href="/compendium/pah" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonary Arterial Hypertension</a></div><div><a href="/compendium/raredisease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Disease</a><a href="/compendium/sma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Spinal Muscular Atrophy</a></div><div><a href="/compendium/respiratory" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Respiratory</a><a href="/compendium/asthma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Asthma</a><a href="/compendium/ipf" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Idiopathic Pulmonary Fibrosis</a></div><div><a href="/compendium/rheumatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rheumatology</a></div><div><a href="/compendium/womens-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Women's Health</a></div></nav></div></div></div></div></div></div><div class="relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Topics<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Topics" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/topic/center-on-health-equity-and-access" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Center on Health Equity & Access</a></div><div><a href="/compendium/digital-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Digital Health</a></div><div><a href="/formulary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Formulary</a></div><div><a href="/compendium/gene-therapy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gene Therapy</a></div><div><a href="/guidelines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Guidelines</a></div><div><a href="/topic/healthcare-cost" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Cost</a></div><div><a href="/topic/healthcare-delivery" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Delivery</a></div><div><a href="/topic/insurance" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insurance</a></div><div><a href="/topic/policy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Policy</a></div><div><a href="/compendium/population" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health</a></div><div><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div><div><a href="/topic/technology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Technology</a></div><div><a href="/topic/value-based-care" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Value-Based Care</a></div></nav></div></div></div></div></div></div></div><div class="flex flex-1 items-center gap-3 overflow-hidden justify-start"><span class="text-md font-semibold whitespace-pre !text-primary filter brightness-75">Spotlight</span><ul id="spotlight-links" class="flex gap-2 h-4 overflow-hidden flex-wrap"><li class="text-xs pt-0.5 whitespace-pre cursor-pointer hover:underline text-gray-800"><a href="/ivbmevents?display=home">Free In-Person Regional Events Focused on Oncology and Population Health</a></li></ul></div></div></div></div></nav><nav class="lg:hidden"><div class="w-full shadow-md bg-primary sticky top-0 z-40"><div class="flex mx-auto container"><div class=" py-4 flex items-stretch justify-between mx-4 items-center w-full"><div class="flex items-center justify-end"><div class="flex items-center"><div class="h-full flex items-center"><button id="menu" aria-label="open menu" aria-expanded="false" class="focus:outline-none focus:ring-2 focus:ring-gray-700 rounded-md text-white"><svg width="30" height="30" viewBox="0 0 24 24" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M21 10H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 6H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 14H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path><path d="M21 18H3" stroke="#fff" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"></path></svg></button></div></div></div><div aria-label="logo" role="img" tabindex="0" class="focus:outline-none relative h-10 w-40"><a role="img" aria-label="logo" class="focus:outline-none relative h-12 w-40 mr-6 flex items-center" href="/"><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:center"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&w=640&q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&w=750&q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&w=828&q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1080&q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1200&q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1920&q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&w=2048&q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:center" loading="lazy"/></noscript></span></a></div><div class="relative w-8 h-8 my grid items-center"><a class="absolute lg:hidden inset-0 mt-1" href="/search"><svg xmlns="http://www.w3.org/2000/svg" class="text-white stroke-current icon icon-tabler icon-tabler-search" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor" fill="none" stroke-linecap="round" stroke-linejoin="round"><path stroke="none" d="M0 0h24v24H0z"></path><circle cx="10" cy="10" r="7"></circle><line x1="21" y1="21" x2="15" y2="15"></line></svg></a></div></div></div><div style="max-height:50px" class="bg-white px-4 transition-all h-12 md:items-stretch mx-auto" id="bottomnav-mobile"><div class="container justify-between h-12 flex items-center md:items-stretch mx-auto"><div class="h-full w-full flex items-center justify-between relative"><div class="flex flex-1 justify-center xs:justify-start items-center relative group h-full z-50 gap-2"><div class="z-1 relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Specialty Area<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Specialty Area" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/compendium/cardiorenalmetabolic" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiorenalmetabolic</a><a href="/compendium/cardiovascular" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cardiovascular</a><a href="/compendium/ckd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Chronic Kidney Disease</a><a href="/compendium/diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Diabetes</a><a href="/compendium/heart-failure" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Heart Failure</a><a href="/compendium/type1diabetes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Type 1 Diabetes</a></div><div><a href="/compendium/dermatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Dermatology</a><a href="/compendium/alopecia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Alopecia</a><a href="/compendium/atopic-dermatitis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Atopic Dermatitis</a><a href="/compendium/psoriasis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Psoriasis</a></div><div><a href="/compendium/gastroenterology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gastroenterology</a></div><div><a href="/compendium/hematology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hematology</a><a href="/compendium/all" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">ALL/AML</a><a href="/compendium/cll" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">CLL/SLL</a><a href="/compendium/gvhd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">GVHD</a><a href="/compendium/hemophilia" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hemophilia</a><a href="/compendium/multiple-myeloma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Myeloma</a><a href="/compendium/myelodysplastic-syndromes" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myelodysplastic Syndromes</a><a href="/compendium/mpn" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myeloproliferative Neoplasms</a><a href="/compendium/nhl" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non-Hodgkin Lymphoma</a><a href="/compendium/rareblood" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Blood</a></div><div><a href="/compendium/hepatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Hepatology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver</a></div><div><a href="/compendium/immunology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immunology</a><a href="/compendium/autoimmune" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Autoimmune</a><a href="/compendium/Inflammation" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Inflammation</a><a href="/compendium/lupus" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Lupus</a><a href="/compendium/myasthenia-gravis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Myasthenia Gravis</a></div><div><a href="/compendium/infectious-disease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Infectious Disease</a><a href="/compendium/covid-19" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COVID-19</a><a href="/compendium/hiv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">HIV</a><a href="/compendium/rsv" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">RSV</a><a href="/compendium/vaccines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Vaccines</a></div><div><a href="/compendium/mash" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">MASH</a></div><div><a href="/compendium/mental-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Mental Health</a><a href="/compendium/mdd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Major Depressive Disorder</a><a href="/compendium/sleep" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Sleep</a></div><div><a href="/compendium/neurology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Neurology</a><a href="/compendium/dmd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Duchenne Muscular Dystrophy</a><a href="/compendium/epilepsy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Epilepsy</a><a href="/compendium/multiple-sclerosis" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Multiple Sclerosis</a><a href="/compendium/parkinson" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Parkinson Disease</a></div><div><a href="/compendium/obesity" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Obesity</a></div><div><a href="/compendium/oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Oncology</a><a href="/compendium/breast-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Breast Cancer</a><a href="/compendium/cholangiocarcinoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Cholangiocarcinoma</a><a href="/compendium/colorectal-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Colorectal Cancer</a><a href="/compendium/immuno-oncology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Immuno-Oncology</a><a href="/compendium/liver-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Liver Cancer</a><a href="/compendium/nsclc" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Non–Small Cell Lung Cancer</a><a href="/compendium/ovarian-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ovarian Cancer</a><a href="/compendium/prostate-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Prostate Cancer</a><a href="/compendium/skincancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Skin Cancer</a><a href="/compendium/lung-cancer" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Small Cell Lung Cancer</a><a href="/compendium/soft-tissue-sarcoma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Soft Tissue Sarcoma</a></div><div><a href="/compendium/ophthalmology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Ophthalmology</a></div><div><a href="/compendium/pulmonology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonology</a><a href="/compendium/copd" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">COPD</a><a href="/compendium/pah" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Pulmonary Arterial Hypertension</a></div><div><a href="/compendium/raredisease" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rare Disease</a><a href="/compendium/sma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Spinal Muscular Atrophy</a></div><div><a href="/compendium/respiratory" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Respiratory</a><a href="/compendium/asthma" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Asthma</a><a href="/compendium/ipf" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Idiopathic Pulmonary Fibrosis</a></div><div><a href="/compendium/rheumatology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Rheumatology</a></div><div><a href="/compendium/womens-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Women's Health</a></div></nav></div></div></div></div></div></div><div class="z-1 relative"><div class="block"><div class=""><div class="mx-auto md:max-w-4xl lg:max-w-5xl xl:max-w-7xl "><div class="flex gap-4 justify-start"><div class=" isolate z-[9999] " data-headlessui-state=""><button class="focus:outline-none rounded font-medium cursor-pointer h-full flex items-center text-xs md:text-sm h-[34px] px-2 py-2 md:px-4 tracking-normal capitalize brightness-[85%] bg-primary text-gray-50 lg:min-w-[140px] justify-between" type="button" aria-expanded="false" data-headlessui-state="">Topics<svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 24 24" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="m11.998 17 7-8h-14z"></path></svg></button><nav role="navigation" aria-label="Topics" class="sr-only"><div><a href="/compendium/biosimilars" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Biosimilars</a></div><div><a href="/topic/center-on-health-equity-and-access" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Center on Health Equity & Access</a></div><div><a href="/compendium/digital-health" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Digital Health</a></div><div><a href="/formulary" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Formulary</a></div><div><a href="/compendium/gene-therapy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Gene Therapy</a></div><div><a href="/guidelines" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Guidelines</a></div><div><a href="/topic/healthcare-cost" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Cost</a></div><div><a href="/topic/healthcare-delivery" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Health Care Delivery</a></div><div><a href="/topic/insurance" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Insurance</a></div><div><a href="/topic/policy" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Policy</a></div><div><a href="/compendium/population" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Population Health</a></div><div><a href="/approvals-launches" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Product Approvals and Launches</a></div><div><a href="/topic/technology" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Technology</a></div><div><a href="/topic/value-based-care" class="flex gap-x-4 py-2 text-sm font-semibold leading-6 text-blue-600 underline">Value-Based Care</a></div></nav></div></div></div></div></div></div></div></div></div></div></div><div class="fixed top-0 w-[85vw] h-full transform -translate-x-full z-40 transition duration-300 lg:hidden min-h-screen bg-primary shadow-lg" id="mobile-nav"><div class="w-full h-full shadow-lg z-40 fixed overflow-y-auto top-0 flex-col justify-between xl:hidden pb-4 transition duration-500 ease-in-out"><div class="px-5 h-full"><div class="flex flex-col justify-between h-full w-full"><div><div class="mt-6 flex w-full items-center justify-between"><div class="border-b border-gray-200 pb-2 flex items-center justify-between w-full"><div aria-label="logo" role="img" tabindex="0" class="focus:outline-none relative h-16 w-40 "><span style="box-sizing:border-box;display:block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:absolute;top:0;left:0;bottom:0;right:0"><img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left"/><noscript><img sizes="100vw" srcSet="/_next/image?url=%2Fajmc_logo_inverted.png&w=640&q=75 640w, /_next/image?url=%2Fajmc_logo_inverted.png&w=750&q=75 750w, /_next/image?url=%2Fajmc_logo_inverted.png&w=828&q=75 828w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1080&q=75 1080w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1200&q=75 1200w, /_next/image?url=%2Fajmc_logo_inverted.png&w=1920&q=75 1920w, /_next/image?url=%2Fajmc_logo_inverted.png&w=2048&q=75 2048w, /_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75 3840w" src="/_next/image?url=%2Fajmc_logo_inverted.png&w=3840&q=75" decoding="async" data-nimg="fill" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%;object-fit:contain;object-position:left" loading="lazy"/></noscript></span></div><button aria-label="close menu" class="focus:outline-none focus:ring-2 rounded-md text-white pl-8 font-bold"><svg width="18" height="18" viewBox="0 0 14 14" fill="#fff" xmlns="http://www.w3.org/2000/svg"><path d="M13 1L1 13" stroke="#fff" stroke-linecap="round" stroke-width="2" stroke-linejoin="round"></path><path d="M1 1L13 13" stroke="#fff" stroke-linecap="round" stroke-width="2" stroke-linejoin="round"></path></svg></button></div></div><ul role="list" class="flex flex-1 flex-col gap-y-7 mt-6"><li><ul role="list" class="-mx-2 space-y-1"><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Spotlight</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>News</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Video</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="/podcasts"><span>Podcasts</span></a></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Conferences</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Journals</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Events</button></div></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>Resources</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="/continuing-education"><span>CE</span></a></li><li><div data-headlessui-state=""><button class="hover:bg-gray-500 flex items-center w-full text-left p-2 gap-x-3 text-sm leading-6 font-semibold text-gray-50" id="headlessui-disclosure-button-undefined" type="button" aria-expanded="false" data-headlessui-state=""><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 320 512" class="text-gray-50 h-5 w-5 shrink-0" aria-hidden="true" height="1em" width="1em" xmlns="http://www.w3.org/2000/svg"><path d="M285.476 272.971L91.132 467.314c-9.373 9.373-24.569 9.373-33.941 0l-22.667-22.667c-9.357-9.357-9.375-24.522-.04-33.901L188.505 256 34.484 101.255c-9.335-9.379-9.317-24.544.04-33.901l22.667-22.667c9.373-9.373 24.569-9.373 33.941 0L285.475 239.03c9.373 9.372 9.373 24.568.001 33.941z"></path></svg>About AJMC</button></div></li><li><a class="hover:bg-gray-500 block rounded-md py-2 pr-2 pl-10 text-sm leading-6 font-semibold text-gray-50" href="https://one.ajmc.com/subscribe"><span>Subscribe</span></a></li></ul></li></ul><div class="flex md:hidden mt-4 items-center gap-2 mt-6 pt-6 border-t"><a rel="noreferrer noopener" target="_blank" href="https://www.facebook.com/TheAmericanJournalOfManagedCare"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="24" width="24" xmlns="http://www.w3.org/2000/svg"><path d="M400 32H48A48 48 0 0 0 0 80v352a48 48 0 0 0 48 48h137.25V327.69h-63V256h63v-54.64c0-62.15 37-96.48 93.67-96.48 27.14 0 55.52 4.84 55.52 4.84v61h-31.27c-30.81 0-40.42 19.12-40.42 38.73V256h68.78l-11 71.69h-57.78V480H400a48 48 0 0 0 48-48V80a48 48 0 0 0-48-48z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="https://twitter.com/AJMC_Journal"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" width="21" height="21" viewBox="12.65 12.65 118.02 118.02"><g transform="translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)"><path d="M 11 4 C 7.134 4 4 7.134 4 11 L 4 39 C 4 42.866 7.134 46 11 46 L 39 46 C 42.866 46 46 42.866 46 39 L 46 11 C 46 7.134 42.866 4 39 4 L 11 4 z M 13.085938 13 L 21.023438 13 L 26.660156 21.009766 L 33.5 13 L 36 13 L 27.789062 22.613281 L 37.914062 37 L 29.978516 37 L 23.4375 27.707031 L 15.5 37 L 13 37 L 22.308594 26.103516 L 13.085938 13 z M 16.914062 15 L 31.021484 35 L 34.085938 35 L 19.978516 15 L 16.914062 15 z" fill="#FFFFFF"></path></g></svg></a><a rel="noreferrer noopener" target="_blank" href="https://www.linkedin.com/company/american-journal-of-managed-care/"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="27" width="27" xmlns="http://www.w3.org/2000/svg"><path d="M416 32H31.9C14.3 32 0 46.5 0 64.3v383.4C0 465.5 14.3 480 31.9 480H416c17.6 0 32-14.5 32-32.3V64.3c0-17.8-14.4-32.3-32-32.3zM135.4 416H69V202.2h66.5V416zm-33.2-243c-21.3 0-38.5-17.3-38.5-38.5S80.9 96 102.2 96c21.2 0 38.5 17.3 38.5 38.5 0 21.3-17.2 38.5-38.5 38.5zm282.1 243h-66.4V312c0-24.8-.5-56.7-34.5-56.7-34.6 0-39.9 27-39.9 54.9V416h-66.4V202.2h63.7v29.2h.9c8.9-16.8 30.6-34.5 62.9-34.5 67.2 0 79.7 44.3 79.7 101.9V416z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="https://www.instagram.com/ajmcjournal/"><svg stroke="currentColor" fill="currentColor" stroke-width="0" viewBox="0 0 448 512" color="#fff" style="color:#fff" height="24" width="24" xmlns="http://www.w3.org/2000/svg"><path d="M224,202.66A53.34,53.34,0,1,0,277.36,256,53.38,53.38,0,0,0,224,202.66Zm124.71-41a54,54,0,0,0-30.41-30.41c-21-8.29-71-6.43-94.3-6.43s-73.25-1.93-94.31,6.43a54,54,0,0,0-30.41,30.41c-8.28,21-6.43,71.05-6.43,94.33S91,329.26,99.32,350.33a54,54,0,0,0,30.41,30.41c21,8.29,71,6.43,94.31,6.43s73.24,1.93,94.3-6.43a54,54,0,0,0,30.41-30.41c8.35-21,6.43-71.05,6.43-94.33S357.1,182.74,348.75,161.67ZM224,338a82,82,0,1,1,82-82A81.9,81.9,0,0,1,224,338Zm85.38-148.3a19.14,19.14,0,1,1,19.13-19.14A19.1,19.1,0,0,1,309.42,189.74ZM400,32H48A48,48,0,0,0,0,80V432a48,48,0,0,0,48,48H400a48,48,0,0,0,48-48V80A48,48,0,0,0,400,32ZM382.88,322c-1.29,25.63-7.14,48.34-25.85,67s-41.4,24.63-67,25.85c-26.41,1.49-105.59,1.49-132,0-25.63-1.29-48.26-7.15-67-25.85s-24.63-41.42-25.85-67c-1.49-26.42-1.49-105.61,0-132,1.29-25.63,7.07-48.34,25.85-67s41.47-24.56,67-25.78c26.41-1.49,105.59-1.49,132,0,25.63,1.29,48.33,7.15,67,25.85s24.63,41.42,25.85,67.05C384.37,216.44,384.37,295.56,382.88,322Z"></path></svg></a><a rel="noreferrer noopener" target="_blank" href="/rss"></a></div></div></div></div></div></div></nav></div></div><div class="container top-ad-div px-4 mx-auto pl-2 pr-2 sm:h-[98px] sm:w-[728px]"><div id="leaderboardWrapper" class="jsx-1661e6713d4eb9b5 leaderboardAdWrapper mx-auto mt-1 flex min-h-0 md:min-h-[90px] justify-center items-center flex-col relative z-[99999] "><div class="jsx-1661e6713d4eb9b5 bg-white md:-translate-x-4"><div class="jsx-1661e6713d4eb9b5 text-[8px] text-center text-gray-600 hidden relative">Advertisement</div><div id="div-gpt-ad-top" class="jsx-1661e6713d4eb9b5 AD728x90 mx-auto text-center x"></div></div></div></div><hr class="mt-8 pt-8 -mb-4 pb-0"/><div class="container mx-auto flex m-1 min-h-[57vh] px-4"><div class="flex-auto w-[calc(100%-300px)] pr-0 md:pr-6 mt-16 sm:mt-0"><div class="pb-24 my-2"><h1 class="text-3xl mt-4">Product Approvals and Launches</h1><div id="description-summary" class="py-2 text-[#444444] text-gray-500"><div class="blockText_blockContent__TbCXh"><p class="pb-2">The <em>AJMC</em><sup class="text-inherit">® </sup>Product Approvals and Launches page will cover the latest FDA product approvals, as well as product launches in the United States.</p></div></div><div class="px-6 sm:px-0 flex flex-wrap w-full"><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-1"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/risdiplam-tablet-for-spinal-muscular-atropy-receives-fda-approval"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/2f366a4ab7421a6a697b539c22b8aedf46713899-6000x4000.jpg?fit=crop&auto=format" alt="FDA approval. | Image Credit: syahrir - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 12th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/risdiplam-tablet-for-spinal-muscular-atropy-receives-fda-approval">Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/giuliana-grossi">Giuliana Grossi</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/risdiplam-tablet-for-spinal-muscular-atropy-receives-fda-approval"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral solution.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-mirdametinib-for-neurofibromatosis-type-1-with-plexiform-neurofibromas"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA approved. | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 12th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-mirdametinib-for-neurofibromatosis-type-1-with-plexiform-neurofibromas">FDA Approves Mirdametinib for Neurofibromatosis Type 1 With Plexiform Neurofibromas</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/giuliana-grossi">Giuliana Grossi</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-mirdametinib-for-neurofibromatosis-type-1-with-plexiform-neurofibromas"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable to complete surgical resection are indicated in the approval.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-brentuximab-vedotin-lenalidomide-rituximab-triplet-for-r-r-lbcl"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/ff9ffbca858fbb2833bf65b18c99e5a9c74b8707-1200x738.jpg?fit=crop&auto=format" alt="FDA approval | Image Credit: © wladimir1804 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">Published: February 12th 2025 | Updated: February 12th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-brentuximab-vedotin-lenalidomide-rituximab-triplet-for-r-r-lbcl">FDA Approves Brentuximab Vedotin, Lenalidomide, Rituximab Triplet for R/R LBCL</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/maggie-l-shaw">Maggie L. Shaw</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-brentuximab-vedotin-lenalidomide-rituximab-triplet-for-r-r-lbcl"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Interim data from the ECHELON-3 trial previously showed that adding brentuximab vedotin to lenalidomide and rituximab improved overall survival among patients who have relapsed or refractory large B-cell lymphoma (R/R LBCL).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/bimzelx-expands-treatment-options-for-inflammatory-conditions"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/6423a9f30c8bc429e9005755f0b06b2c4bd99078-1893x986.png?fit=crop&auto=format" alt="Jeff Stark, MD, vice president, head of medical immunology, UCB." width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 10th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/bimzelx-expands-treatment-options-for-inflammatory-conditions">Bimekizumab-bkzx Expands Treatment Options for Inflammatory Conditions</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/cameron-santoro">Cameron Santoro</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/maggie-l-shaw">Maggie L. Shaw</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/jeffrey-stark-md">Jeffrey Stark, MD</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/bimzelx-expands-treatment-options-for-inflammatory-conditions"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals and the remaining challenges.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/evolent-s-wonsettler-sees-outcomes-based-reimbursement-as-a-healthy-tool-"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/8aa43400435897ab5bb0a33acb12825a618857bf-323x323.jpg?fit=crop&auto=format" alt="Terra Wonsettler, PharmD, MBA | Image credit: Evolent" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 7th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/evolent-s-wonsettler-sees-outcomes-based-reimbursement-as-a-healthy-tool-">Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/interview-by-mary-caffrey">Interview by Mary Caffrey</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/terra-wonsettler-pharmd-mba">Terra Wonsettler, PharmD, MBA</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/evolent-s-wonsettler-sees-outcomes-based-reimbursement-as-a-healthy-tool-"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-approval-offers-novel-option-for-allo-hsct-conditioning-in-aml-mds"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b60f4e85aeb9d33a7da0658f96541e8b5373838c-1032x574.png?fit=crop&auto=format" alt="Mikkael Sekeres, MD" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 7th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-approval-offers-novel-option-for-allo-hsct-conditioning-in-aml-mds">Treosulfan Approval Offers Novel Option for Allo-HSCT Conditioning in AML/MDS</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/rose-mcnulty">Rose McNulty</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/mikkael-a-sekeres-md">Mikkael A. Sekeres, MD</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-approval-offers-novel-option-for-allo-hsct-conditioning-in-aml-mds"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT) conditioning in acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-7"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-shown-effective-safe-as-conditioning-for-allo-hsct-in-aml-mds"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/10bc2cb3804d6a94f413d9a5cb8071be332f7ad5-724x404.png?fit=crop&auto=format" alt="Mikkael Sekeres, MD" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 6th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-shown-effective-safe-as-conditioning-for-allo-hsct-in-aml-mds">Treosulfan Shown Effective, Safe as Conditioning for Allo-HSCT in AML/MDS</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/mikkael-a-sekeres-md">Mikkael A. Sekeres, MD</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/rose-mcnulty">Rose McNulty</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-shown-effective-safe-as-conditioning-for-allo-hsct-in-aml-mds"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Mikkael A. Sekeres, MD, of Sylvester Comprehensive Cancer Center, University of Miami, discussed data supporting the FDA approval of treosulfan as part of conditioning for allogeneic hematopoeitic stem cell transplantation (allo-HSCT). </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/dr-jeff-stark-new-bimzelx-dose-offers-simplicity-and-choice"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/893e836b204582bb2c27b9679b0ceab9e719963e-1200x675.jpg?fit=crop&auto=format" alt="Jeff Stark, MD, UCB" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 6th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/dr-jeff-stark-new-bimzelx-dose-offers-simplicity-and-choice">Dr Jeff Stark: New Bimzelx Dose Offers Simplicity and Choice</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/maggie-l-shaw">Maggie L. Shaw</a><span class="jsx-ad50481d5ee26850 mr-1 ml-[1px]"> </span><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/jeff-stark-md">Jeff Stark, MD</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/dr-jeff-stark-new-bimzelx-dose-offers-simplicity-and-choice"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-subcutaneous-apomorphine-device-for-parkinson-disease"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/8f653113486fc52cd1daac9f7124732eb4da7809-1200x800.jpg?fit=crop&auto=format" alt="Parkinson disease | Image credit: wladimir1804 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">February 4th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-subcutaneous-apomorphine-device-for-parkinson-disease">FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/skylar-jeremias">Skylar Jeremias</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-subcutaneous-apomorphine-device-for-parkinson-disease"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-ranibizumab-injection-in-treatment-of-dme"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA approved. | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">Published: February 4th 2025 | Updated: February 4th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-ranibizumab-injection-in-treatment-of-dme">FDA Approves Ranibizumab Implant in Treatment of DME</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/julia-bonavitacola">Julia Bonavitacola</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-ranibizumab-injection-in-treatment-of-dme"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year for the treatment of diabetic macular edema (DME).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-celltrion-s-tocilizumab-anoh-biosimilar-to-actemra"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/a0cb6495daeaee9e3fb7822d0e083c4ace68041e-6000x4000.jpg?fit=crop&auto=format" alt="FDA approved. | Image Credit: Olivier Le Moal - stock.adobe.com " width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 31st 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-celltrion-s-tocilizumab-anoh-biosimilar-to-actemra">FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/cameron-santoro">Cameron Santoro</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-celltrion-s-tocilizumab-anoh-biosimilar-to-actemra"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients. </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/suzetrigine-the-first-non-opiate-pain-therapy-is-fda-approved"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/2f366a4ab7421a6a697b539c22b8aedf46713899-6000x4000.jpg?fit=crop&auto=format" alt="Image Credit: Image Credit: syahrir - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 31st 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/suzetrigine-the-first-non-opiate-pain-therapy-is-fda-approved">Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/giuliana-grossi">Giuliana Grossi</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/suzetrigine-the-first-non-opiate-pain-therapy-is-fda-approved"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as a selective NaV1.8 pain signal inhibitor, an alternative to opiates.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-13"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-companion-diagnostic-for-tovorafenib-in-braf-altered-pediatric-low-grade-glioma"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/d7d2fd821f87077daeef38311eebbe230514ccf3-1200x738.jpg?fit=crop&auto=format" alt="FDA Approval | Image credit: wladimir1804 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 29th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-companion-diagnostic-for-tovorafenib-in-braf-altered-pediatric-low-grade-glioma">FDA Approves Companion Diagnostic for Tovorafenib in BRAF-Altered Pediatric Low-Grade Glioma</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/ashling-wahner">Ashling Wahner</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-companion-diagnostic-for-tovorafenib-in-braf-altered-pediatric-low-grade-glioma"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Tovorafenib generated durable drug holiday responses in pediatric patients with BRAF-altered relapsed/refractory low-grade glioma.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-expands-semaglutide-use-for-cv-kidney-risks-in-t2d-ckd"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/a5d351e64efb13433b50de220709d3d9d11705d2-4610x3254.jpg?fit=crop&auto=format" alt="FDA approval | image credit: Aquir - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 28th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-expands-semaglutide-use-for-cv-kidney-risks-in-t2d-ckd">FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/kyle-munz">Kyle Munz</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-expands-semaglutide-use-for-cv-kidney-risks-in-t2d-ckd"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks. </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-regimen-approved-for-allohsct-conditioning-in-aml-mds"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA approved. | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 23rd 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-regimen-approved-for-allohsct-conditioning-in-aml-mds">Treosulfan Regimen Approved for Allo-HSCT Conditioning in AML/MDS</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/rose-mcnulty">Rose McNulty</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/treosulfan-regimen-approved-for-allohsct-conditioning-in-aml-mds"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult and pediatric patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). </div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/esketamine-approved-by-fda-as-first-monotherapy-for-treatment-resistent-depression"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA approved. | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 21st 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/esketamine-approved-by-fda-as-first-monotherapy-for-treatment-resistent-depression">Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/giuliana-grossi">Giuliana Grossi</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/esketamine-approved-by-fda-as-first-monotherapy-for-treatment-resistent-depression"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD) with inadequate response to at least 2 oral antidepressants.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-grants-2-traditional-approvals-for-acalabrutinib"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/d7d2fd821f87077daeef38311eebbe230514ccf3-1200x738.jpg?fit=crop&auto=format" alt="FDA approval | Image Credit: © wladimir1804 - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 17th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-grants-2-traditional-approvals-for-acalabrutinib">FDA Grants 2 Traditional Approvals for Acalabrutinib</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/maggie-l-shaw">Maggie L. Shaw</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-grants-2-traditional-approvals-for-acalabrutinib"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated mantle cell lymphoma (MCL) ineligible for autologous hematopoietic stem cell transplantation and as monotherapy in previously treated MCL.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-sotorasib-plus-panitumumab-for-kras-g12c-mutated-metastatic-crc"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/407d27c5fd74836a18293620e5dbacab64d631cd-2000x2000.jpg?fit=crop&auto=format" alt="FDA Approved" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 17th 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-sotorasib-plus-panitumumab-for-kras-g12c-mutated-metastatic-crc">FDA Approves Sotorasib Plus Panitumumab for KRAS G12C-Mutated Metastatic CRC</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/julia-bonavitacola">Julia Bonavitacola</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-sotorasib-plus-panitumumab-for-kras-g12c-mutated-metastatic-crc"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free survival.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-19"></div></div></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-tislelizumab-jsgr-as-first-line-therapy-for-her2-gastric-cancers"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/504d2d94cf61879727ad2313dbe018741c0aef00-3600x2400.jpg?fit=crop&auto=format" alt="gastric cancer | Image credit: Crystal light - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">January 2nd 2025</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-tislelizumab-jsgr-as-first-line-therapy-for-her2-gastric-cancers">FDA Approves Tislelizumab-jsgr as First-Line Therapy for HER2– Gastric Cancers</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/skylar-jeremias">Skylar Jeremias</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-tislelizumab-jsgr-as-first-line-therapy-for-her2-gastric-cancers"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic HER2-negative (HER–) gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/5-key-drug-approvals-and-crls-in-2024"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="Paper with FDA approved on top of a magnifying glass and a keyboard | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 27th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/5-key-drug-approvals-and-crls-in-2024">5 Key Drug Approvals and CRLs in 2024</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/laura-joszt">Laura Joszt, MA</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/5-key-drug-approvals-and-crls-in-2024"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug, but patients with schizophrenia gained the first new treatment with a new mechanism of action in decades.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/first-subcutaneous-prophylaxis-for-hemophilia-a-and-b-with-inhibitors-approved-by-fda"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/9218bd8ec17bcbd1f819d87da6b7afbff7b24fdf-1200x738.jpg?fit=crop&auto=format" alt="FDA-Deni-stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 23rd 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/first-subcutaneous-prophylaxis-for-hemophilia-a-and-b-with-inhibitors-approved-by-fda">First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/giuliana-grossi">Giuliana Grossi</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/first-subcutaneous-prophylaxis-for-hemophilia-a-and-b-with-inhibitors-approved-by-fda"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with inhibitors by preventing or reducing bleeding episodes in adults and children 12 years and older.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-generic-daily-glp-1-injection-for-type-2-diabetes"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 23rd 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-generic-daily-glp-1-injection-for-type-2-diabetes">FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/rose-mcnulty">Rose McNulty</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-first-generic-daily-glp-1-injection-for-type-2-diabetes"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-sotagliflozin-for-type-1-diabetes-lexicon-shifts-focus"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/ebfb40d061db8cb94776018fe5f4c50f7871539b-5293x3529.jpg?fit=crop&auto=format" alt="FDA website | Image credit: Postmodern Studio – stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 20th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-sotagliflozin-for-type-1-diabetes-lexicon-shifts-focus">FDA Rejects Sotagliflozin for Type 1 Diabetes; Lexicon Shifts Focus</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-sotagliflozin-for-type-1-diabetes-lexicon-shifts-focus"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA issued a complete response letter for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-encorafenib-with-cetuximab-and-mfolfox6-for-metastatic-crc"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/407d27c5fd74836a18293620e5dbacab64d631cd-2000x2000.jpg?fit=crop&auto=format" alt="FDA Approved" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 20th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-encorafenib-with-cetuximab-and-mfolfox6-for-metastatic-crc">FDA Approves Encorafenib With Cetuximab and mFOLFOX6 for Metastatic CRC</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/julia-bonavitacola">Julia Bonavitacola</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-encorafenib-with-cetuximab-and-mfolfox6-for-metastatic-crc"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Patients with the BRAF V600E mutation and metastatic colorectal cancer (CRC) can be treated with a combination of encorafenib with cetuximab and mFOLFOX6.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div><div><div class="text-[8px] text-center text-gray-500 hidden">Advertisement</div><div id="div-gpt-ad-infeed-25"></div></div></div><div class="jsx-ad50481d5ee26850 flex md:hidden justify-center items-center"></div><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-seventh-ustekinumab-biosimilar-to-reference-stelara"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/ca845f7e6dfc35ab2f006b74744bb6c3a34fff11-5500x4093.jpg?fit=crop&auto=format" alt="FDA approval with stamp. | Image Credit: Surendra - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 20th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-seventh-ustekinumab-biosimilar-to-reference-stelara">FDA Approves Seventh Ustekinumab Biosimilar to Reference Stelara</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/cameron-santoro">Cameron Santoro</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-approves-seventh-ustekinumab-biosimilar-to-reference-stelara"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to reference Stelara after a year of multiple ustekinumab biosimilar approvals.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/ensartinib-receives-fda-approval-for-alk-positive-locally-advanced-or-metastatic-nsclc"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/b0002ea79080e3493345e3c993b00be4690f0087-4279x2706.jpg?fit=crop&auto=format" alt="FDA approval. | Image Credit: Pawel - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 19th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/ensartinib-receives-fda-approval-for-alk-positive-locally-advanced-or-metastatic-nsclc">Ensartinib Receives FDA Approval for ALK-Positive Locally Advanced or Metastatic NSCLC</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/cameron-santoro">Cameron Santoro</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/ensartinib-receives-fda-approval-for-alk-positive-locally-advanced-or-metastatic-nsclc"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naive to ALK treatment.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-subcutaneous-amivantamab-for-nsclc-over-manufacturing-concerns"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/1b0ea624bff10262e2da3d5ec75d235207a08adc-1200x630.jpg?fit=crop&auto=format" alt="Syringe and vials | Image credit: Aliaksandr Marko – stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 17th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-subcutaneous-amivantamab-for-nsclc-over-manufacturing-concerns">FDA Rejects Subcutaneous Amivantamab for NSCLC Over Manufacturing Concerns</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/fda-rejects-subcutaneous-amivantamab-for-nsclc-over-manufacturing-concerns"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Subcutaneous amivantamab joins a growing list of drugs receiving complete response letters due to manufacturing facility issues.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/cosibelimab-approved-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/3deabc81aa93f0e49190012e256a274872b958e8-4363x3438.jpg?fit=crop&auto=format" alt="FDA approved stamp in black with a red ribbon across it | Image credit: BHM - stock.adobe.com" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 16th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/cosibelimab-approved-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma">Cosibelimab Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/kristi-rosa">Kristi Rosa</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/cosibelimab-approved-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">The FDA has approved cosibelimab-ipdl for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/durvalumab-approval-redefines-resectable-nsclc-treatment-strategies"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/1ec091ec5293e43b6addd5389b5c28855d74083a-2549x1426.png?fit=crop&auto=format" alt="Martin Dietrich, MD, PhD" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 13th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/durvalumab-approval-redefines-resectable-nsclc-treatment-strategies">Durvalumab Approval Redefines Resectable NSCLC Treatment Strategies</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/hayden-e-klein">Hayden E. Klein</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/durvalumab-approval-redefines-resectable-nsclc-treatment-strategies"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage non–small cell lung cancer (NSCLC).</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div><div class="jsx-ad50481d5ee26850 w-full h-full"><div class="jsx-ad50481d5ee26850 flex flex-col sm:flex-row justify-between my-4 "><a class="jsx-ad50481d5ee26850" href="/view/next-gen-strategies-for-resistance-in-egfr-mutated-lung-cancer"><img src="https://cdn.sanity.io/images/0vv8moc6/ajmc/398f81181f2692ac562b24bc01c26f9ba8dd0284-1200x675.jpg?fit=crop&auto=format" alt="Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center" width="288" class="jsx-ad50481d5ee26850 max-h-[200px] xs:w-[288px] "/></a><div class="jsx-ad50481d5ee26850 article-detail flex flex-col gap-[0.2rem] w-full sm:w-[46%] md:w-[65%]"><span class="jsx-ad50481d5ee26850 article-publish-date block italic text-sm text-gray-500 mt-[1rem] sm:mt-0">December 13th 2024</span><p class="jsx-ad50481d5ee26850 article-title font-bold text-[1rem]"><a class="jsx-ad50481d5ee26850" href="/view/next-gen-strategies-for-resistance-in-egfr-mutated-lung-cancer">Next-Gen Strategies for Resistance in EGFR-Mutated Lung Cancer</a></p><div class="jsx-ad50481d5ee26850 authors flex-row wrap gap-[0.2rem]"><a class="jsx-ad50481d5ee26850 text-[#00ADEF] underline text-sm italic" href="/authors/maggie-l-shaw">Maggie L. Shaw</a></div><div class="jsx-ad50481d5ee26850 article-summary"><a class="jsx-ad50481d5ee26850" href="/view/next-gen-strategies-for-resistance-in-egfr-mutated-lung-cancer"><div class="jsx-ad50481d5ee26850 text-sm text-gray-500 py-1">To conclude our interview with Joshua K. Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses that could help to overcome treatment resistance in non–small cell lung cancer.</div></a></div></div></div><div style="border-bottom:1px solid #CCCCCC" class="jsx-ad50481d5ee26850"></div></div></div><div class="mt-4"><div class="w-full text-center flex justify-center pb-24"><a class="px-4 py-2 border-y border-r bg-primary text-white" href="/approvals-launches?page=1">1</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=2">2</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=3">3</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=4">4</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=5">5</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=6">6</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=7">7</a><a class="px-4 py-2 border-y border-r " href="/approvals-launches?page=8">8</a><div class="px-4 py-2 border-y border-r">...</div><a class="px-4 py-2 border-y border-r" href="/approvals-launches?page=11">11</a><a class="px-4 py-2 border-y border-r" href="/approvals-launches?page=2">></a></div></div></div></div><div class="flex-none w-[300px] z-[9999] relative hidden md:block"><div style="top:5rem" class="sticky custom-spacing"><div class="collapse-container " style="overflow:hidden;max-height:900px;transition:max-height .4s ease-in-out"></div></div></div></div><div id="div-gpt-ad-pixel" style="width:1px;height:1px" class=""></div><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NK5KQXS" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><div id="footerOuterWrap" class=" mx-auto flex"><div class="bg-[#00598D] xl:w-[70%] w-[70%] py-12 pl-auto"><div class="xxl:w-[75%] w-[90%] ml-auto"><div><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27300%27%20height=%2744%27/%3e"/></span><img alt="" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="" srcSet="/_next/image?url=%2Fan_mjhls_brand_ko.png&w=384&q=75 1x, /_next/image?url=%2Fan_mjhls_brand_ko.png&w=640&q=75 2x" src="/_next/image?url=%2Fan_mjhls_brand_ko.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div><div class="flex"><div class="flex justify-between pt-6"><div class="w-[40%]"><div class="text-footer-text-color text-xs"><p>2 Commerce Drive<br/>Suite 100<br/>Cranbury, NJ 08512</p></div><div class="self-start py-6" style="display:flex;flex-wrap:wrap"><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.facebook.com/TheAmericanJournalOfManagedCare"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='facebook' fill='#FFFFFF' fillRule='nonzero'> <path d='M512,256 C512,114.6 397.4,0 256,0 C114.6,0 0,114.6 0,256 C0,397.4 114.6,512 256,512 C257.5,512 259,512 260.5,511.9 L260.5,312.7 L205.5,312.7 L205.5,248.6 L260.5,248.6 L260.5,201.4 C260.5,146.7 293.9,116.9 342.7,116.9 C366.1,116.9 386.2,118.6 392,119.4 L392,176.6 L358.4,176.6 C331.9,176.6 326.7,189.2 326.7,207.7 L326.7,248.5 L390.2,248.5 L381.9,312.6 L326.7,312.6 L326.7,502.1 C433.7,471.4 512,372.9 512,256 Z' id='Path' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" href="https://twitter.com/AJMC_Journal"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" width="25" height="25" viewBox="1.41 1.41 252.9 252.9"><g transform="translate(1.4065934065934016 1.4065934065934016) scale(2.81 2.81)"><polygon points="24.89,23.01 57.79,66.99 65.24,66.99 32.34,23.01" fill="#FFFFFF" transform="matrix(1 0 0 1 0 0)"></polygon><path d="M 45 0 L 45 0 C 20.147 0 0 20.147 0 45 v 0 c 0 24.853 20.147 45 45 45 h 0 c 24.853 0 45 -20.147 45 -45 v 0 C 90 20.147 69.853 0 45 0 z M 56.032 70.504 L 41.054 50.477 L 22.516 70.504 h -4.765 L 38.925 47.63 L 17.884 19.496 h 16.217 L 47.895 37.94 l 17.072 -18.444 h 4.765 L 50.024 40.788 l 22.225 29.716 H 56.032 z" fill="#FFFFFF" transform="matrix(1 0 0 1 0 0)" stroke-linecap="round"></path></g></svg></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.linkedin.com/company/american-journal-of-managed-care/"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='linkedin' fill='#FFFFFF' fillRule='nonzero'> <path d='M256,0 C114.636719,0 0,114.636719 0,256 C0,397.363281 114.636719,512 256,512 C397.363281,512 512,397.363281 512,256 C512,114.636719 397.363281,0 256,0 Z M181.609375,387 L119.261719,387 L119.261719,199.425781 L181.609375,199.425781 L181.609375,387 Z M150.4375,173.8125 L150.03125,173.8125 C129.109375,173.8125 115.578125,159.410156 115.578125,141.410156 C115.578125,123.003906 129.523438,109 150.851562,109 C172.179688,109 185.304688,123.003906 185.710938,141.410156 C185.710938,159.410156 172.179688,173.8125 150.4375,173.8125 Z M406.421875,387 L344.082031,387 L344.082031,286.652344 C344.082031,261.433594 335.054688,244.234375 312.496094,244.234375 C295.273438,244.234375 285.015625,255.835938 280.507812,267.035156 C278.859375,271.042969 278.457031,276.644531 278.457031,282.25 L278.457031,387 L216.113281,387 C216.113281,387 216.929688,217.023438 216.113281,199.425781 L278.457031,199.425781 L278.457031,225.984375 C286.742188,213.203125 301.566406,195.023438 334.644531,195.023438 C375.664062,195.023438 406.421875,221.832031 406.421875,279.445312 L406.421875,387 Z' id='Shape' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="https://www.instagram.com/ajmcjournal/"><p> <svg width='25px' height='25px' viewBox='0 0 512 512' version='1.1' xmlns='http://www.w3.org/2000/svg'> <g id='Page-1' stroke='none' strokeWidth='1' fill='none' fillRule='evenodd'> <g id='instagram' fill='#FFFFFF' fillRule='nonzero'> <path d='M305,256 C305,283.0625 283.0625,305 256,305 C228.9375,305 207,283.0625 207,256 C207,228.9375 228.9375,207 256,207 C283.0625,207 305,228.9375 305,256 Z' id='Path' /> <path d='M370.59375,169.304688 C368.238281,162.921875 364.480469,157.144531 359.597656,152.402344 C354.855469,147.519531 349.082031,143.761719 342.695312,141.40625 C337.515625,139.394531 329.734375,137 315.402344,136.347656 C299.898438,135.640625 295.25,135.488281 256,135.488281 C216.746094,135.488281 212.097656,135.636719 196.597656,136.34375 C182.265625,137 174.480469,139.394531 169.304688,141.40625 C162.917969,143.761719 157.140625,147.519531 152.402344,152.402344 C147.519531,157.144531 143.761719,162.917969 141.402344,169.304688 C139.390625,174.484375 136.996094,182.269531 136.34375,196.601562 C135.636719,212.101562 135.484375,216.75 135.484375,256.003906 C135.484375,295.253906 135.636719,299.902344 136.34375,315.40625 C136.996094,329.738281 139.390625,337.519531 141.402344,342.699219 C143.761719,349.085938 147.515625,354.859375 152.398438,359.601562 C157.140625,364.484375 162.914062,368.242188 169.300781,370.597656 C174.480469,372.613281 182.265625,375.007812 196.597656,375.660156 C212.097656,376.367188 216.742188,376.515625 255.996094,376.515625 C295.253906,376.515625 299.902344,376.367188 315.398438,375.660156 C329.730469,375.007812 337.515625,372.613281 342.695312,370.597656 C355.515625,365.652344 365.648438,355.519531 370.59375,342.699219 C372.605469,337.519531 375,329.738281 375.65625,315.40625 C376.363281,299.902344 376.511719,295.253906 376.511719,256.003906 C376.511719,216.75 376.363281,212.101562 375.65625,196.601562 C375.003906,182.269531 372.609375,174.484375 370.59375,169.304688 L370.59375,169.304688 Z M256,331.484375 C214.308594,331.484375 180.511719,297.691406 180.511719,256 C180.511719,214.308594 214.308594,180.515625 256,180.515625 C297.6875,180.515625 331.484375,214.308594 331.484375,256 C331.484375,297.691406 297.6875,331.484375 256,331.484375 Z M334.46875,195.171875 C324.726562,195.171875 316.828125,187.273438 316.828125,177.53125 C316.828125,167.789062 324.726562,159.890625 334.46875,159.890625 C344.210938,159.890625 352.109375,167.789062 352.109375,177.53125 C352.105469,187.273438 344.210938,195.171875 334.46875,195.171875 Z' id='Shape' /> <path d='M256,0 C114.636719,0 0,114.636719 0,256 C0,397.363281 114.636719,512 256,512 C397.363281,512 512,397.363281 512,256 C512,114.636719 397.363281,0 256,0 Z M402.113281,316.605469 C401.402344,332.253906 398.914062,342.9375 395.28125,352.289062 C387.644531,372.035156 372.035156,387.644531 352.289062,395.28125 C342.941406,398.914062 332.253906,401.398438 316.609375,402.113281 C300.933594,402.828125 295.925781,403 256.003906,403 C216.078125,403 211.074219,402.828125 195.394531,402.113281 C179.75,401.398438 169.0625,398.914062 159.714844,395.28125 C149.902344,391.589844 141.019531,385.804688 133.675781,378.324219 C126.199219,370.984375 120.414062,362.097656 116.722656,352.289062 C113.089844,342.941406 110.601562,332.253906 109.890625,316.609375 C109.167969,300.929688 109,295.921875 109,256 C109,216.078125 109.167969,211.070312 109.886719,195.394531 C110.597656,179.746094 113.082031,169.0625 116.714844,159.710938 C120.40625,149.902344 126.195312,141.015625 133.675781,133.675781 C141.015625,126.195312 149.902344,120.410156 159.710938,116.71875 C169.0625,113.085938 179.746094,110.601562 195.394531,109.886719 C211.070312,109.171875 216.078125,109 256,109 C295.921875,109 300.929688,109.171875 316.605469,109.890625 C332.253906,110.601562 342.9375,113.085938 352.289062,116.714844 C362.097656,120.40625 370.984375,126.195312 378.328125,133.675781 C385.804688,141.019531 391.59375,149.902344 395.28125,159.710938 C398.917969,169.0625 401.402344,179.746094 402.117188,195.394531 C402.832031,211.070312 403,216.078125 403,256 C403,295.921875 402.832031,300.929688 402.113281,316.605469 L402.113281,316.605469 Z' id='Shape' /> </g> </g> </svg> </p></a><a rel="noreferrer noopener" class="pr-1" target="_blank" href="/rss"><p><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svgjs="http://svgjs.com/svgjs" version="1.1" width="25px" height="25px" x="0" y="0" viewBox="0 0 512 512" style="enable-background:new 0 0 512 512" xml:space="preserve"> <g> <path xmlns="http://www.w3.org/2000/svg" d="m437.019531 74.980469c-48.351562-48.351563-112.640625-74.980469-181.019531-74.980469s-132.667969 26.628906-181.019531 74.980469c-48.351563 48.351562-74.980469 112.640625-74.980469 181.019531s26.628906 132.667969 74.980469 181.019531c48.351562 48.351563 112.640625 74.980469 181.019531 74.980469s132.667969-26.628906 181.019531-74.980469c48.351563-48.351562 74.980469-112.640625 74.980469-181.019531s-26.628906-132.667969-74.980469-181.019531zm-267.757812 292.957031c-13.730469 0-24.90625-11.171875-24.90625-24.90625s11.175781-24.90625 24.90625-24.90625c13.734375 0 24.90625 11.171875 24.90625 24.90625s-11.171875 24.90625-24.90625 24.90625zm80.277343 4.925781c-8.28125 0-15-6.714843-15-15 0-44.171875-35.9375-80.109375-80.109374-80.109375-8.285157 0-15-6.71875-15-15 0-8.285156 6.714843-15 15-15 60.714843 0 110.109374 49.394532 110.109374 110.109375 0 8.285157-6.714843 15-15 15zm67.09375 0c-8.285156 0-15-6.714843-15-15 0-81.167969-66.035156-147.203125-147.203124-147.203125-8.285157 0-15-6.714844-15-15s6.714843-15 15-15c97.710937 0 177.203124 79.492188 177.203124 177.203125 0 8.285157-6.714843 15-15 15zm66.292969 0c-8.28125 0-15-6.714843-15-15 0-117.722656-95.773437-213.496093-213.496093-213.496093-8.285157 0-15-6.714844-15-15 0-8.285157 6.714843-15 15-15 65.039062 0 126.1875 25.328124 172.179687 71.316406 45.988281 45.992187 71.316406 107.140625 71.316406 172.179687 0 8.285157-6.714843 15-15 15zm0 0" fill="#ffffff" data-original="#000000" style=""/> </g> </svg></p></a></div><div class="text-footer-text-color text-xs"><p>© 2025 MJH Life Sciences<sup>®</sup> and AJMC®.<br/> All rights reserved.</p></div></div><div class="flex flex-row flex-wrap self-start w-[60%]"><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/about-us">About</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/contactus">Contact</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/editorial-boards">Editorial Boards</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/advertise">Advertise</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_blank" href="https://www.mjhlifesciences.com/ccpa?domain=www.ajmc.com">Do Not Sell My Information</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/terms">Terms & Conditions</a></div><div class="w-[50%] pb-3 px-2 my-0 cursor-pointer text-footer-text-color hover:text-footer-text-color/80 hover:underline"><a class="text-md" target="_self" href="/privacy">Privacy Policy</a></div></div><div class="flex items-start mr-6 lg:mr-10"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27251%27%20height=%2768%27/%3e"/></span><img alt="AJMC Managed Markets Network Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="AJMC Managed Markets Network Logo" srcSet="/_next/image?url=%2FAJMC_MMN_logo_light.png&w=256&q=75 1x, /_next/image?url=%2FAJMC_MMN_logo_light.png&w=640&q=75 2x" src="/_next/image?url=%2FAJMC_MMN_logo_light.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></div></div></div></div></div><div class="w-[30%] bg-[#003767] flex items-center justify-center "><div class="flex flex-col justify-between "><a target="_self" rel="noopener noreferrer" class="my-2 px-8" href="/topic/center-on-health-equity-and-access"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27315%27%20height=%2777%27/%3e"/></span><img alt="CH Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="CH Logo" srcSet="/_next/image?url=%2FCHA_Logo.png&w=384&q=75 1x, /_next/image?url=%2FCHA_Logo.png&w=640&q=75 2x" src="/_next/image?url=%2FCHA_Logo.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></a><a target="_blank" rel="noopener noreferrer" class="my-2 px-8" href="https://www.centerforbiosimilars.com/"><span style="box-sizing:border-box;display:inline-block;overflow:hidden;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;position:relative;max-width:100%"><span style="box-sizing:border-box;display:block;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0;max-width:100%"><img style="display:block;max-width:100%;width:initial;height:initial;background:none;opacity:1;border:0;margin:0;padding:0" alt="" aria-hidden="true" src="data:image/svg+xml,%3csvg%20xmlns=%27http://www.w3.org/2000/svg%27%20version=%271.1%27%20width=%27315%27%20height=%2777%27/%3e"/></span><img alt="Center for Biosimilars Logo" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%"/><noscript><img alt="Center for Biosimilars Logo" srcSet="/_next/image?url=%2FCB.png&w=384&q=75 1x, /_next/image?url=%2FCB.png&w=640&q=75 2x" src="/_next/image?url=%2FCB.png&w=640&q=75" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" loading="lazy"/></noscript></span></a></div></div></div></div></div><script id="__NEXT_DATA__" type="application/json">{"props":{"pageProps":{"pageProps":{},"cache":{"main_menu":[{"name":"News","is_active":true,"navParent":null,"subQuery":[{"_updatedAt":"2020-04-14T13:30:35Z","_rev":"sBk7YzjWMuBuhiatU3YIhQ","_type":"mainNavigation","children":[],"_createdAt":"2020-04-14T13:30:35Z","url":"/news","name":"All News","_id":"1376963d-32e8-4647-bb5e-59c984e35893","is_active":true,"navParent":{"_type":"reference","_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b"}},{"children":[],"_createdAt":"2020-04-14T13:30:57Z","url":"/press-release","navParent":{"_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_type":"reference"},"_type":"mainNavigation","_id":"2af5da5e-78c2-42c8-90b8-3900f8c89889","_updatedAt":"2020-04-14T13:30:57Z","name":"Press Releases","is_active":true,"_rev":"QxOJBWa4XErmibN6Cb5OcA"},{"_rev":"jvOgZ3KZdbRHfWlt9ePmOA","_type":"mainNavigation","name":"Product Approvals and Launches","_id":"854a1ad1-9831-4387-bda9-ffb93a074ace","is_active":true,"_updatedAt":"2022-01-07T20:44:44Z","navParent":{"_ref":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_type":"reference"},"_createdAt":"2021-07-29T12:15:49Z","url":"/approvals-launches","children":[]}],"_type":"mainNavigation","_id":"e8c503ba-34b9-43d5-8ce1-e8603c4e4b6b","_updatedAt":"2020-04-14T13:26:21Z","_createdAt":"2020-04-14T13:26:14Z","sortOrder":1,"_rev":"Yw6MEKZDMdk6hC2JCRdGN7"},{"navParent":null,"sortOrder":2,"_rev":"rcwwj6TiN2Q0ymhqDzIFjO","_type":"mainNavigation","name":"Video","is_active":true,"_createdAt":"2020-04-14T13:26:30Z","_id":"821e259a-db55-4862-985a-5cd089bbf894","_updatedAt":"2024-05-24T16:36:15Z","subQuery":[{"_createdAt":"2024-05-24T16:37:06Z","_rev":"rcwwj6TiN2Q0ymhqDzJ8ty","_type":"mainNavigation","_updatedAt":"2024-05-24T16:52:54Z","url":"/video-hub","is_active":true,"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_id":"f51d85fa-cabc-4c7d-85d0-11301088b7f6","children":[],"sortOrder":1,"name":"All Video Types"},{"_createdAt":"2024-05-24T16:38:14Z","_id":"a99a3683-5173-46b3-94b0-21b7d6b06a24","url":"/interviews","name":"AJMC TV","_updatedAt":"2024-05-28T19:38:54Z","children":[],"is_active":true,"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_type":"mainNavigation","_rev":"LJrwYxwtzLC9JsOYMk8TBr"},{"_type":"mainNavigation","name":"Guidelines","_createdAt":"2025-02-14T19:40:54Z","url":"/guidelines","children":[],"is_active":true,"_rev":"4IWvQAHLC63503PAHcJfUU","_updatedAt":"2025-02-14T19:41:11Z","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_id":"9affe463-8f89-4d72-b806-62281069ebba"},{"_type":"mainNavigation","children":[],"_createdAt":"2020-04-14T13:43:45Z","_rev":"Yw6MEKZDMdk6hC2JCRda8Z","name":"Insights","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_id":"b03ccbf6-6387-48de-8edc-4f1f23debe40","_updatedAt":"2020-04-14T13:43:45Z","url":"/insights","is_active":true},{"is_active":true,"_createdAt":"2020-04-14T13:44:19Z","name":"OnLocation","_id":"f3d69d10-636b-4927-8ff4-4f54fabc940a","children":[],"_updatedAt":"2020-04-14T13:44:19Z","url":"/onlocation","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"k6N5FycA5UhVnvpzSEa3Rp","_type":"mainNavigation"},{"_createdAt":"2022-10-05T15:29:11Z","_rev":"37PW14Mg02p9z7FTF1SGE9","_updatedAt":"2022-10-05T15:29:11Z","is_active":true,"_type":"mainNavigation","_id":"d4e3d69c-8a07-4191-af89-27d7e838af08","url":"/payer-perspectives","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"name":"Payer Perspectives","children":[]},{"_id":"8f602f1e-1840-4c32-8cdb-9a26d6c0e873","_createdAt":"2020-04-14T13:44:43Z","name":"Peer Exchange","_type":"mainNavigation","navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"url":"/peer-exchange","is_active":true,"children":[],"_rev":"VdTcsTJkAuZveXGf2i9Pes","_updatedAt":"2020-04-14T13:44:43Z"},{"is_active":true,"_createdAt":"2024-05-24T18:27:43Z","_rev":"Jz2W7keLhiw1UYkGHgA51N","name":"Post Conference Perspectives","children":[],"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_updatedAt":"2024-05-24T18:27:43Z","url":"/post-conference-perspectives","_type":"mainNavigation","_id":"0f532685-cd4c-4350-89cd-b8a388e6495b"},{"url":"/stakeholder-summit","_type":"mainNavigation","name":"Stakeholder Summit","_createdAt":"2020-12-01T22:43:10Z","children":[],"is_active":true,"navParent":{"_ref":"821e259a-db55-4862-985a-5cd089bbf894","_type":"reference"},"_rev":"y3lsbm3yQTliOnC9CU5TiR","_updatedAt":"2020-12-01T22:43:26Z","_id":"bbc55ff8-1532-475e-9f51-f9d5eb39e369"}]},{"sortOrder":3,"_rev":"rcwwj6TiN2Q0ymhqDzIUb7","_type":"mainNavigation","_id":"4939ee15-ae6f-4aba-8481-9ee27ce729d3","navParent":null,"subQuery":[],"url":"/podcasts","_createdAt":"2024-05-24T16:40:58Z","is_active":true,"_updatedAt":"2024-05-24T16:41:18Z","name":"Podcasts"},{"_createdAt":"2020-04-14T13:27:01Z","_rev":"rcwwj6TiN2Q0ymhqDzIVAU","_type":"mainNavigation","name":"Conferences","_id":"6841664a-93f2-4f56-8760-836ec9c7b483","_updatedAt":"2024-05-24T16:41:40Z","navParent":null,"sortOrder":4,"is_active":true,"subQuery":[{"_updatedAt":"2020-08-21T22:11:23Z","is_active":true,"_type":"mainNavigation","_id":"f45b532b-23e3-4b44-8d7f-2f3c13c9ae81","_rev":"pI9SawGKsTP14Lioy589Kx","name":"Conference Coverage","children":[],"navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"},"_createdAt":"2020-06-12T15:17:29Z","url":"/latest-conference","sortOrder":1},{"_updatedAt":"2020-06-12T15:19:26Z","sortOrder":2,"is_active":true,"children":[],"_rev":"FxFuWbqTkFGbPWgBBSR6xp","_id":"004461ae-46cb-45ef-916e-f03c6d99d6d3","_createdAt":"2020-06-12T15:18:28Z","name":"Conference Listing","url":"/conference","_type":"mainNavigation","navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"}},{"navParent":{"_ref":"6841664a-93f2-4f56-8760-836ec9c7b483","_type":"reference"},"name":"Post Conference Perspectives","_id":"a006d0df-0cc9-4386-abfb-b1931a3918d4","sortOrder":3,"is_active":true,"_type":"mainNavigation","_updatedAt":"2024-07-03T19:00:13Z","url":"/post-conference-perspectives","_createdAt":"2024-07-03T19:00:13Z","children":[],"_rev":"ZU3dXbR1BZtBbbPuRGxz53"}]},{"sortOrder":5,"navParent":null,"_id":"94f13109-c3cc-47b5-bf49-96ed727c8150","_updatedAt":"2024-05-24T16:41:49Z","is_active":true,"subQuery":[{"url":"/publications","sortOrder":1,"children":[],"navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"_createdAt":"2020-05-04T21:06:00Z","_updatedAt":"2024-05-24T16:42:23Z","_rev":"rcwwj6TiN2Q0ymhqDzIVyQ","name":"All Journals","_type":"mainNavigation","_id":"48193abd-ecf4-4c90-b0ae-984ca2be88c9","is_active":true},{"_id":"08081ddf-ffd8-4b17-a2ff-dfe6a0ac64a3","url":"/publications/issue","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"sortOrder":2,"name":"The American Journal of Managed Care","children":[],"is_active":true,"_updatedAt":"2024-05-24T16:42:39Z","_rev":"rcwwj6TiN2Q0ymhqDzIWug","_type":"mainNavigation","_createdAt":"2020-04-14T13:55:29Z"},{"is_active":true,"sortOrder":3,"_rev":"4fso9RuTzczLhlxmnMQ1bu","_type":"mainNavigation","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"_id":"47782239-2714-4bd1-99e6-750443bd39ea","children":[],"_createdAt":"2020-04-14T13:56:01Z","name":"Population Health, Equity \u0026 Outcomes","_updatedAt":"2024-09-16T13:23:11Z","url":"/publications/ajac"},{"sortOrder":4,"_type":"mainNavigation","name":"Evidence-Based Oncology","_id":"b99cc54f-5801-46e9-bd20-e690623ed12c","_createdAt":"2020-04-14T13:56:21Z","url":"/publications/evidence-based-oncology","is_active":true,"navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"_rev":"uJbbwQWkLESsncBrcLL4uf","children":[],"_updatedAt":"2024-05-24T16:43:12Z"},{"name":"About Supplements and Featured Publications","children":[],"_id":"6e7e3485-ef8b-40e3-8320-3c434df6bbb5","_updatedAt":"2024-05-24T16:43:26Z","is_active":true,"_createdAt":"2024-05-23T20:59:41Z","_rev":"rcwwj6TiN2Q0ymhqDzIY1L","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"sortOrder":5,"_type":"mainNavigation","url":"/supplement"},{"_id":"a2112c87-8e92-4b64-b42d-3117117f67a3","navParent":{"_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150","_type":"reference"},"sortOrder":6,"_type":"mainNavigation","_rev":"uJbbwQWkLESsncBrcLL5w0","_updatedAt":"2024-05-24T16:43:32Z","url":"/publications/supplement","is_active":true,"name":"Supplements and Featured Publications Issues","children":[],"_createdAt":"2020-04-14T13:56:51Z"},{"_type":"mainNavigation","is_active":true,"navParent":{"_type":"reference","_ref":"94f13109-c3cc-47b5-bf49-96ed727c8150"},"sortOrder":7,"url":"/submit-a-manuscript","name":"Submit a Manuscript","_id":"fa8c9edc-3d32-4e9e-b68b-47d5c15694a5","children":[],"_createdAt":"2023-03-14T13:29:11Z","_rev":"rcwwj6TiN2Q0ymhqDzIYDp","_updatedAt":"2024-05-24T16:43:38Z"}],"_createdAt":"2020-04-14T13:27:20Z","_rev":"uJbbwQWkLESsncBrcLL0hr","_type":"mainNavigation","name":"Journals"},{"url":"/events","navParent":null,"subQuery":[{"navParent":{"_ref":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_type":"reference"},"name":"Institute for Value-Based Medicine","url":"/ivbmevents","children":[],"_createdAt":"2024-05-24T16:44:43Z","_rev":"Jz2W7keLhiw1UYkGHgA4Yf","_id":"de4fe195-3db9-4d12-842d-f26100fbea5b","_type":"mainNavigation","_updatedAt":"2024-05-24T18:26:23Z","is_active":true},{"is_active":true,"navParent":{"_ref":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_type":"reference"},"name":"Patient-Centered Oncology Care","_createdAt":"2024-05-24T16:45:02Z","_type":"mainNavigation","_updatedAt":"2024-05-24T18:26:42Z","url":"https://pcoc.ajmc.com/","_rev":"Jz2W7keLhiw1UYkGHgA4eP","_id":"dddfc37d-8958-4e0a-91e3-0634bb6502a3","children":[]}],"sortOrder":6,"name":"Events","is_active":true,"_rev":"8ZvheBjSwe5Dc4gCmgsR0M","_type":"mainNavigation","_id":"ad5c19be-040c-4ea8-b639-807f54c9a1aa","_updatedAt":"2020-05-08T20:03:10Z","_createdAt":"2020-04-14T13:27:17Z"},{"_rev":"rcwwj6TiN2Q0ymhqDzIdco","_type":"mainNavigation","name":"Resources","_updatedAt":"2024-05-24T16:45:37Z","sortOrder":7,"_id":"86b03e38-f3d2-41d1-89e7-c3175c571a55","is_active":true,"_createdAt":"2020-04-14T13:29:34Z","navParent":null,"subQuery":[{"children":[],"navParent":{"_type":"reference","_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55"},"_rev":"rcwwj6TiN2Q0ymhqDzIfXP","is_active":true,"name":"Interactive Tools","sortOrder":1,"_type":"mainNavigation","url":"/interactive-tools","_id":"4a08b5fc-379c-4952-bec1-0d9dacb11170","_updatedAt":"2024-05-24T16:46:13Z","_createdAt":"2020-04-14T13:51:39Z"},{"_type":"mainNavigation","name":"Formulary Central","_updatedAt":"2025-02-14T19:42:02Z","_createdAt":"2025-02-14T19:41:37Z","_rev":"4IWvQAHLC63503PAHcJhJi","url":"/formulary","is_active":true,"navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"sortOrder":3,"_id":"db1214fd-aa4d-4f12-a6f5-72d7e3927ce9","children":[]},{"navParent":{"_type":"reference","_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55"},"name":"Clinical Spotlight","_updatedAt":"2024-05-23T20:32:07Z","url":"/clinical-spotlight","is_active":true,"_id":"43960f88-0c8d-404b-b9d9-d90432c2c516","children":[],"_createdAt":"2020-10-16T13:03:47Z","_rev":"rcwwj6TiN2Q0ymhqDyFVrf","_type":"mainNavigation"},{"_rev":"rcwwj6TiN2Q0ymhqDzIhDR","name":"Microsites","_updatedAt":"2024-05-24T16:46:44Z","url":"/custom-email","navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"children":[],"_type":"mainNavigation","is_active":true,"_createdAt":"2024-05-24T16:46:44Z","_id":"38aa3af0-8a34-4ae6-898c-37214580d384"},{"name":"Sponsored Content","_updatedAt":"2024-05-24T16:47:05Z","url":"/sponsored","is_active":true,"_createdAt":"2024-05-24T16:47:05Z","_id":"d0b0683f-18e1-4e75-89fd-fb4e578a562f","_type":"mainNavigation","navParent":{"_ref":"86b03e38-f3d2-41d1-89e7-c3175c571a55","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDzIiDr","children":[]}]},{"_updatedAt":"2024-08-27T15:31:04Z","name":"CE","url":"/continuing-education","_createdAt":"2020-04-14T14:00:08Z","_rev":"LtkInV1jlQdtEIFjVpi9sG","_type":"mainNavigation","is_active":true,"_id":"621fccf5-dcdb-40a9-af70-9bf3ccf79278","sortOrder":8,"navParent":null,"subQuery":[]},{"_id":"c14e4637-909c-4bf6-bf81-64eeb6005352","_updatedAt":"2024-05-24T16:48:11Z","navParent":null,"subQuery":[{"children":[],"_rev":"Jz2W7keLhiw1UYkGHgBp6D","_type":"mainNavigation","_id":"be637b3b-f72a-4049-91b8-409809b2d815","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"_createdAt":"2024-05-24T19:05:57Z","_updatedAt":"2024-05-24T19:05:57Z","url":"/editorial","is_active":true,"name":"AJMC Staff"},{"_id":"5298152f-5135-4c2c-a46e-a14ad0300bf4","is_active":true,"_type":"mainNavigation","name":"Anniversary","children":[],"_updatedAt":"2024-05-24T16:48:30Z","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"_createdAt":"2024-05-24T16:48:30Z","_rev":"rcwwj6TiN2Q0ymhqDzIn5Y","url":"/anniversary"},{"_rev":"AGf4LvcO2r7q1La1cjR7dD","_id":"28d33143-d9a9-45bd-af63-bed8d2198118","_updatedAt":"2024-07-23T13:38:48Z","_type":"mainNavigation","name":"Seema Sonnad Award","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"is_active":true,"children":[],"_createdAt":"2024-05-24T18:24:23Z","url":"/about/seema-sonnad-nomination"},{"_type":"mainNavigation","url":"/partners","children":[],"is_active":true,"_rev":"uJbbwQWkLESsncBrcLLVEZ","_updatedAt":"2024-05-24T16:49:00Z","_createdAt":"2024-05-24T16:49:00Z","name":"Strategic Alliance Partners","navParent":{"_ref":"c14e4637-909c-4bf6-bf81-64eeb6005352","_type":"reference"},"_id":"acb7dc53-dfab-462a-b2e9-b0cfc8675da4"}],"sortOrder":9,"_rev":"rcwwj6TiN2Q0ymhqDzIlc0","_type":"mainNavigation","name":"About AJMC","is_active":true,"_createdAt":"2024-05-24T16:48:11Z"},{"url":"https://one.ajmc.com/subscribe","_createdAt":"2020-06-22T20:56:33Z","_rev":"gFXie0Ldruy1o91XppbLLd","subQuery":[],"blank":true,"_type":"mainNavigation","name":"Subscribe","_id":"1e279576-0b33-4e57-8782-b6b1edbf68da","sortOrder":9,"_updatedAt":"2024-03-11T14:58:15Z","is_active":true,"navParent":null}],"sub_menu":[{"_id":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","name":"Specialty Area","sortOrder":1,"_rev":"Jz2W7keLhiw1UYkGHfbRHa","navParent":null,"url":"/compendium","is_active":true,"_type":"subNavigation","subQuery":[{"children":[],"_rev":"Jz2W7keLhiw1UYkGHfbM3A","_type":"subNavigation","is_active":true,"name":"Biosimilars","_id":"aa3904f3-c0d8-495d-a77f-afcc41f27045","_updatedAt":"2024-05-24T05:06:44Z","_createdAt":"2024-05-24T05:06:44Z","url":"/compendium/biosimilars","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"}},{"_updatedAt":"2025-01-17T17:17:34Z","is_active":true,"_createdAt":"2024-05-24T05:30:27Z","_rev":"aW9ZvtW6d5z6x1Negj6Jxc","navParent":{"_type":"reference","_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e"},"_type":"subNavigation","name":"Cardiorenalmetabolic","url":"/compendium/cardiorenalmetabolic","_id":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","children":[{"_rev":"Jz2W7keLhiw1UYkGHfbquf","_updatedAt":"2024-05-24T05:30:54Z","is_active":true,"navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"name":"Cardiovascular","_id":"c3566f20-e7c6-4b38-bf9f-7d52055698b1","url":"/compendium/cardiovascular","_createdAt":"2024-05-24T05:30:54Z","_type":"subNavigation"},{"_createdAt":"2024-05-24T05:32:42Z","name":"Chronic Kidney Disease","_id":"f3a69e16-dc38-4135-886e-d70e18532bf4","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfbumO","_type":"subNavigation","_updatedAt":"2024-05-24T05:32:42Z","url":"/compendium/ckd","navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"}},{"is_active":true,"_createdAt":"2024-05-24T05:31:14Z","navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbrEl","_type":"subNavigation","name":"Diabetes","_id":"79c02dc8-3c2d-451b-9797-008b25d61d4d","_updatedAt":"2024-05-24T05:31:14Z","url":"/compendium/diabetes"},{"_createdAt":"2024-05-24T05:31:38Z","_type":"subNavigation","_id":"84c7dd54-fb21-4bc5-86bc-9bbf39a7f836","url":"/compendium/heart-failure","is_active":true,"navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_updatedAt":"2024-05-24T05:31:38Z","_rev":"Jz2W7keLhiw1UYkGHfbrQF","name":"Heart Failure"},{"is_active":true,"_type":"subNavigation","_id":"aadd9bdc-4dd1-4ac1-be4f-2afb4315b6cb","url":"/compendium/type1diabetes","navParent":{"_ref":"6c47e32a-ae7f-4f3a-92e2-c99d54ae28ab","_type":"reference"},"_createdAt":"2024-05-24T05:32:00Z","_rev":"Jz2W7keLhiw1UYkGHfbsbS","name":"Type 1 Diabetes","_updatedAt":"2024-05-24T05:32:00Z"}]},{"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"url":"/compendium/dermatology","is_active":true,"children":[{"_type":"subNavigation","_id":"04523862-a8a1-4626-b288-95b3d4114267","navParent":{"_ref":"7599f50b-36ff-42a5-8d72-82814db9b988","_type":"reference"},"_createdAt":"2024-05-23T21:42:49Z","_rev":"Jz2W7keLhiw1UYkGHfbTPe","name":"Alopecia","_updatedAt":"2024-05-24T05:12:43Z","url":"/compendium/alopecia","is_active":true},{"_type":"subNavigation","_updatedAt":"2024-05-24T05:12:02Z","is_active":true,"_createdAt":"2024-05-24T05:12:02Z","_rev":"Jz2W7keLhiw1UYkGHfbSvV","name":"Atopic Dermatitis","_id":"637a0b1e-1b12-42bf-81a3-e6db5a997021","url":"/compendium/atopic-dermatitis","navParent":{"_ref":"7599f50b-36ff-42a5-8d72-82814db9b988","_type":"reference"}},{"navParent":{"_type":"reference","_ref":"7599f50b-36ff-42a5-8d72-82814db9b988"},"_createdAt":"2024-05-24T05:12:30Z","_rev":"Jz2W7keLhiw1UYkGHfbTJu","name":"Psoriasis","_id":"a9dcce80-4f29-488e-b7ef-51f0fb562a5a","is_active":true,"_type":"subNavigation","_updatedAt":"2024-05-24T05:12:36Z","url":"/compendium/psoriasis"}],"_id":"7599f50b-36ff-42a5-8d72-82814db9b988","_createdAt":"2024-05-24T05:10:35Z","_type":"subNavigation","_updatedAt":"2024-05-24T05:10:35Z","_rev":"Jz2W7keLhiw1UYkGHfbSVf","name":"Dermatology"},{"is_active":true,"name":"Gastroenterology","_createdAt":"2024-11-25T15:12:24Z","url":"/compendium/gastroenterology","_rev":"I64rexdokWxpEDPZsg5Lox","_type":"subNavigation","children":[],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_updatedAt":"2024-11-25T15:12:43Z","_id":"3c425964-bf72-4f93-bfbc-4d44d42dc2fe"},{"_createdAt":"2024-05-24T05:13:48Z","_rev":"Jz2W7keLhiw1UYkGHfbU3q","name":"Hematology","_updatedAt":"2024-05-24T05:13:48Z","is_active":true,"_id":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","children":[{"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-29T15:28:26Z","_rev":"Iat2IZiT321TmGHwkF66wB","name":"ALL/AML","url":"/compendium/all","is_active":true,"_type":"subNavigation","_id":"d79f2b30-e7f2-4915-bef8-1a73a9190a91","_updatedAt":"2024-05-29T15:28:26Z"},{"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-29T15:26:57Z","name":"CLL/SLL","_id":"664a6ece-64dd-41f8-87a0-7f5a47323c3b","url":"/compendium/cll","is_active":true,"_rev":"Iat2IZiT321TmGHwkF65Md","_type":"subNavigation","_updatedAt":"2024-05-29T15:27:46Z"},{"_updatedAt":"2024-05-29T15:28:51Z","navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"Iat2IZiT321TmGHwkF67tn","name":"GVHD","_id":"32cf626c-1ce6-4fb5-9dd7-088522dc46e6","is_active":true,"_createdAt":"2024-05-29T15:28:51Z","_type":"subNavigation","url":"/compendium/gvhd"},{"url":"/compendium/hemophilia","_createdAt":"2024-05-24T05:14:15Z","_rev":"Jz2W7keLhiw1UYkGHfbUDt","_type":"subNavigation","name":"Hemophilia","_id":"4dd2ce64-8f4d-4285-bc1a-ec40ffc99b51","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_updatedAt":"2024-05-24T05:14:15Z"},{"is_active":true,"_createdAt":"2024-05-24T05:45:17Z","_type":"subNavigation","name":"Multiple Myeloma","_id":"84e2d674-0fe1-4bd1-9d97-2f8bc8589ba0","url":"/compendium/multiple-myeloma","navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"Iat2IZiT321TmGHwkF6NtX","_updatedAt":"2024-05-29T15:35:07Z"},{"_rev":"Iat2IZiT321TmGHwkF6a5X","_updatedAt":"2024-05-29T15:35:22Z","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-24T05:45:36Z","_type":"subNavigation","name":"Myelodysplastic Syndromes","_id":"3a327f90-a5fc-4d87-9a18-02f54cb40b8e","url":"/compendium/myelodysplastic-syndromes"},{"name":"Myeloproliferative Neoplasms","_id":"a6003c4f-e7f0-422a-8129-49a2d78eb113","url":"/compendium/mpn","is_active":true,"_createdAt":"2024-05-29T15:29:21Z","_type":"subNavigation","navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_rev":"Up1TL5YPo1fhI8V2tpNnMb","_updatedAt":"2024-06-05T20:02:27Z"},{"is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-24T05:43:54Z","_id":"fc247a6b-0b33-4e18-ae78-56e677c6bb18","url":"/compendium/nhl","_rev":"rmdpbbz4U7GL9ExaGp96DY","_type":"subNavigation","name":"Non-Hodgkin Lymphoma","_updatedAt":"2024-06-25T17:42:12Z"},{"url":"/compendium/rareblood","_rev":"Jz2W7keLhiw1UYkGHfbUPN","_type":"subNavigation","_id":"85e2fc3e-ac5c-4b47-8b14-411d730d20d9","_updatedAt":"2024-05-24T05:14:40Z","is_active":true,"navParent":{"_ref":"d1c6a8fa-d54d-4aa5-84e5-0e1ee2b639d4","_type":"reference"},"_createdAt":"2024-05-24T05:14:40Z","name":"Rare Blood"}],"url":"/compendium/hematology","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_type":"subNavigation"},{"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"a96e7dbc-b037-41f4-bd5e-d96abf8f3c7d","_type":"subNavigation","_updatedAt":"2025-01-17T17:19:10Z","url":"/compendium/hepatology","_createdAt":"2024-05-24T05:34:29Z","name":"Hepatology","children":[{"_createdAt":"2024-05-24T05:34:54Z","navParent":{"_ref":"a96e7dbc-b037-41f4-bd5e-d96abf8f3c7d","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbwkP","_type":"subNavigation","name":"Liver","_id":"2aefee8c-db97-4e7d-b600-efb48e6bcb6c","_updatedAt":"2024-05-24T05:34:54Z","url":"/compendium/liver-cancer","is_active":true}],"is_active":true,"_rev":"IZ4ZA8avncRcTDvyuUbX0o"},{"_id":"1b1e3727-8b82-42da-9a62-b20472b9c797","url":"/compendium/immunology","is_active":true,"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_createdAt":"2024-05-24T05:23:19Z","_type":"subNavigation","children":[{"is_active":true,"navParent":{"_type":"reference","_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797"},"_rev":"Jz2W7keLhiw1UYkGHfbkp8","_updatedAt":"2024-05-24T05:23:39Z","url":"/compendium/autoimmune","_createdAt":"2024-05-24T05:23:39Z","_type":"subNavigation","name":"Autoimmune","_id":"b3daefd0-0ac3-4be2-ad23-f9c3fa37cf37"},{"_updatedAt":"2024-05-24T05:23:59Z","url":"/compendium/Inflammation","is_active":true,"navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfbkzB","_type":"subNavigation","name":"Inflammation","_id":"6016d41d-9d43-49fa-99b6-7caca304f30d","_createdAt":"2024-05-24T05:23:59Z"},{"_type":"subNavigation","url":"/compendium/lupus","is_active":true,"_createdAt":"2024-05-24T05:24:47Z","_rev":"Jz2W7keLhiw1UYkGHfbmd6","name":"Lupus","_id":"b537fcea-aea3-40ca-83c1-0907fdc9ccb5","_updatedAt":"2024-05-24T05:24:47Z","navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"}},{"_type":"subNavigation","name":"Myasthenia Gravis","_updatedAt":"2024-05-24T05:25:23Z","is_active":true,"navParent":{"_ref":"1b1e3727-8b82-42da-9a62-b20472b9c797","_type":"reference"},"_id":"ef6c4efc-5932-4148-b626-cbf42e1c49c3","url":"/compendium/myasthenia-gravis","_createdAt":"2024-05-24T05:25:23Z","_rev":"Jz2W7keLhiw1UYkGHfbn7F"}],"_rev":"Jz2W7keLhiw1UYkGHfbkam","name":"Immunology","_updatedAt":"2024-05-24T05:23:19Z"},{"url":"/compendium/infectious-disease","_type":"subNavigation","_id":"b62af616-818b-4bda-b606-bd64287f9a85","_updatedAt":"2024-05-24T05:35:38Z","children":[{"is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_createdAt":"2024-05-24T05:36:03Z","_rev":"rcwwj6TiN2Q0ymhqDyeyP3","_type":"subNavigation","_updatedAt":"2024-05-24T05:36:03Z","url":"/compendium/covid-19","name":"COVID-19","_id":"ffcd30d0-169f-4a8f-9f01-616142f33712"},{"_createdAt":"2024-05-24T05:36:22Z","_type":"subNavigation","_updatedAt":"2024-05-24T05:36:29Z","is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcAxn","name":"HIV","_id":"a53004c6-9fe2-4b9c-a86a-ad74f9204b3a","url":"/compendium/hiv"},{"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_type":"subNavigation","_updatedAt":"2024-05-24T05:37:06Z","is_active":true,"_createdAt":"2024-05-24T05:37:06Z","_rev":"rcwwj6TiN2Q0ymhqDyezNO","name":"RSV","_id":"ca70e9ab-a981-4629-a766-81f7890b3977","url":"/compendium/rsv"},{"_createdAt":"2024-05-24T05:37:53Z","url":"/compendium/vaccines","_updatedAt":"2024-05-24T05:37:53Z","is_active":true,"navParent":{"_ref":"b62af616-818b-4bda-b606-bd64287f9a85","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcFFM","_type":"subNavigation","name":"Vaccines","_id":"a0ec0591-b4a1-4723-b984-b681c957523f"}],"is_active":true,"name":"Infectious Disease","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_createdAt":"2024-05-24T05:35:38Z","_rev":"Jz2W7keLhiw1UYkGHfcA9Y"},{"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"28c2b871-3034-43e1-b2b3-613ceefea3f1","url":"/compendium/mash","is_active":true,"name":"MASH","_type":"subNavigation","_updatedAt":"2025-01-17T17:02:58Z","children":[],"_createdAt":"2025-01-15T14:59:47Z","_rev":"aW9ZvtW6d5z6x1Negj3Mh7"},{"_createdAt":"2024-05-24T05:38:33Z","children":[{"is_active":true,"_type":"subNavigation","_id":"efcab5a8-97d8-4f5a-ba99-0a0555531f5a","_updatedAt":"2024-05-24T05:38:58Z","url":"/compendium/mdd","navParent":{"_ref":"db67ff69-2c58-4931-ad3d-767a636e38b0","_type":"reference"},"_createdAt":"2024-05-24T05:38:58Z","_rev":"rcwwj6TiN2Q0ymhqDyf7Qk","name":"Major Depressive Disorder"},{"_rev":"rcwwj6TiN2Q0ymhqDyf96m","name":"Sleep","_updatedAt":"2024-05-24T05:39:18Z","url":"/compendium/sleep","is_active":true,"navParent":{"_ref":"db67ff69-2c58-4931-ad3d-767a636e38b0","_type":"reference"},"_id":"f52dbfa9-aefe-4d21-b432-7052a136ae98","_createdAt":"2024-05-24T05:39:18Z","_type":"subNavigation"}],"_rev":"rcwwj6TiN2Q0ymhqDyf4PU","_id":"db67ff69-2c58-4931-ad3d-767a636e38b0","is_active":true,"name":"Mental Health","_type":"subNavigation","_updatedAt":"2024-05-24T05:38:33Z","url":"/compendium/mental-health","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"}},{"name":"Neurology","_updatedAt":"2025-01-17T17:18:32Z","is_active":true,"_createdAt":"2024-05-24T05:39:38Z","_type":"subNavigation","children":[{"navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyfERb","_id":"3e24f5af-027e-4f0b-a7e2-a3ffaf756a35","is_active":true,"_createdAt":"2024-05-24T05:40:18Z","_type":"subNavigation","name":"Duchenne Muscular Dystrophy","_updatedAt":"2024-05-24T05:40:18Z","url":"/compendium/dmd"},{"navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_createdAt":"2024-05-24T05:40:30Z","_type":"subNavigation","name":"Epilepsy","_updatedAt":"2024-05-24T05:40:38Z","url":"/compendium/epilepsy","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDyfIhq","_id":"d4e270df-2a59-4109-a7be-9c10f80722a7"},{"name":"Multiple Sclerosis","_updatedAt":"2024-05-24T05:41:07Z","_createdAt":"2024-05-24T05:41:07Z","_rev":"rcwwj6TiN2Q0ymhqDyfJRc","_type":"subNavigation","url":"/compendium/multiple-sclerosis","is_active":true,"navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_id":"7539f9b5-8f2a-4e1b-a10f-8cc748cd1489"},{"is_active":true,"name":"Parkinson Disease","_updatedAt":"2024-05-24T05:41:29Z","url":"/compendium/parkinson","_id":"90ebd8e7-e6d1-4128-8010-0b205fedb430","navParent":{"_ref":"bafe1c52-a8b5-4786-bcee-668409d14a11","_type":"reference"},"_createdAt":"2024-05-24T05:41:29Z","_rev":"rcwwj6TiN2Q0ymhqDyfJiG","_type":"subNavigation"}],"_id":"bafe1c52-a8b5-4786-bcee-668409d14a11","url":"/compendium/neurology","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"wsljz10lCZachwUMK3D8Fg"},{"children":[],"_type":"subNavigation","_updatedAt":"2024-09-04T14:25:34Z","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"name":"Obesity","_id":"fe48de19-78d2-4ed0-83fa-8884fb340de2","url":"/compendium/obesity","is_active":true,"_createdAt":"2024-09-04T14:25:34Z","_rev":"B2kOGngERQtEUh1WG5WXvd"},{"url":"/compendium/oncology","_createdAt":"2024-05-24T05:41:55Z","children":[{"_createdAt":"2024-05-24T05:42:17Z","_rev":"rcwwj6TiN2Q0ymhqDyfMpl","_id":"03ea9371-55cd-42e2-b300-7078b94ff467","url":"/compendium/breast-cancer","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_type":"subNavigation","name":"Breast Cancer","_updatedAt":"2024-05-24T05:42:17Z","is_active":true},{"is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:42:35Z","_rev":"rcwwj6TiN2Q0ymhqDyfatY","_type":"subNavigation","url":"/compendium/cholangiocarcinoma","name":"Cholangiocarcinoma","_id":"8b57fc91-4191-420c-a224-cb869f8fa0d7","_updatedAt":"2024-05-24T05:42:35Z"},{"_rev":"Jz2W7keLhiw1UYkGHfcTh6","name":"Colorectal Cancer","url":"/compendium/colorectal-cancer","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:43:23Z","_id":"e45ff858-e1bc-4b4a-9398-e12877b61607","_updatedAt":"2024-05-24T05:43:23Z","is_active":true,"_type":"subNavigation"},{"_id":"289f747b-dffd-4006-a27d-4933a46fd7c1","url":"/compendium/immuno-oncology","_createdAt":"2024-05-24T05:44:17Z","_rev":"Jz2W7keLhiw1UYkGHfsKT5","_type":"subNavigation","name":"Immuno-Oncology","is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_updatedAt":"2024-05-24T13:25:09Z"},{"_id":"9d17bccc-3f33-4793-90e3-0adecfa71fa1","_updatedAt":"2024-05-29T15:32:02Z","url":"/compendium/liver-cancer","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-29T15:32:02Z","_type":"subNavigation","is_active":true,"_rev":"Iat2IZiT321TmGHwkF6F4B","name":"Liver Cancer"},{"_createdAt":"2024-05-24T05:45:56Z","_type":"subNavigation","_updatedAt":"2024-05-24T13:24:22Z","url":"/compendium/nsclc","is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfsIwL","name":"Non–Small Cell Lung Cancer","_id":"85d30c37-d6a1-4028-9c0f-ecdf36de220d"},{"navParent":{"_type":"reference","_ref":"90b398eb-3349-4b6a-b205-780a34cb4717"},"_rev":"Jz2W7keLhiw1UYkGHfcbF4","name":"Ovarian Cancer","_id":"5a67adcb-11d8-48a6-8c39-b2956f5f3e86","_updatedAt":"2024-05-24T05:46:17Z","is_active":true,"_createdAt":"2024-05-24T05:46:17Z","_type":"subNavigation","url":"/compendium/ovarian-cancer"},{"_createdAt":"2024-05-24T05:47:42Z","_rev":"rcwwj6TiN2Q0ymhqDyfmoB","_id":"bcfe0d88-7498-4268-95e6-875c94a2dab5","_updatedAt":"2024-05-24T05:47:42Z","is_active":true,"navParent":{"_type":"reference","_ref":"90b398eb-3349-4b6a-b205-780a34cb4717"},"_type":"subNavigation","name":"Prostate Cancer","url":"/compendium/prostate-cancer"},{"navParent":{"_type":"reference","_ref":"90b398eb-3349-4b6a-b205-780a34cb4717"},"_createdAt":"2024-05-24T05:48:18Z","_rev":"rcwwj6TiN2Q0ymhqDyfpKE","_type":"subNavigation","_id":"a3a04e72-c707-450d-b9d3-f9ebacc9f997","_updatedAt":"2024-05-24T05:48:18Z","is_active":true,"url":"/compendium/skincancer","name":"Skin Cancer"},{"is_active":true,"_type":"subNavigation","_id":"89f99f56-72a9-4dcd-9d8c-3d717d66a5f0","name":"Small Cell Lung Cancer","_updatedAt":"2025-01-14T18:47:45Z","url":"/compendium/lung-cancer","navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-24T05:44:58Z","_rev":"36ELbxF4To1FbIa7xZVI3e"},{"is_active":true,"navParent":{"_ref":"90b398eb-3349-4b6a-b205-780a34cb4717","_type":"reference"},"_createdAt":"2024-05-29T15:30:06Z","_rev":"Iat2IZiT321TmGHwkF69Qd","_type":"subNavigation","name":"Soft Tissue Sarcoma","_id":"6d1dc4b4-1be8-41ee-9bba-90ad4ce546b3","_updatedAt":"2024-05-29T15:30:06Z","url":"/compendium/soft-tissue-sarcoma"}],"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyfKov","_id":"90b398eb-3349-4b6a-b205-780a34cb4717","is_active":true,"name":"Oncology","_type":"subNavigation","_updatedAt":"2024-05-24T05:41:55Z"},{"name":"Ophthalmology","children":[],"_updatedAt":"2024-05-24T05:48:54Z","navParent":{"_type":"reference","_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e"},"_type":"subNavigation","url":"/compendium/ophthalmology","_createdAt":"2024-05-24T05:48:54Z","_rev":"Jz2W7keLhiw1UYkGHfcePj","_id":"eee19078-eb50-46e7-a97c-8f16d79eea97","is_active":true},{"_updatedAt":"2025-01-17T17:19:27Z","_type":"subNavigation","_createdAt":"2024-05-24T05:49:11Z","url":"/compendium/pulmonology","is_active":true,"_id":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","children":[{"_createdAt":"2024-05-24T05:49:28Z","_rev":"rcwwj6TiN2Q0ymhqDyfrwW","_type":"subNavigation","is_active":true,"navParent":{"_ref":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","_type":"reference"},"name":"COPD","_id":"3a19d535-d61e-43b1-bf6a-d6ced486a0b9","_updatedAt":"2024-05-24T05:49:28Z","url":"/compendium/copd"},{"_rev":"rcwwj6TiN2Q0ymhqDyfuBv","_type":"subNavigation","_id":"474080cd-4295-4a70-907d-e1fc93c435cc","is_active":true,"navParent":{"_ref":"e6c5e55f-7a5a-4f23-add2-fbf91df76400","_type":"reference"},"_createdAt":"2024-05-24T05:49:52Z","name":"Pulmonary Arterial Hypertension","_updatedAt":"2024-05-24T05:49:52Z","url":"/compendium/pah"}],"navParent":{"_type":"reference","_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e"},"_rev":"IZ4ZA8avncRcTDvyuUbYi3","name":"Pulmonology"},{"_type":"subNavigation","url":"/compendium/raredisease","navParent":{"_type":"reference","_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e"},"_id":"de690920-3cdc-4c43-a27e-ba4e38a62059","_createdAt":"2024-05-24T05:50:50Z","name":"Rare Disease","_updatedAt":"2024-05-24T05:50:50Z","is_active":true,"_rev":"rcwwj6TiN2Q0ymhqDyg1Ah","children":[{"is_active":true,"navParent":{"_ref":"de690920-3cdc-4c43-a27e-ba4e38a62059","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyg1k4","_type":"subNavigation","_id":"9e780f76-2008-441b-ab5f-00d3a6d1a5b0","_updatedAt":"2024-05-24T05:51:19Z","url":"/compendium/sma","_createdAt":"2024-05-24T05:51:19Z","name":"Spinal Muscular Atrophy"}]},{"navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_rev":"Jz2W7keLhiw1UYkGHfcjSf","_type":"subNavigation","_id":"f2a34114-0396-44cb-b241-11ef7b175500","_updatedAt":"2024-05-24T05:50:22Z","url":"/compendium/respiratory","is_active":true,"_createdAt":"2024-05-24T05:50:22Z","name":"Respiratory","children":[{"navParent":{"_ref":"f2a34114-0396-44cb-b241-11ef7b175500","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDyg2wy","name":"Asthma","_updatedAt":"2024-05-24T05:52:02Z","is_active":true,"_createdAt":"2024-05-24T05:52:02Z","_type":"subNavigation","_id":"b2b2802f-2918-4431-8f4f-3bc7e6e6042f","url":"/compendium/asthma"},{"is_active":true,"_createdAt":"2024-06-03T18:31:07Z","name":"Idiopathic Pulmonary Fibrosis","_id":"4dac47d5-8dd1-4e90-b4be-b6b5e605f6f5","url":"/compendium/ipf","navParent":{"_type":"reference","_ref":"f2a34114-0396-44cb-b241-11ef7b175500"},"_rev":"5DUHcaiKRKj5c8wHOPKtuf","_type":"subNavigation","_updatedAt":"2024-06-03T18:31:07Z"}]},{"_id":"3ecb2952-6710-46b1-ab05-36997bfb4a33","is_active":true,"name":"Rheumatology","_rev":"Jz2W7keLhiw1UYkGHfcm6J","_type":"subNavigation","_updatedAt":"2024-05-24T05:52:28Z","url":"/compendium/rheumatology","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_createdAt":"2024-05-24T05:52:28Z","children":[]},{"_createdAt":"2024-05-24T05:52:51Z","name":"Women's Health","is_active":true,"_rev":"Jz2W7keLhiw1UYkGHfcmDU","_type":"subNavigation","navParent":{"_ref":"97a2a8fe-1a67-45d7-b1f8-294ab1f64c1e","_type":"reference"},"_id":"ead467ba-7c17-4a1b-9deb-a7af56a7366e","url":"/compendium/womens-health","_updatedAt":"2024-05-24T05:52:51Z","children":[]}],"_updatedAt":"2024-05-24T05:08:37Z","_createdAt":"2020-04-14T14:04:25Z"},{"sortOrder":2,"_rev":"rcwwj6TiN2Q0ymhqDyHDJ3","_type":"subNavigation","is_active":true,"_createdAt":"2024-05-23T20:47:34Z","_updatedAt":"2024-05-23T21:04:52Z","navParent":null,"subQuery":[{"url":"/ivbmevents?display=home","children":[],"_updatedAt":"2024-05-23T21:05:49Z","navParent":{"_ref":"db56b0e2-ad58-4407-aff2-5c27cb3145c1","_type":"reference"},"_createdAt":"2024-05-23T21:04:56Z","is_active":true,"_type":"subNavigation","_rev":"uJbbwQWkLESsncBrcJSd1N","name":"Free In-Person Regional Events Focused on Oncology and Population Health","_id":"f5b2c97b-d6d4-468b-8a9a-4814364994c8"}],"name":"Spotlight","_id":"db56b0e2-ad58-4407-aff2-5c27cb3145c1"},{"is_active":true,"_type":"subNavigation","url":"/topic","name":"Topics","_id":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","sortOrder":2,"_createdAt":"2020-04-14T14:05:54Z","_rev":"iEeBpgQLYwZXMeCflboLMu","_updatedAt":"2020-08-21T22:11:57Z","navParent":null,"subQuery":[{"_updatedAt":"2024-05-24T05:05:19Z","sortOrder":1,"_type":"subNavigation","children":[],"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_createdAt":"2024-05-24T05:05:19Z","url":"/compendium/biosimilars","is_active":true,"_id":"43207521-4e5f-42d2-b013-34763a4d964c","_rev":"Jz2W7keLhiw1UYkGHfbHQ4","name":"Biosimilars"},{"children":[],"_id":"4161ff97-2901-4526-80ee-3749b6dc6345","_createdAt":"2022-12-23T21:04:41Z","_updatedAt":"2024-06-12T13:58:35Z","url":"/topic/center-on-health-equity-and-access","is_active":true,"_rev":"N7mKycgLbGtEq6btkPIW3d","_type":"subNavigation","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"name":"Center on Health Equity \u0026 Access"},{"url":"/compendium/digital-health","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDygl51","_updatedAt":"2024-05-24T05:56:42Z","is_active":true,"_type":"subNavigation","_id":"232e30a0-2f7d-4ce1-9e4d-cc0cee73b20a","_createdAt":"2024-05-24T05:56:42Z","name":"Digital Health","children":[]},{"_id":"3887cee2-5461-4cb3-b54f-297fcceb11ee","_createdAt":"2024-05-24T05:57:01Z","navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"children":[],"_rev":"Jz2W7keLhiw1UYkGHfdAmX","_type":"subNavigation","_updatedAt":"2024-05-24T05:57:01Z","is_active":true,"name":"Formulary","url":"/formulary"},{"name":"Gene Therapy","_id":"56aff93b-4f24-48fc-9dda-2d394397f956","_type":"subNavigation","_updatedAt":"2024-05-24T05:57:41Z","_createdAt":"2024-05-24T05:57:41Z","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDygmDl","url":"/compendium/gene-therapy","children":[]},{"url":"/guidelines","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"children":[],"_createdAt":"2024-05-24T06:00:55Z","_type":"subNavigation","name":"Guidelines","_rev":"rcwwj6TiN2Q0ymhqDygv9D","is_active":true,"_id":"69723346-76b2-4896-b2d9-2db53ed5da96","_updatedAt":"2024-05-24T06:00:55Z"},{"url":"/","is_active":true,"_id":"cd6edcff-faa3-4bee-9071-042f8186052d","children":[{"_updatedAt":"2024-05-24T13:53:42Z","url":"/compendium/employers","is_active":true,"navParent":{"_type":"reference","_ref":"cd6edcff-faa3-4bee-9071-042f8186052d"},"_createdAt":"2024-05-24T05:58:26Z","_rev":"rcwwj6TiN2Q0ymhqDz6EMB","_type":"subNavigation","name":"Employers","_id":"83fca4ec-4ff0-4766-9e49-0376d44179e8"},{"_type":"subNavigation","url":"/compendium/medicare","_id":"5647b438-aca9-4b57-9d4d-2df660b5a6ce","_updatedAt":"2024-05-24T13:53:53Z","is_active":true,"navParent":{"_ref":"cd6edcff-faa3-4bee-9071-042f8186052d","_type":"reference"},"_createdAt":"2024-05-24T05:58:44Z","_rev":"rcwwj6TiN2Q0ymhqDz6F3s","name":"Medicare"},{"navParent":{"_ref":"cd6edcff-faa3-4bee-9071-042f8186052d","_type":"reference"},"_type":"subNavigation","name":"Reimbursement","_id":"2c8ff713-9c43-4afc-aaca-e33ceb98f00c","url":"/compendium/reimbursement","is_active":true,"_createdAt":"2024-05-24T05:59:16Z","_rev":"rcwwj6TiN2Q0ymhqDz6G8S","_updatedAt":"2024-05-24T13:54:23Z"}],"name":"Health Care Administration","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_rev":"rcwwj6TiN2Q0ymhqDz7eaC","_updatedAt":"2024-05-24T14:10:39Z","_createdAt":"2024-05-24T13:53:24Z","_type":"subNavigation"},{"name":"Health Care Cost","_id":"c9a8f6fd-0ad0-4a82-a385-13c03fe688d0","_updatedAt":"2021-02-25T17:30:59Z","url":"/topic/healthcare-cost","is_active":true,"children":[],"_createdAt":"2020-04-14T14:06:29Z","navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"_rev":"wx7I38TXtYeZdHCfn60Syn","_type":"subNavigation"},{"children":[],"url":"/topic/healthcare-delivery","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_updatedAt":"2021-02-25T17:29:58Z","_rev":"YN5IiYQkhJ3hq0R7jM8DQW","_createdAt":"2020-04-14T14:06:43Z","_type":"subNavigation","name":"Health Care Delivery","_id":"d01b9875-6e51-42d1-bdf5-93fd8771855c"},{"_rev":"lslStCipHxtG437RQOGJ7p","_type":"subNavigation","url":"/topic/insurance","_createdAt":"2020-04-14T14:07:01Z","children":[],"_updatedAt":"2022-12-21T19:05:52Z","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"name":"Insurance","_id":"d8eab058-f5ec-4c42-a95a-941c0a506543"},{"_createdAt":"2020-04-14T14:07:15Z","_type":"subNavigation","_rev":"T035zdq5xruIFPyK3OzgdQ","name":"Policy","_updatedAt":"2020-04-14T14:07:15Z","url":"/topic/policy","children":[],"navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"is_active":true,"_id":"fd066f36-78ee-4112-a121-4e02f8e45b0b"},{"_createdAt":"2024-05-24T05:59:24Z","_rev":"rcwwj6TiN2Q0ymhqDygvgV","_id":"d7893fef-5eb0-4b2d-b13d-a0bec73b2c14","_type":"subNavigation","_updatedAt":"2024-05-24T06:01:29Z","is_active":true,"name":"Population Health","url":"/compendium/population","children":[],"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"}},{"_type":"subNavigation","children":[],"_updatedAt":"2024-05-24T13:24:58Z","is_active":true,"navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"_createdAt":"2024-05-24T06:01:51Z","url":"/approvals-launches","_rev":"Jz2W7keLhiw1UYkGHfsKLu","name":"Product Approvals and Launches","_id":"6188ac2f-7ec8-4cbb-a154-5822f606f3fa"},{"_id":"4e2fe99b-3ac4-4b48-89ed-774dd51675df","navParent":{"_type":"reference","_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2"},"children":[],"_rev":"QxOJBWa4XErmibN6Cb5bN0","_type":"subNavigation","url":"/topic/technology","is_active":true,"_createdAt":"2020-04-14T14:07:28Z","name":"Technology","_updatedAt":"2020-04-14T14:07:28Z"},{"_updatedAt":"2020-04-14T14:07:42Z","_id":"22bd1bd6-88a6-4278-a846-e086cf30b141","is_active":true,"_createdAt":"2020-04-14T14:07:42Z","url":"/topic/value-based-care","name":"Value-Based Care","_type":"subNavigation","_rev":"T035zdq5xruIFPyK3OzhkC","navParent":{"_ref":"8f999f83-7d66-4c5d-a82c-ecf6b72037f2","_type":"reference"},"children":[]}]},{"is_active":true,"sortOrder":3,"_rev":"N0LuVAjtHhQSyVgQyS0Kyv","name":"Institute for Value-Based Medicine","_updatedAt":"2020-04-27T18:48:23Z","_createdAt":"2020-04-27T18:48:09Z","_type":"subNavigation","subQuery":[{"children":[],"_updatedAt":"2020-05-06T13:11:16Z","navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"_rev":"cyKVTGb2fpu5E4X0UMrv4p","_id":"f7379c68-40be-45e4-9747-484dcec584d3","url":"/ivbm","_createdAt":"2020-05-06T13:11:16Z","_type":"subNavigation","is_active":true,"name":"All Coverage"},{"name":"Event Coverage","_id":"cc8a827f-3e94-413a-aa0c-0d8b40eb5f18","_createdAt":"2020-04-27T18:49:41Z","_rev":"k2D4PisPM2pBS5NIl95QbN","_updatedAt":"2020-04-27T18:49:41Z","url":"/ivbm/event-coverage","is_active":true,"children":[],"_type":"subNavigation","navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"}},{"is_active":true,"_type":"subNavigation","url":"/ivbm/interviews","_updatedAt":"2020-04-27T18:50:03Z","_id":"aa3f3bb8-9e8c-457d-aeb6-7b94b968395a","navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"_createdAt":"2020-04-27T18:50:03Z","_rev":"k2D4PisPM2pBS5NIl95RlO","children":[],"name":"Interviews"},{"_type":"subNavigation","_id":"1be7e99c-8d37-4d70-a009-67eb03fae5ba","children":[],"name":"News","url":"/ivbm/news","is_active":true,"_rev":"XtnP0djhkej33kSTbdUgmN","_updatedAt":"2020-04-27T18:50:34Z","navParent":{"_ref":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","_type":"reference"},"_createdAt":"2020-04-27T18:50:34Z"}],"_id":"6389c35d-3d2d-41db-978d-b3aa4d10cb8e","url":"/ivbm","navParent":null},{"_rev":"lsW1cEPdRFwwIdupAS8Stb","name":"About AJMC","_id":"9a07b754-3383-43ac-9d2d-a370d44406d1","is_active":true,"navParent":null,"subQuery":[{"_rev":"NGYpFwzJghlKjBIAt48VzS","_type":"subNavigation","_updatedAt":"2020-05-07T17:05:52Z","children":[],"is_active":true,"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"_createdAt":"2020-05-07T17:05:52Z","name":"AJMC Journals","_id":"4e10ead3-6a42-43df-b251-b93b912a24cb","url":"/about"},{"_type":"subNavigation","_id":"4451f4fa-a919-45b4-b6e5-282668cd792e","children":[],"_updatedAt":"2020-04-14T14:09:38Z","url":"/anniversary","is_active":true,"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"_createdAt":"2020-04-14T14:09:38Z","_rev":"rHX8vIEJKWyjgUO02y82fe","name":"Anniversary"},{"children":[],"_createdAt":"2020-04-14T14:10:37Z","_rev":"VmKMEDy0rHs5jzhO3eZVVM","_type":"subNavigation","url":"/authorshipforms","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"name":"Author Forms","is_active":true,"_id":"99bccc8e-9329-496f-b588-ec3d080f0859","_updatedAt":"2020-06-09T11:44:06Z"},{"_createdAt":"2020-04-14T14:10:19Z","_id":"518317a5-297f-4c4f-9d2a-6da7b8c98d9c","name":"Authors","url":"/authors","is_active":true,"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"children":[],"_rev":"0JTsteyxJPdyCvciQ9yBPv","_type":"subNavigation","_updatedAt":"2020-05-06T12:53:11Z"},{"name":"Nominate a Rising Leader","is_active":true,"_type":"subNavigation","children":[],"_updatedAt":"2020-06-15T17:13:51Z","navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"},"_createdAt":"2020-06-15T17:13:51Z","_rev":"m6BzyPIGe9IGx2bV3pSCbq","url":"/seema-sonnad-nomination","_id":"a96a44c9-4d51-47c6-8f81-4263bd2f58b4"},{"_createdAt":"2023-03-14T13:29:28Z","_rev":"TctAtfg0qER1kILh39bPC4","_type":"subNavigation","url":"/submit-a-manuscript","children":[],"name":"Submit a Manuscript","_id":"4420e458-acb4-4edb-9f33-c4fc4504ff41","_updatedAt":"2023-03-14T13:29:28Z","is_active":true,"navParent":{"_ref":"9a07b754-3383-43ac-9d2d-a370d44406d1","_type":"reference"}}],"_createdAt":"2020-04-14T14:09:11Z","sortOrder":4,"_type":"subNavigation","_updatedAt":"2020-04-27T18:48:27Z"}],"site_setting":{"keywords":["American Journal of Managed Care","AJMC"],"creativeLayout":null,"socialLinks":[{"blank":true,"_type":"urlArray","_key":"5a09ae68c48c","title":"Facebook","url":"https://www.facebook.com/TheAmericanJournalOfManagedCare"},{"blank":true,"_type":"urlArray","_key":"ad6b3d250e0b","title":"Twitter","url":"https://twitter.com/AJMC_Journal"},{"_type":"urlArray","_key":"7d1e53fa7d09","title":"LinkedIn","url":"https://www.linkedin.com/company/american-journal-of-managed-care/","blank":true},{"_key":"2478204aa05c","title":"Instagram","url":"https://www.instagram.com/ajmcjournal/","blank":true,"_type":"urlArray"},{"blank":true,"_type":"urlArray","_key":"0ba4cf990c2f","title":"RSS","url":"/rss"}],"name":"AJMC - Managed Care News, Research, and Expert Insights","_id":"siteSettings","_rev":"iBzEylCaJfBlbg7ZehwyvL","siteURL":"www.ajmc.com","footerLinks":[{"title":"About","url":"/about-us","_type":"urlArray","_key":"6170fdefc8129a5a7ef9dfdd78a2573e"},{"_type":"urlArray","_key":"281c240875d5","title":"Contact","url":"/contactus"},{"url":"/editorial-boards","_type":"urlArray","_key":"25e9e6fb7b4422cd0ac20e1a1d993228","title":"Editorial Boards"},{"url":"/advertise","_type":"urlArray","_key":"20a44c137e8d","title":"Advertise"},{"title":"Do Not Sell My Information","url":"https://www.mjhlifesciences.com/ccpa?domain=www.ajmc.com","blank":true,"_type":"urlArray","_key":"21b84fcc9b6e"},{"_type":"urlArray","_key":"2f35307aab1f","title":"Terms \u0026 Conditions","url":"/terms"},{"title":"Privacy Policy","url":"/privacy","_type":"urlArray","_key":"50ecd8627d01"}],"description":"The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.","_type":"siteSettings","copyRightText":"AJMC®","enableSanity2":true,"alternateName":"The American Journal of Managed Care","orangizationName":"AJMC","_updatedAt":"2025-01-23T16:12:11Z","salesforceDMPId":"tr3xsudox","_createdAt":"2020-04-14T14:14:32Z","gaID":"UA-155582410-5,UA-11140057-3","creativeLayoutLatestNews":null},"clinicalData":[{"children":[],"_id":"4ee49086-e720-4a65-883e-4efc24de53bb","name":"Center on Health Equity \u0026 Access","identifier":"center-on-health-equity-and-access","sortOrder":null},{"_id":"topic_clinical","name":"Clinical","identifier":"clinical","sortOrder":null,"children":[]},{"identifier":"healthcare-cost","sortOrder":null,"children":[],"_id":"topic_healthcare-cost","name":"Health Care Cost"},{"identifier":"healthcare-delivery","sortOrder":null,"children":[],"_id":"topic_healthcare-delivery","name":"Health Care Delivery"},{"sortOrder":null,"children":[],"_id":"topic_insurance","name":"Insurance","identifier":"insurance"},{"name":"Policy","identifier":"policy","sortOrder":null,"children":[],"_id":"topic_policy"},{"sortOrder":null,"children":[],"_id":"topic_technology","name":"Technology","identifier":"technology"},{"_id":"topic_value-based-care","name":"Value-Based Care","identifier":"value-based-care","sortOrder":null,"children":[]}],"seo_data":[],"recent_news":[{"_id":"2eada1ba-6694-4c11-b981-a83bacf411f1","title":"Kansas City’s TB Outbreak Can Be Contained With the Lessons From COVID-19","summary":"In this final interview clip, Michael A. Bernstein, MD, stresses the need for effective communication and proactive screening to contain the ongoing tuberculosis (TB) outbreak in Kansas City.","thumbnail":{"_type":"mainImage","alt":"Dr Michael Bernstein","asset":{"_ref":"image-4e67a71e53a44a0736c2c37c0e31fa17cf1c24cc-2876x1537-png","_type":"reference"}},"url":{"current":"kansas-city-s-tb-outbreak-can-be-contained-with-the-lessons-from-covid-19","_type":"slug"},"authorMapping":{"profileImage":{"asset":{"_ref":"image-1fe4e81696463cdd9c1d6b62a2e47c2228d7df99-430x430-png","_type":"reference"},"_type":"mainImage","alt":"Brooke McCormick"},"_updatedAt":"2025-01-08T16:42:13Z","firstName":"Brooke","_createdAt":"2023-06-21T17:59:19Z","_type":"author","biography":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Brooke is an associate editor for ","_key":"8d68730a8da0"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"730c46c984c9"},{"_type":"span","marks":[],"text":"® (","_key":"0b218fbaa571"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b1b5b3d9cff0"},{"marks":[],"text":"®). She joined ","_key":"7de919198f04","_type":"span"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"f31a60d737e2"},{"_type":"span","marks":[],"text":" in 2023, where she produces written content covering multiple disease states.","_key":"df11193684f8"}],"_type":"block","style":"normal","_key":"936ecf4b7f0c"},{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"5731fbb8e0ae"}],"_type":"block","style":"normal","_key":"9af540ce04de"},{"children":[{"text":"She has a BA in journalism from Seton Hall University. You can connect with Brooke on ","_key":"bb68b5e8ee83","_type":"span","marks":[]},{"_key":"4bb222fe2840","_type":"span","marks":["80a1c1a9d7cd"],"text":"LinkedIn"},{"text":".","_key":"c87621477700","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"98aee68dab9d","markDefs":[{"href":"https://www.linkedin.com/in/brooke-mccormick-1a254b1b6/","_key":"80a1c1a9d7cd","nofollow":true,"blank":true,"_type":"link"}]}],"_id":"00af9d05-a2c4-4451-a6d1-0e28b08cbb65","url":{"current":"brooke-mccormick","_type":"slug"},"lastName":"McCormick","authorType":"author","displayName":"Brooke McCormick","_rev":"A9UM2QVfJg2GpKiBNGLBGh"},"contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"published":"2025-02-15T14:00:00.000Z","factCheckAuthorMapping":null},{"_id":"4558ddec-cea0-44fa-8b00-9bc10ca97dbc","url":{"current":"powles-highlights-transformative-benefit-of-ev-plus-pembro-while-sharing-long-term-data-for-ev-302","_type":"slug"},"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"authorMapping":{"biography":[{"_type":"block","style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_key":"f56917041c08","_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for "},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"text":"AJMC","_key":"3c5f9805f644","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_key":"953d8c643cce","_type":"span","marks":["em"],"text":"AJMC"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}]},{"markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"text":"LinkedIn","_key":"9737335da1ed1","_type":"span","marks":["4f88673cb2c4"]},{"marks":[],"text":".","_key":"9737335da1ed2","_type":"span"}],"_type":"block","style":"normal","_key":"a03d32973d6e"}],"_updatedAt":"2023-10-12T05:02:06Z","url":{"current":"mary-caffrey","_type":"slug"},"displayName":"Mary Caffrey","_createdAt":"2020-05-05T10:50:00Z","_rev":"fWre465xUeSiaQm83HJghZ","_type":"author","_id":"author_6732921f288a3775abb89da57903428b"},"factCheckAuthorMapping":null,"title":"Powles Highlights “Transformative” Benefit of EV Plus Pembro While Sharing Long-Term Data for EV-302","summary":"The lead investigator for EV-302 said not long ago, survival of 12 to 14 months in this type of bladder cancer was considered an achievement; in this study, median overall survival was 34 months after treatment with enfortumab vedotin (EV) and pembrolizumab (pembro).","thumbnail":{"_type":"mainImage","asset":{"_ref":"image-3a19b338994d57764d7f408c063ffc36b037edcc-640x410-jpg","_type":"reference"}},"published":"2025-02-15T13:42:00.000Z"},{"published":"2025-02-15T04:02:00.000Z","factCheckAuthorMapping":null,"summary":"City of Hope's Salvador Jaime-Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody-drug conjugate (ADC) combinations in advanced urothelial cancer. ","title":"Analysis Looks at Benefits, Toxicity of ADC Combinations in Advanced Bladder Cancer","thumbnail":{"_type":"mainImage","caption":"Padcev packaging | Image: Astellas/Seagen","asset":{"_ref":"image-a13ef0cd0e6b56f4e0f3835241425ff4035f5ade-600x450-jpg","_type":"reference"}},"url":{"current":"analysis-looks-at-benefits-toxicity-of-adc-combinations-in-advanced-bladder-cancer","_type":"slug"},"authorMapping":{"_createdAt":"2020-05-05T10:50:00Z","_rev":"fWre465xUeSiaQm83HJghZ","_type":"author","_id":"author_6732921f288a3775abb89da57903428b","biography":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_key":"f56917041c08","_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for "},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"text":"AJMC","_key":"3c5f9805f644","_type":"span","marks":["em"]},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_key":"953d8c643cce","_type":"span","marks":["em"],"text":"AJMC"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal","_key":"80606b0b2412"},{"markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"text":"LinkedIn","_key":"9737335da1ed1","_type":"span","marks":["4f88673cb2c4"]},{"marks":[],"text":".","_key":"9737335da1ed2","_type":"span"}],"_type":"block","style":"normal","_key":"a03d32973d6e"}],"_updatedAt":"2023-10-12T05:02:06Z","url":{"current":"mary-caffrey","_type":"slug"},"displayName":"Mary Caffrey"},"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"_id":"3ed48850-d9c6-4a8c-ba73-c594f3511884"},{"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"title":"Adults With DMD More Than Twice as Likely to Experience Fractures","summary":"Less than half of patients had undergone bone monitoring, suggesting a need for better clinical guidance and management of osteoporosis in adult men with Duchenne muscular dystrophy (DMD). ","thumbnail":{"_type":"mainImage","alt":"Vertebral fractures are common in glucocorticoid-associated osteoporosis and are a clinical indicator of osteoporosis in young patients. | Image credit: Hugnaka - stock.adobe.com","asset":{"_ref":"image-06061deade20b7548bf1379ea5954d86c9277e14-1200x675-jpg","_type":"reference"}},"url":{"current":"adults-with-dmd-more-than-twice-as-likely-to-experience-fractures","_type":"slug"},"published":"2025-02-14T19:58:31.989Z","authorMapping":{"biography":[{"_key":"3a2b873558e3","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Rose is an associate editorial director at ","_key":"123612bd9b2b0"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"2cd28f20d2b9"},{"marks":["superscript"],"text":"®","_key":"032c8e723210","_type":"span"},{"_type":"span","marks":[],"text":" (","_key":"e2d5625eae03"},{"text":"AJMC","_key":"3af109dc927a","_type":"span","marks":["em"]},{"marks":["superscript"],"text":"®","_key":"1903cd426eb6","_type":"span"},{"_type":"span","marks":[],"text":").","_key":"688f269c2ad0"}],"_type":"block","style":"normal"},{"children":[{"text":"She has a BA in journalism \u0026 media studies and Spanish from Rutgers University. You can connect with Rose on ","_key":"3abc796e3805","_type":"span","marks":[]},{"_type":"span","marks":["a1a427c7e90e"],"text":"LinkedIn","_key":"123612bd9b2b1"},{"marks":[],"text":".","_key":"123612bd9b2b2","_type":"span"}],"_type":"block","style":"normal","_key":"3a18842aed2b","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/rose-mcnulty-652a09126/","_key":"a1a427c7e90e","nofollow":true}]}],"profileImage":{"_type":"mainImage","alt":"Rose McNulty","asset":{"_ref":"image-8445b436ab605560bc20c7e9c6f4f60912e914df-430x430-png","_type":"reference"}},"firstName":"Rose","_createdAt":"2020-10-06T12:46:55Z","_rev":"N7mKycgLbGtEq6btkTWlrd","_id":"9243ec08-02c0-4c8e-b586-619334f7f95d","_updatedAt":"2024-06-13T13:26:39Z","url":{"current":"rose-mcnulty","_type":"slug"},"lastName":"McNulty","displayName":"Rose McNulty","_type":"author"},"factCheckAuthorMapping":null,"_id":"e8553f02-8c8e-474a-aff1-3fc1c824a93a"}],"latest_publications":[{"published":"2025-02-11T14:00:00.000Z","authorDetails":[{"showSocialShare":null,"displayName":"Hinpetch Daungsupawong, PhD","firstName":"Hinpetch","lastName":"Daungsupawong","url":{"_type":"slug","current":"hinpetch-daungsupawong-phd"},"profileImage":null,"biography":null},{"biography":null,"showSocialShare":null,"displayName":"Viroj Wiwanitkit, MD","firstName":"Viroj","lastName":"Wiwanitkit","url":{"_type":"slug","current":"viroj-wiwanitkit-md"},"profileImage":null}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Hinpetch Daungsupawong, PhD","firstName":"Hinpetch","lastName":"Daungsupawong","url":{"current":"hinpetch-daungsupawong-phd","_type":"slug"},"profileImage":null},{"url":{"_type":"slug","current":"viroj-wiwanitkit-md"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Viroj Wiwanitkit, MD","firstName":"Viroj","lastName":"Wiwanitkit"}],"thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"metadata":{"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"lightMuted":{"population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52,"background":"#18568d"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93,"background":"#cae1f2"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png"}},"issueGroup":{"_ref":"cfc4ad72-548d-4101-af2d-9fff7f70ed64","_type":"reference"},"title":"KAP Regarding ChatGPT Among Health Care Professionals: Correspondence","summary":"This letter discusses previously published research that paves the way for deeper exploration of the ethical and human aspects of artificial intelligence in health care.","url":"kap-regarding-chatgpt-among-health-care-professionals-correspondence","_id":"029c0e16-5487-4d46-8669-9c80e6c775d2"},{"issueGroup":{"_ref":"cfc4ad72-548d-4101-af2d-9fff7f70ed64","_type":"reference"},"title":"Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans","summary":"This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.","url":"medical-policy-determinations-for-pharmacogenetic-tests-among-us-health-plans","published":"2025-02-10T14:00:00.000Z","authorDetails":[{"showSocialShare":null,"displayName":"Jai N. Patel, PharmD","firstName":"Jai","lastName":"Patel","url":{"current":"jai-n-patel-pharmd","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"Lena","lastName":"Chaihorsky","url":{"current":"lena-chaihorsky-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Lena Chaihorsky, BS"},{"lastName":"Dong","url":{"_type":"slug","current":"olivia-m-dong-phd"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Olivia M. Dong, PhD","firstName":"Olivia"},{"lastName":"Lu","url":{"current":"christine-y-lu-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Christine Y. Lu, PhD","firstName":"Christine"},{"showSocialShare":null,"displayName":"Chad Moretz, ScD","firstName":"Chad","lastName":"Moretz","url":{"current":"chad-moretz-scd","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"Emily Reese, PhD, MPH","firstName":"Emily","lastName":"Reese","url":{"current":"emily-reese-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Wrenda","lastName":"Teeple","url":{"current":"wrenda-teeple-pharmd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Wrenda Teeple, PharmD"},{"url":{"current":"benjamin-brown-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Benjamin Brown, BS","firstName":"Benjamin ","lastName":"Brown"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Sara Rogers, PharmD","firstName":"Sara","lastName":"Rogers","url":{"current":"sara-rogers-pharmd","_type":"slug"}}],"_id":"90b5927a-b28a-40cd-a19e-2ad54b3a4de3","thumbnail":{"asset":{"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93,"background":"#cae1f2"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382}},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png"},"_type":"mainImage","alt":"AJMC"},"factCheckBy":[{"displayName":"Jai N. Patel, PharmD","firstName":"Jai","lastName":"Patel","url":{"current":"jai-n-patel-pharmd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"lastName":"Chaihorsky","url":{"current":"lena-chaihorsky-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Lena Chaihorsky, BS","firstName":"Lena"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Olivia M. Dong, PhD","firstName":"Olivia","lastName":"Dong","url":{"current":"olivia-m-dong-phd","_type":"slug"}},{"displayName":"Christine Y. Lu, PhD","firstName":"Christine","lastName":"Lu","url":{"current":"christine-y-lu-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Chad Moretz, ScD","firstName":"Chad","lastName":"Moretz","url":{"current":"chad-moretz-scd","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"Emily","lastName":"Reese","url":{"_type":"slug","current":"emily-reese-phd-mph"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Emily Reese, PhD, MPH"},{"biography":null,"showSocialShare":null,"displayName":"Wrenda Teeple, PharmD","firstName":"Wrenda","lastName":"Teeple","url":{"current":"wrenda-teeple-pharmd","_type":"slug"},"profileImage":null},{"showSocialShare":null,"displayName":"Benjamin Brown, BS","firstName":"Benjamin ","lastName":"Brown","url":{"current":"benjamin-brown-bs","_type":"slug"},"profileImage":null,"biography":null},{"lastName":"Rogers","url":{"current":"sara-rogers-pharmd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Sara Rogers, PharmD","firstName":"Sara"}]},{"published":"2025-02-07T18:00:00.000Z","authorDetails":[{"lastName":"Xie","url":{"current":"zhigang-xie-phd-mpa","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Zhigang Xie, PhD, MPA","firstName":"Zhigang"},{"displayName":"Hanadi Y. Hamadi, PhD","firstName":"Hanadi","lastName":"Hamadi","url":{"current":"hanadi-y-hamadi-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Elissa Barr, PhD","firstName":"Elissa","lastName":"Barr","url":{"_type":"slug","current":"elissa-barr-phd"},"profileImage":null,"biography":null,"showSocialShare":null},{"biography":null,"showSocialShare":null,"displayName":"Beomyoung Cho, PhD, MPH","firstName":"Beomyoung","lastName":"Cho","url":{"current":"beomyoung-cho-phd-mph","_type":"slug"},"profileImage":null},{"lastName":"Patel","url":{"current":"shraddha-patel-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Shraddha Patel, MPH","firstName":"Shraddha"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Young-Rock Hong, PhD, MPH","firstName":"Young-Rock","lastName":"Hong","url":{"current":"young-rock-hong-phd-mph","_type":"slug"}}],"_id":"86a76eae-6bea-47a1-b6d4-35fc79593c22","issueGroup":{"_ref":"cfc4ad72-548d-4101-af2d-9fff7f70ed64","_type":"reference"},"thumbnail":{"asset":{"size":203185,"metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"muted":{"foreground":"#fff","title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71,"background":"#37536a"}},"hasAlpha":true,"lqip":"data:image/png;base64,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"},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png"},"_type":"mainImage","alt":"AJMC"},"factCheckBy":[{"displayName":"Zhigang Xie, PhD, MPA","firstName":"Zhigang","lastName":"Xie","url":{"current":"zhigang-xie-phd-mpa","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Hanadi","lastName":"Hamadi","url":{"current":"hanadi-y-hamadi-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Hanadi Y. Hamadi, PhD"},{"displayName":"Elissa Barr, PhD","firstName":"Elissa","lastName":"Barr","url":{"current":"elissa-barr-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"url":{"_type":"slug","current":"beomyoung-cho-phd-mph"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Beomyoung Cho, PhD, MPH","firstName":"Beomyoung","lastName":"Cho"},{"lastName":"Patel","url":{"current":"shraddha-patel-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Shraddha Patel, MPH","firstName":"Shraddha"},{"displayName":"Young-Rock Hong, PhD, MPH","firstName":"Young-Rock","lastName":"Hong","url":{"current":"young-rock-hong-phd-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"title":"Hospitalization Patterns Among Older Patients With Cancer With and Without Dementia","summary":"Dementia was more prevalent in older patients with some cancer types, and comorbid dementia in this population was associated with unplanned or unnecessary hospitalization.","url":"hospitalization-patterns-among-older-patients-with-cancer-with-and-without-dementia"},{"_id":"a74e0c61-1db8-4176-a3ff-356818f8f1bc","title":"MRD and Other Predictors From FELIX for Obe-Cel Success in R/R B-ALL","summary":null,"url":"mrd-and-other-predictors-from-felix-for-obe-cel-success-in-r-r-b-all","factCheckBy":[{"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null,"biography":[{"_type":"block","style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"marks":["em"],"text":"AJMC","_key":"3c5f9805f644","_type":"span"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}]},{"_key":"a03d32973d6e","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}],"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}],"_type":"block","style":"normal"}],"showSocialShare":null},{"biography":null,"showSocialShare":null,"displayName":"Elias J. Jabbour, MD","firstName":null,"lastName":null,"url":{"current":"elias-j-jabbour-md","_type":"slug"},"profileImage":null}],"issueGroup":{"_type":"reference","_ref":"5115f1e5-56a6-462e-9219-36c2ee74bc64"},"thumbnail":{"asset":{"mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/d7b07ba2f95a91eead9b2ff8ea1eab8b3e1e9ff2-360x202.jpg","originalFilename":"Elias Jabbour MD.jpg","assetId":"d7b07ba2f95a91eead9b2ff8ea1eab8b3e1e9ff2","uploadId":"AI9UWYzlKUzpNZoSkOg0eaGj37ri4uGg","_rev":"03H5IWZJxxErG40FSFrSh1","_type":"sanity.imageAsset","sha1hash":"d7b07ba2f95a91eead9b2ff8ea1eab8b3e1e9ff2","path":"images/0vv8moc6/ajmc/d7b07ba2f95a91eead9b2ff8ea1eab8b3e1e9ff2-360x202.jpg","extension":"jpg","metadata":{"isOpaque":true,"blurHash":"MKL;jYxvNZ%MMw%0?a%g-;IA~qWBs:aeWB","_type":"sanity.imageMetadata","palette":{"muted":{"title":"#fff","population":1.13,"background":"#8d624f","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#ececfc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.02},"darkVibrant":{"background":"#5d3626","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0},"lightMuted":{"title":"#fff","population":0.2,"background":"#c6b8b8","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.25,"background":"#c78e77"},"dominant":{"population":5.59,"background":"#563d35","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#563d35","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.59}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAALABQDASIAAhEBAxEB/8QAGAAAAwEBAAAAAAAAAAAAAAAAAAYHBAX/xAAjEAABBAIBAwUAAAAAAAAAAAABAAIDBAURBhITIjEyQXGR/8QAFQEBAQAAAAAAAAAAAAAAAAAAAAH/xAAZEQACAwEAAAAAAAAAAAAAAAAAAQIREjL/2gAMAwEAAhEDEQA/AKrfz9jIYi9Xp9feMTg0s9QuJxKTKYziUZtwvY17yQCdkLThR2pnGPxJ0Dr7TFaAdMyIjcfT7fhXC6G6TiJsj7Uzy8MdooVHr1YBEAImfiFAf//Z","dimensions":{"width":360,"aspectRatio":1.7821782178217822,"height":202,"_type":"sanity.imageDimensions"}},"size":8344,"_createdAt":"2025-01-22T01:39:28Z","_id":"image-d7b07ba2f95a91eead9b2ff8ea1eab8b3e1e9ff2-360x202-jpg","_updatedAt":"2025-01-22T01:39:28Z"},"_type":"mainImage","alt":"Elias Jabbour, MD | Image credit: MD Anderson","caption":"Elias Jabbour, MD | Image credit: MD Anderson"},"published":"2025-01-22T01:20:00.000Z","authorDetails":[{"firstName":null,"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"},"profileImage":null,"biography":[{"markDefs":[],"children":[{"_key":"9737335da1ed0","_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span","marks":["em"]},{"_key":"1b94f48924f3","_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for "},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal","_key":"80606b0b2412"},{"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4","nofollow":true,"blank":true}],"children":[{"marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357","_type":"span"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_key":"9737335da1ed2","_type":"span","marks":[],"text":"."}]}],"showSocialShare":null,"displayName":"Mary Caffrey"},{"biography":null,"showSocialShare":null,"displayName":"Elias J. Jabbour, MD","firstName":null,"lastName":null,"url":{"current":"elias-j-jabbour-md","_type":"slug"},"profileImage":null}]},{"published":"2025-01-20T17:00:00.000Z","authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Denise Tran, PharmD","firstName":"Denise","lastName":"Tran","url":{"current":"denise-tran-pharmd","_type":"slug"},"profileImage":null},{"showSocialShare":null,"displayName":"Haesuk Park, PhD","firstName":"Haesuk","lastName":"Park","url":{"_type":"slug","current":"haesuk-park-phd"},"profileImage":null,"biography":null},{"biography":null,"showSocialShare":null,"displayName":"Jordon Rabey, MS","firstName":"Jordon","lastName":"Rabey","url":{"current":"jordon-rabey-ms","_type":"slug"},"profileImage":null},{"url":{"current":"seth-killion-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Seth Killion, BS","firstName":"Seth","lastName":"Killion"},{"lastName":"Arelli","url":{"current":"s-bobby-arelli-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"S. Bobby Arelli, MD","firstName":"S."},{"showSocialShare":null,"displayName":"Elaine Murphy, BS","firstName":"Elaine","lastName":"Murphy","url":{"current":"elaine-murphy-bs","_type":"slug"},"profileImage":null,"biography":null},{"url":{"current":"yoona-kim-pharmd-phd","_type":"slug"},"profileImage":null,"biography":[{"style":"normal","_key":"bf797f939822","markDefs":[{"_type":"link","href":"https://www.arine.io/?utm_campaign=Public%20Relations\u0026utm_source=Bylined%20Article\u0026utm_medium=AJMC\u0026utm_content=Optimizing%20Medication%20Outcomes","_key":"531fb76b610f","nofollow":true,"blank":true}],"children":[{"marks":[],"text":"Yoona Kim, PharmD, PhD, is the CEO and co-founder of ","_key":"f5c43b0094150","_type":"span"},{"text":"Arine","_key":"1e6470ee49ca","_type":"span","marks":["531fb76b610f"]},{"_type":"span","marks":[],"text":", a next-generation medication intelligence company with a mission to solve medication mismanagement across the health care continuum. Arine’s proprietary platform pulls insights from a complex ecosystem of clinical, socioeconomic, and behavioral data to optimize patient outcomes and deliver value-based care. The technology uses predictive analytics to target care to at-risk members, develops artificial intelligence (AI)-driven personalized care plans for each patient, and uses machine learning to continuously optimize members’ medication therapy. Arine overcomes the limits of traditional, manually driven medication management approaches by making the practice scalable and allowing time-strapped health care providers to deliver care to large populations and with a far greater impact. Arine’s clients have achieved the highest quality ratings and have reduced hospital admissions by 40%.","_key":"2ad98b63e1fb"}],"_type":"block"},{"_type":"block","style":"normal","_key":"816767524ea1","markDefs":[],"children":[{"text":"Arine’s AI-driven technology platform is powering successful interventions that navigate complexities discussed in this article. For example, Arine’s platform identified a 67-year-old Latinx male in Medicare Advantage with diabetes and an elevated hemoglobin A","_key":"ee58d5fd8fca0","_type":"span","marks":[]},{"_type":"span","marks":["subscript"],"text":"1C","_key":"2886ba74f33e"},{"_type":"span","marks":[],"text":" at high risk for hyperglycemic crisis. He had a history of medication nonadherence and canceling appointments and expressed difficulty affording a branded diabetes medication. Arine’s platform identified a generic option, along with several other recommendations, to optimize the member’s array of medications for other comorbidities. The platform also flagged a pattern of underutilization of care, indicated by an absence of a primary care visit within the last year and connected the member to an appointment. These measures were supplemented by auto-generated Spanish-language educational materials on the importance of medications and lifestyle changes for diabetes management. Ultimately, the member was very receptive to the recommendations and started taking his medications more regularly.","_key":"00cebefaa126"}]},{"children":[{"_type":"span","marks":[],"text":"Prior to Arine, Yoona has held various roles at digital health, pharma, and consulting companies. She holds a bachelor’s degree from Stanford University; a PharmD with an emphasis in health policy and management from the University of California, San Francisco; and a PhD in health economics and outcomes from the University of Texas at Austin.","_key":"9db59a3d155d0"}],"_type":"block","style":"normal","_key":"88840c7d9452","markDefs":[]},{"children":[{"text":"","_key":"49f538df32460","_type":"span","marks":[]}],"_type":"block","style":"normal","_key":"f9ff3fa5d2f5","markDefs":[]}],"showSocialShare":null,"displayName":"Yoona Kim, PharmD, PhD","firstName":"Yoona","lastName":"Kim"}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Denise Tran, PharmD","firstName":"Denise","lastName":"Tran","url":{"current":"denise-tran-pharmd","_type":"slug"},"profileImage":null},{"displayName":"Haesuk Park, PhD","firstName":"Haesuk","lastName":"Park","url":{"current":"haesuk-park-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Jordon","lastName":"Rabey","url":{"current":"jordon-rabey-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jordon Rabey, MS"},{"firstName":"Seth","lastName":"Killion","url":{"current":"seth-killion-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Seth Killion, BS"},{"firstName":"S.","lastName":"Arelli","url":{"current":"s-bobby-arelli-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"S. Bobby Arelli, MD"},{"firstName":"Elaine","lastName":"Murphy","url":{"current":"elaine-murphy-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Elaine Murphy, BS"},{"firstName":"Yoona","lastName":"Kim","url":{"current":"yoona-kim-pharmd-phd","_type":"slug"},"profileImage":null,"biography":[{"_type":"block","style":"normal","_key":"bf797f939822","markDefs":[{"_key":"531fb76b610f","nofollow":true,"blank":true,"_type":"link","href":"https://www.arine.io/?utm_campaign=Public%20Relations\u0026utm_source=Bylined%20Article\u0026utm_medium=AJMC\u0026utm_content=Optimizing%20Medication%20Outcomes"}],"children":[{"_key":"f5c43b0094150","_type":"span","marks":[],"text":"Yoona Kim, PharmD, PhD, is the CEO and co-founder of "},{"_type":"span","marks":["531fb76b610f"],"text":"Arine","_key":"1e6470ee49ca"},{"_type":"span","marks":[],"text":", a next-generation medication intelligence company with a mission to solve medication mismanagement across the health care continuum. Arine’s proprietary platform pulls insights from a complex ecosystem of clinical, socioeconomic, and behavioral data to optimize patient outcomes and deliver value-based care. The technology uses predictive analytics to target care to at-risk members, develops artificial intelligence (AI)-driven personalized care plans for each patient, and uses machine learning to continuously optimize members’ medication therapy. Arine overcomes the limits of traditional, manually driven medication management approaches by making the practice scalable and allowing time-strapped health care providers to deliver care to large populations and with a far greater impact. Arine’s clients have achieved the highest quality ratings and have reduced hospital admissions by 40%.","_key":"2ad98b63e1fb"}]},{"_type":"block","style":"normal","_key":"816767524ea1","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Arine’s AI-driven technology platform is powering successful interventions that navigate complexities discussed in this article. For example, Arine’s platform identified a 67-year-old Latinx male in Medicare Advantage with diabetes and an elevated hemoglobin A","_key":"ee58d5fd8fca0"},{"_type":"span","marks":["subscript"],"text":"1C","_key":"2886ba74f33e"},{"_type":"span","marks":[],"text":" at high risk for hyperglycemic crisis. He had a history of medication nonadherence and canceling appointments and expressed difficulty affording a branded diabetes medication. Arine’s platform identified a generic option, along with several other recommendations, to optimize the member’s array of medications for other comorbidities. The platform also flagged a pattern of underutilization of care, indicated by an absence of a primary care visit within the last year and connected the member to an appointment. These measures were supplemented by auto-generated Spanish-language educational materials on the importance of medications and lifestyle changes for diabetes management. Ultimately, the member was very receptive to the recommendations and started taking his medications more regularly.","_key":"00cebefaa126"}]},{"_type":"block","style":"normal","_key":"88840c7d9452","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Prior to Arine, Yoona has held various roles at digital health, pharma, and consulting companies. She holds a bachelor’s degree from Stanford University; a PharmD with an emphasis in health policy and management from the University of California, San Francisco; and a PhD in health economics and outcomes from the University of Texas at Austin.","_key":"9db59a3d155d0"}]},{"_key":"f9ff3fa5d2f5","markDefs":[],"children":[{"_type":"span","marks":[],"text":"","_key":"49f538df32460"}],"_type":"block","style":"normal"}],"showSocialShare":null,"displayName":"Yoona Kim, PharmD, PhD"}],"_id":"83a8ce9d-6abb-4501-81a9-077d46c26bf1","issueGroup":{"_ref":"3be6d418-ebd1-4073-af15-1f73168f5c71","_type":"reference"},"summary":"A nurse-led personalized care program conducted through a specialty pharmacy prolonged medication persistence among patients with cancer receiving olaparib.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"metadata":{"_type":"sanity.imageMetadata","palette":{"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc"},"vibrant":{"population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightVibrant":{"population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.09,"background":"#044679"}},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj"},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png"}},"title":"Effects of Individualized Nurse-Led Care Plans on Olaparib Treatment Duration","url":"effects-of-individualized-nurse-led-care-plans-on-olaparib-treatment-duration"},{"published":"2025-01-17T14:00:00.000Z","authorDetails":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Zachary Villaverde, BS","firstName":"Zachary","lastName":"Villaverde","url":{"current":"zachary-villaverde-bs","_type":"slug"}},{"url":{"current":"roy-h-hinman-ii-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Roy H. Hinman II, MD","firstName":"Roy","lastName":"Hinman"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Richard M. Grimes, PhD","firstName":"Richard","lastName":"Grimes","url":{"current":"richard-m-grimes-phd","_type":"slug"}}],"factCheckBy":[{"showSocialShare":null,"displayName":"Zachary Villaverde, BS","firstName":"Zachary","lastName":"Villaverde","url":{"_type":"slug","current":"zachary-villaverde-bs"},"profileImage":null,"biography":null},{"displayName":"Roy H. Hinman II, MD","firstName":"Roy","lastName":"Hinman","url":{"current":"roy-h-hinman-ii-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"url":{"current":"richard-m-grimes-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Richard M. Grimes, PhD","firstName":"Richard","lastName":"Grimes"}],"_id":"4f36a408-190c-4587-b6a4-404014c81e1f","issueGroup":{"_ref":"3be6d418-ebd1-4073-af15-1f73168f5c71","_type":"reference"},"thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"_type":"sanity.imageMetadata","palette":{"darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"foreground":"#fff","title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"foreground":"#fff","title":"#fff","population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette"},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj"},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z"}},"title":"Physiologic Insulin Resensitization Lowers Cost in Patients With Diabetes and Kidney Disease","summary":"Patients with diabetes and chronic kidney disease receiving physiologic insulin resensitization had much lower annual costs of care than similar patients not receiving it.","url":"physiologic-insulin-resensitization-lowers-cost-in-patients-with-diabetes-and-kidney-disease"},{"url":"telephone-follow-up-on-medicare-patient-surveys-remains-critical","published":"2025-01-16T14:00:00.000Z","factCheckBy":[{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Ann Haas, MS, MPH","firstName":"Ann","lastName":"Haas","url":{"current":"ann-haas-ms-mph","_type":"slug"}},{"lastName":"Quigley","url":{"current":"denise-d-quigley-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Denise D. Quigley, PhD","firstName":"Denise"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Amelia M. Haviland, PhD","firstName":"Amelia","lastName":"Haviland","url":{"current":"amelia-m-haviland-phd","_type":"slug"}},{"showSocialShare":null,"displayName":"Nate Orr, MA","firstName":"Nate","lastName":"Orr","url":{"current":"nate-orr-ma","_type":"slug"},"profileImage":null,"biography":null},{"displayName":"Julie Brown, BA","firstName":"Julie","lastName":"Brown","url":{"current":"julie-brown-ba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Sarah Gaillot, PhD","firstName":"Sarah","lastName":"Gaillot","url":{"current":"sarah-gaillot-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Marc","lastName":"Elliott","url":{"current":"marc-n-elliott-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Marc N. Elliott, PhD"}],"authorDetails":[{"firstName":"Ann","lastName":"Haas","url":{"current":"ann-haas-ms-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Ann Haas, MS, MPH"},{"biography":null,"showSocialShare":null,"displayName":"Denise D. Quigley, PhD","firstName":"Denise","lastName":"Quigley","url":{"_type":"slug","current":"denise-d-quigley-phd"},"profileImage":null},{"displayName":"Amelia M. Haviland, PhD","firstName":"Amelia","lastName":"Haviland","url":{"current":"amelia-m-haviland-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Nate Orr, MA","firstName":"Nate","lastName":"Orr","url":{"_type":"slug","current":"nate-orr-ma"},"profileImage":null,"biography":null},{"lastName":"Brown","url":{"current":"julie-brown-ba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Julie Brown, BA","firstName":"Julie"},{"biography":null,"showSocialShare":null,"displayName":"Sarah Gaillot, PhD","firstName":"Sarah","lastName":"Gaillot","url":{"current":"sarah-gaillot-phd","_type":"slug"},"profileImage":null},{"displayName":"Marc N. Elliott, PhD","firstName":"Marc","lastName":"Elliott","url":{"current":"marc-n-elliott-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"_id":"55d58c83-54a8-4ffd-83e6-7c1642cb2c0a","issueGroup":{"_ref":"3be6d418-ebd1-4073-af15-1f73168f5c71","_type":"reference"},"title":"Telephone Follow-Up on Medicare Patient Surveys Remains Critical","summary":"Including a telephone component in Medicare Consumer Assessment of Healthcare Providers and Systems survey administration continues to be valuable because telephone responses comprise a substantial portion of responses for several underserved groups.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38,"background":"#628cad"},"lightVibrant":{"population":0.93,"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000"},"darkVibrant":{"population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.52},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette"},"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"}},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z"}}},{"title":"Spotlight on Access and Equity: Bispecifics for Multiple Myeloma in the Community Setting","url":"spotlight-on-access-and-equity-bispecifics-for-multiple-myeloma-in-the-community-setting","published":"2025-01-11T17:28:00.000Z","authorDetails":[{"showSocialShare":null,"displayName":"Luke Halpern","firstName":null,"lastName":null,"url":{"current":"luke-halpern","_type":"slug"},"profileImage":null,"biography":null},{"lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"style":"normal","_key":"b28d8058b3d8","markDefs":[{"_key":"f77b28536a8d","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/"},{"href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link"}],"children":[{"_key":"48d199d8ecd5","_type":"span","marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on "},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"_type":"span","marks":[],"text":" or ","_key":"67a67d3764f02"},{"marks":["c419f18a7ffe"],"text":"Twitter","_key":"67a67d3764f03","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block"}],"showSocialShare":true,"displayName":"Laura Joszt, MA","firstName":"Laura"}],"factCheckBy":[{"displayName":"Luke Halpern","firstName":null,"lastName":null,"url":{"current":"luke-halpern","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Laura Joszt, MA","firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00","_type":"span"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"style":"normal","_key":"b28d8058b3d8","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"nofollow":true,"blank":true,"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5","_type":"span","marks":[]},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"marks":[],"text":" or ","_key":"67a67d3764f02","_type":"span"},{"_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"],"text":"Twitter"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block"}],"showSocialShare":true}],"_id":"de999a47-35fe-4e8d-8527-755d8e08ce93","issueGroup":{"_ref":"5115f1e5-56a6-462e-9219-36c2ee74bc64","_type":"reference"},"summary":null,"thumbnail":{"_type":"mainImage","asset":{"mimeType":"image/jpeg","sha1hash":"d24a7ae4df61f95992f74a25b4d5666da68a6206","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/d24a7ae4df61f95992f74a25b4d5666da68a6206-200x200.jpg","originalFilename":"ontada_logo.jpg","extension":"jpg","assetId":"d24a7ae4df61f95992f74a25b4d5666da68a6206","_id":"image-d24a7ae4df61f95992f74a25b4d5666da68a6206-200x200-jpg","_createdAt":"2025-01-22T17:37:51Z","_updatedAt":"2025-01-22T17:37:51Z","uploadId":"AJOmAkothnE9756fQQSjcbTCOOjl6EfV","_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/d24a7ae4df61f95992f74a25b4d5666da68a6206-200x200.jpg","size":4528,"metadata":{"isOpaque":true,"blurHash":"e96IKkfxRiogRTWCf8fRayfP02e]t8WAt4t7fhfioeju_Lk6R$ogRn","_type":"sanity.imageMetadata","palette":{"lightMuted":{"foreground":"#000","title":"#000","population":0.14,"background":"#c5d0da","_type":"sanity.imagePaletteSwatch"},"vibrant":{"background":"#bde428","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.02},"dominant":{"title":"#fff","population":79.02,"background":"#0c2c44","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"_type":"sanity.imagePalette","darkMuted":{"background":"#334961","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.14},"muted":{"foreground":"#fff","title":"#fff","population":0.44,"background":"#697988","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"foreground":"#000","title":"#fff","population":0,"background":"#c4dc54","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#0c2c44","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":79.02}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAUABQDASIAAhEBAxEB/8QAGAABAAMBAAAAAAAAAAAAAAAAAAEEBgf/xAAgEAACAQQDAAMAAAAAAAAAAAAAAQIDBAUREiExE1Fh/8QAGAEBAAMBAAAAAAAAAAAAAAAAAAEDBAX/xAAZEQEBAQADAAAAAAAAAAAAAAAAAhEBElH/2gAMAwEAAhEDEQA/AOBpN+EpN+Jmgo562pW8IQx1LnFLc2TSz9tDTdhBy72+u/w3xdVvacc7OPWfSf0wXchexua6nSp/FHilxQLEKOhoACUgAB//2Q==","dimensions":{"width":200,"aspectRatio":1,"height":200,"_type":"sanity.imageDimensions"}},"_rev":"z05Cxco1bGw7CBDJOjIZyP"}}},{"_id":"e7f1792f-598b-4b39-a6aa-40177d13717c","url":"spotlight-cilta-cel-shows-sustained-mrd-negativity-leads-to-prolonged-pfs-in-multiple-myeloma","factCheckBy":[{"showSocialShare":null,"displayName":"Pearl Steinzor","firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"biography":null}],"published":"2025-01-09T00:20:00.000Z","authorDetails":[{"firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"profileImage":{"asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"},"_type":"mainImage","alt":"Pearl Steinzor"},"biography":null,"showSocialShare":null,"displayName":"Pearl Steinzor"}],"issueGroup":{"_ref":"5115f1e5-56a6-462e-9219-36c2ee74bc64","_type":"reference"},"title":"SPOTLIGHT: Cilta-Cel Shows Sustained MRD Negativity; Leads to Prolonged PFS in Multiple Myeloma","summary":null,"thumbnail":{"asset":{"_type":"sanity.imageAsset","_updatedAt":"2025-01-22T00:31:10Z","extension":"jpg","metadata":{"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAYABQDASIAAhEBAxEB/8QAGAABAQEBAQAAAAAAAAAAAAAAAAUGAgP/xAAiEAACAQQCAgMBAAAAAAAAAAABAgMABAURBhIiQSExYTL/xAAYAQACAwAAAAAAAAAAAAAAAAABAwACBP/EABsRAAICAwEAAAAAAAAAAAAAAAABAhEDEiEx/9oADAMBAAIRAxEAPwDwy+VTD4Nrsr2k31RT7NZXHcrzJv4Y87YmO2uj1hYLrVXb2FcpFaRuFdIZllZT7Aqzm44r+S3iaMFYyHQqP516pM5tSSRrxQi8bk34TJIB3OxSu7y6VJyoA+KVOlOGO4fk5EzsBlcujnqwP1o1Y5jzOW5uHtcdqC2j8S6jybX7SlO1V2I2damHlzN2H8Zm1+0pSiA//9k=","dimensions":{"_type":"sanity.imageDimensions","width":205,"aspectRatio":0.8333333333333334,"height":246},"isOpaque":true,"blurHash":"eAEoV-x^0#Iq=F~CX9.7xuNG0gxt=FV?Eg.8n~D%WqWA-UWCS2s:V[","_type":"sanity.imageMetadata","palette":{"dominant":{"title":"#fff","population":6.83,"background":"#d5a18e","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.02,"background":"#50343d"},"muted":{"title":"#fff","population":0.01,"background":"#a4505c","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#dbae9e","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0},"darkVibrant":{"title":"#fff","population":2.18,"background":"#532f27","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"foreground":"#000","title":"#fff","population":1.92,"background":"#a9b5b9","_type":"sanity.imagePaletteSwatch"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.83,"background":"#d5a18e"}}},"_rev":"0atQJUC04BTO87jLlB2QZm","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/74682bc40139d223bd547d491e60f19bbf4a7a89-205x246.jpg","path":"images/0vv8moc6/ajmc/74682bc40139d223bd547d491e60f19bbf4a7a89-205x246.jpg","_createdAt":"2025-01-22T00:31:10Z","size":4599,"assetId":"74682bc40139d223bd547d491e60f19bbf4a7a89","_id":"image-74682bc40139d223bd547d491e60f19bbf4a7a89-205x246-jpg","originalFilename":"Yi Lin MD PhD.jpg","uploadId":"ow8Gv8Np3Nj1GOIUCHMbYvdmmOqXIgMk","mimeType":"image/jpeg","sha1hash":"74682bc40139d223bd547d491e60f19bbf4a7a89"},"_type":"mainImage","alt":"Yi Lin, MD, PhD "}},{"authorDetails":[{"lastName":null,"url":{"current":"interview-by-mary-caffrey","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Interview by Mary Caffrey","firstName":null}],"_id":"261d60f2-d321-4f0c-b80a-b02f3f9da3ba","issueGroup":{"_ref":"020f348b-83bc-4402-8a0e-56dfd206392b","_type":"reference"},"title":"The High Cost of Shortages of Low-Cost Chemotherapy","published":"2024-12-19T15:00:00.000Z","summary":null,"thumbnail":{"_type":"mainImage","alt":"chemotherapy | Image credit: Penn Medicine","asset":{"extension":"png","uploadId":"eCMXCsgcAvTQfUHoAFR5Dl14CWyEWapm","_rev":"bAl93RvH29PY4NpeP8EuRS","mimeType":"image/png","sha1hash":"fc90c1bb74fbe4ee2cf001ef6f3c16b51ccacce4","size":600696,"originalFilename":"CHEMO PENN MEDICINE.png","assetId":"fc90c1bb74fbe4ee2cf001ef6f3c16b51ccacce4","_createdAt":"2024-12-19T20:25:38Z","path":"images/0vv8moc6/ajmc/fc90c1bb74fbe4ee2cf001ef6f3c16b51ccacce4-1000x658.png","_updatedAt":"2024-12-19T20:25:38Z","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1000,"aspectRatio":1.5197568389057752,"height":658},"isOpaque":true,"blurHash":"VIKnbqx^%M%Mx]_4?b%MIV-=tRogNGxtxaxst7kDozt6","_type":"sanity.imageMetadata","palette":{"dominant":{"background":"#3c3f48","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.26},"_type":"sanity.imagePalette","darkMuted":{"background":"#3c3f48","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.26},"muted":{"foreground":"#fff","title":"#fff","population":0.63,"background":"#a98a6a","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.07,"background":"#c8b386"},"darkVibrant":{"population":1.52,"background":"#84723e","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":2.17,"background":"#ccc3af"},"vibrant":{"population":0.08,"background":"#cdbb65","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"}},"hasAlpha":false},"_type":"sanity.imageAsset","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/fc90c1bb74fbe4ee2cf001ef6f3c16b51ccacce4-1000x658.png","_id":"image-fc90c1bb74fbe4ee2cf001ef6f3c16b51ccacce4-1000x658-png"}},"url":"the-high-cost-of-shortages-of-low-cost-chemotherapy","factCheckBy":[{"showSocialShare":null,"displayName":"Interview by Mary Caffrey","firstName":null,"lastName":null,"url":{"current":"interview-by-mary-caffrey","_type":"slug"},"profileImage":null,"biography":null}]},{"thumbnail":{"alt":"Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC, leads the panel. | Image credit: Greg Smit for AJMC","caption":"Susan Sabo-Wagner, MSN, RN, OCN, NEA-BC, leads the panel. | Image credit: Greg Smit for AJMC","asset":{"metadata":{"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":7974,"aspectRatio":1.4991539763113366,"height":5319},"isOpaque":true,"blurHash":"VjI=47gO%go}Rj_Nt7%MxuM{o~WYxuafWARjRiaeRjj[","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#e3c7b2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":2.13},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.6,"background":"#582911"},"lightMuted":{"foreground":"#000","title":"#fff","population":1.39,"background":"#c7afaf","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":0.16,"background":"#ca422b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"background":"#987254","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":4.07},"_type":"sanity.imagePalette","darkMuted":{"population":0.51,"background":"#31395a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"foreground":"#fff","title":"#fff","population":4.07,"background":"#987254","_type":"sanity.imagePaletteSwatch"}}},"_type":"sanity.imageAsset","extension":"jpg","sha1hash":"e97c1a1352bf0f13d912b5ccefdf27200d11ec6e","assetId":"e97c1a1352bf0f13d912b5ccefdf27200d11ec6e","_createdAt":"2024-12-18T16:55:14Z","originalFilename":"PCOC Day 1-256.jpg","uploadId":"zGjhajs8WaevHZzaU0m7jijJUWTk7r4v","_id":"image-e97c1a1352bf0f13d912b5ccefdf27200d11ec6e-7974x5319-jpg","_rev":"bAl93RvH29PY4NpeOwJOVS","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/e97c1a1352bf0f13d912b5ccefdf27200d11ec6e-7974x5319.jpg","path":"images/0vv8moc6/ajmc/e97c1a1352bf0f13d912b5ccefdf27200d11ec6e-7974x5319.jpg","size":15130898,"_updatedAt":"2024-12-18T16:55:14Z","mimeType":"image/jpeg"},"_type":"mainImage"},"published":"2024-12-18T16:20:00.000Z","factCheckBy":[{"showSocialShare":null,"displayName":"Pearl Steinzor","firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"biography":null}],"_id":"cd895057-d7f7-4dac-9612-731993914702","issueGroup":{"_ref":"b0733662-6367-4a92-b97f-a3f09117b473","_type":"reference"},"title":"Navigating Persistent Financial Toxicity in the Patient Experience","summary":null,"url":"navigating-persistent-financial-toxicity-in-the-patient-experience","authorDetails":[{"firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"profileImage":{"asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"},"_type":"mainImage","alt":"Pearl Steinzor"},"biography":null,"showSocialShare":null,"displayName":"Pearl Steinzor"}]},{"published":"2024-12-18T16:15:00.000Z","_id":"e50959e8-10ce-479c-840d-6305809f2085","title":"SPOTLIGHT: “I Didn’t Go to Med School to Learn How to Save People Money”","url":"spotlight-i-didn-t-go-to-med-school-to-learn-how-to-save-people-money-","authorDetails":[{"displayName":"Laura Joszt, MA","firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00"}],"_type":"block","style":"normal","_key":"4a950aea97b3"},{"children":[{"_key":"48d199d8ecd5","_type":"span","marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on "},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"_type":"span","marks":[],"text":" or ","_key":"67a67d3764f02"},{"marks":["c419f18a7ffe"],"text":"Twitter","_key":"67a67d3764f03","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block","style":"normal","_key":"b28d8058b3d8","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link"}]}],"showSocialShare":true},{"displayName":"Mary Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-caffrey","_type":"slug"},"profileImage":null,"biography":[{"style":"normal","_key":"80606b0b2412","markDefs":[],"children":[{"_key":"9737335da1ed0","_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® ("},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962","_type":"span","marks":["em"]},{"_key":"1b94f48924f3","_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for "},{"_type":"span","marks":["em"],"text":"AJMC","_key":"3c5f9805f644"},{"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block"},{"_key":"a03d32973d6e","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/","_key":"4f88673cb2c4"}],"children":[{"marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357","_type":"span"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_key":"9737335da1ed2","_type":"span","marks":[],"text":"."}],"_type":"block","style":"normal"}],"showSocialShare":null}],"factCheckBy":[{"firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"children":[{"marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00","_type":"span"}],"_type":"block","style":"normal","_key":"4a950aea97b3","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}]},{"children":[{"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5","_type":"span","marks":[]},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"marks":[],"text":" or ","_key":"67a67d3764f02","_type":"span"},{"_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"],"text":"Twitter"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block","style":"normal","_key":"b28d8058b3d8","markDefs":[{"href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true,"blank":true,"_type":"link"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true}]}],"showSocialShare":true,"displayName":"Laura Joszt, MA"},{"firstName":null,"lastName":null,"url":{"_type":"slug","current":"mary-caffrey"},"profileImage":null,"biography":[{"markDefs":[],"children":[{"_type":"span","marks":[],"text":"Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (","_key":"9737335da1ed0"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b8dda18bb0dc"},{"_type":"span","marks":[],"text":"®). She joined AJMC® in 2013 and is the primary staff editor for ","_key":"f56917041c08"},{"_type":"span","marks":["em"],"text":"Evidence-Based Oncology, ","_key":"8c710bb1d962"},{"_type":"span","marks":[],"text":"the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for ","_key":"1b94f48924f3"},{"marks":["em"],"text":"AJMC","_key":"3c5f9805f644","_type":"span"},{"_type":"span","marks":[],"text":"®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for ","_key":"d533ba55a862"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"953d8c643cce"},{"_type":"span","marks":[],"text":" readers. ","_key":"182af2348b04"}],"_type":"block","style":"normal","_key":"80606b0b2412"},{"children":[{"_type":"span","marks":[],"text":"Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on ","_key":"c2027cf5a357"},{"_type":"span","marks":["4f88673cb2c4"],"text":"LinkedIn","_key":"9737335da1ed1"},{"_type":"span","marks":[],"text":".","_key":"9737335da1ed2"}],"_type":"block","style":"normal","_key":"a03d32973d6e","markDefs":[{"_key":"4f88673cb2c4","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/marykcaffrey/"}]}],"showSocialShare":null,"displayName":"Mary Caffrey"}],"issueGroup":{"_ref":"b0733662-6367-4a92-b97f-a3f09117b473","_type":"reference"},"summary":null,"thumbnail":{"_type":"mainImage","alt":"A. Mark Fendrick, MD","asset":{"_createdAt":"2024-12-18T17:18:30Z","_id":"image-822daaa6aa904a352704626ad00be7e21e1e810e-1024x512-webp","extension":"webp","metadata":{"isOpaque":true,"blurHash":"MNKdJL-U0~9Fn4~qRj%MIUR,yDM{oLa#sS","_type":"sanity.imageMetadata","palette":{"darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.15,"background":"#463837"},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":4.75,"background":"#977b73"},"lightVibrant":{"background":"#f6bbad","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.1},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0,"background":"#781f0c","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":2.05,"background":"#c69f95","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"background":"#ee7257","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.06},"dominant":{"background":"#977b73","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":4.75},"_type":"sanity.imagePalette"},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAKABQDASIAAhEBAxEB/8QAGAAAAwEBAAAAAAAAAAAAAAAAAAUGBAf/xAAlEAACAQMDAgcAAAAAAAAAAAABAgADBAUGESEScQcTFiI0QsH/xAAVAQEBAAAAAAAAAAAAAAAAAAAEA//EABkRAQADAQEAAAAAAAAAAAAAAAEAAhEDIf/aAAwDAQACEQMRAD8AttL5lBcVbYOUbo6gRzuYuzF/XW8qu9zVY0mDKGXaIdPE+o7fn7CUeU92onDcjymOx7Q6bYI7mlednJmreI6qwBrncDmE5FkvlHt+mEu2RyDKD7P/2Q==","dimensions":{"_type":"sanity.imageDimensions","width":1024,"aspectRatio":2,"height":512}},"_rev":"DwR10qWgSie3DjeRpieYPC","_type":"sanity.imageAsset","mimeType":"image/webp","size":26588,"_updatedAt":"2024-12-18T17:18:30Z","uploadId":"m7V9XtPiXtYYOT8dK5g5IcA1r8PNnvpB","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/822daaa6aa904a352704626ad00be7e21e1e810e-1024x512.webp","path":"images/0vv8moc6/ajmc/822daaa6aa904a352704626ad00be7e21e1e810e-1024x512.webp","sha1hash":"822daaa6aa904a352704626ad00be7e21e1e810e","assetId":"822daaa6aa904a352704626ad00be7e21e1e810e","originalFilename":"Mark Fendrick new photo 2017_i.webp"}}},{"url":"spotlight-sarah-hogue-pharmd-on-expanding-the-role-of-oncology-pharmacists","authorDetails":[{"showSocialShare":null,"displayName":"Cameron Santoro","firstName":"Cameron","lastName":"Santoro","url":{"current":"cameron-santoro","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Cameron Santoro","asset":{"_ref":"image-6ae51a61642a5ecba7cf4085fe97e68814e3c917-430x430-png","_type":"reference"}},"biography":[{"markDefs":[],"children":[{"text":"Cameron Santoro is an associate editor for ","_key":"93662c5c4cfd","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"213c257c1eca"},{"text":"®","_key":"f546acb0aa91","_type":"span","marks":["superscript"]},{"_type":"span","marks":[],"text":" (","_key":"acd931edd707"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"843f7d4e787d"},{"_type":"span","marks":["superscript"],"text":"®","_key":"7c809e803edb"},{"_type":"span","marks":[],"text":"), AJMC.com, and The Center for Biosimilars","_key":"35b69a01dbbe"},{"_type":"span","marks":["superscript"],"text":"®","_key":"8ddca200bc46"},{"_type":"span","marks":[],"text":".","_key":"ba3cca6122e3"}],"_type":"block","style":"normal","_key":"3da8fced8696"}]}],"factCheckBy":[{"displayName":"Cameron Santoro","firstName":"Cameron","lastName":"Santoro","url":{"current":"cameron-santoro","_type":"slug"},"profileImage":{"alt":"Cameron Santoro","asset":{"_ref":"image-6ae51a61642a5ecba7cf4085fe97e68814e3c917-430x430-png","_type":"reference"},"_type":"mainImage"},"biography":[{"_key":"3da8fced8696","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Cameron Santoro is an associate editor for ","_key":"93662c5c4cfd"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"213c257c1eca"},{"text":"®","_key":"f546acb0aa91","_type":"span","marks":["superscript"]},{"_type":"span","marks":[],"text":" (","_key":"acd931edd707"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"843f7d4e787d"},{"_type":"span","marks":["superscript"],"text":"®","_key":"7c809e803edb"},{"marks":[],"text":"), AJMC.com, and The Center for Biosimilars","_key":"35b69a01dbbe","_type":"span"},{"marks":["superscript"],"text":"®","_key":"8ddca200bc46","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"ba3cca6122e3"}],"_type":"block","style":"normal"}],"showSocialShare":null}],"_id":"566e44be-5a20-4b15-8a06-e36cb8b51fc7","issueGroup":{"_ref":"b0733662-6367-4a92-b97f-a3f09117b473","_type":"reference"},"title":"SPOTLIGHT: Sarah Hogue, PharmD, on Expanding the Role of Oncology Pharmacists","summary":null,"thumbnail":{"_type":"mainImage","alt":"Sarah Hogue, PharmD | Image credit: photo provided by Hogue","asset":{"_type":"sanity.imageAsset","mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/79fb2408a93301e41fdf9845653bd0f85247e02f-1402x1402.jpg","_updatedAt":"2024-12-18T19:33:19Z","originalFilename":"SHogue Headshot.JPG","_rev":"bAl93RvH29PY4NpeOyHPDS","metadata":{"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1402,"aspectRatio":1,"height":1402},"isOpaque":true,"blurHash":"ePM=?+5Y~NIS,mWrID$*%2WF?DxqxV?FNbxVRQxaxaWDWCoKRkofR,","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#fcc774","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":2.15},"darkVibrant":{"title":"#fff","population":7.29,"background":"#c27813","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"title":"#fff","population":5.76,"background":"#d7b9a7","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"title":"#fff","population":3.96,"background":"#e8c807","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"dominant":{"background":"#c27813","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.29},"_type":"sanity.imagePalette","darkMuted":{"background":"#564636","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.41},"muted":{"title":"#fff","population":2.62,"background":"#8a6d5a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":false},"uploadId":"B7ctqdgDqDdcHBKDxYYrFhHh9susWYi0","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/79fb2408a93301e41fdf9845653bd0f85247e02f-1402x1402.jpg","size":178571,"_id":"image-79fb2408a93301e41fdf9845653bd0f85247e02f-1402x1402-jpg","extension":"jpg","sha1hash":"79fb2408a93301e41fdf9845653bd0f85247e02f","_createdAt":"2024-12-18T19:33:19Z","assetId":"79fb2408a93301e41fdf9845653bd0f85247e02f"}},"published":"2024-12-18T16:11:00.000Z"},{"authorDetails":[{"displayName":"Roy G. Marcus, MD","firstName":"Roy","lastName":"Marcus","url":{"current":"roy-g-marcus-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"David M. Miller, MBA","firstName":"David","lastName":"Miller","url":{"current":"david-m-miller-mba","_type":"slug"},"profileImage":null,"biography":null},{"url":{"current":"brian-h-nathanson-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Brian H. Nathanson, PhD","firstName":"Brian","lastName":"Nathanson"},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Douglas Eckhardt, MBA","firstName":"Douglas","lastName":"Eckhardt","url":{"current":"douglas-eckhardt-mba","_type":"slug"}},{"displayName":"Steven Henry, PharmD","firstName":"Steven","lastName":"Henry","url":{"current":"steven-henry-pharmd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"showSocialShare":null,"displayName":"Katherine Kwon, MD","firstName":"Katherine","lastName":"Kwon","url":{"current":"katherine-kwon-md","_type":"slug"},"profileImage":null,"biography":null},{"firstName":"Rohit","lastName":"Sharma","url":{"current":"rohit-sharma-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Rohit Sharma, MD"},{"lastName":"Vakharia","url":{"current":"nirav-vakharia-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Nirav Vakharia, MD","firstName":"Nirav"}],"_id":"d38be53d-4528-46a4-bccc-0e2417cb289b","issueGroup":{"_ref":"336c2bd9-8d6c-4558-8bd3-24df074cf426","_type":"reference"},"title":"A Standardized Care Pathway Increases Optimal Dialysis Starts","summary":"The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"originalFilename":"AJMC_logo_NEW.png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"metadata":{"hasAlpha":true,"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"foreground":"#fff","title":"#fff","population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch"}}},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z"}},"url":"a-standardized-care-pathway-increases-optimal-dialysis-starts","published":"2024-12-17T14:00:00.000Z","factCheckBy":[{"displayName":"Roy G. Marcus, MD","firstName":"Roy","lastName":"Marcus","url":{"current":"roy-g-marcus-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"David M. Miller, MBA","firstName":"David","lastName":"Miller","url":{"current":"david-m-miller-mba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Brian H. Nathanson, PhD","firstName":"Brian","lastName":"Nathanson","url":{"current":"brian-h-nathanson-phd","_type":"slug"}},{"displayName":"Douglas Eckhardt, MBA","firstName":"Douglas","lastName":"Eckhardt","url":{"current":"douglas-eckhardt-mba","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"biography":null,"showSocialShare":null,"displayName":"Steven Henry, PharmD","firstName":"Steven","lastName":"Henry","url":{"current":"steven-henry-pharmd","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Katherine Kwon, MD","firstName":"Katherine","lastName":"Kwon","url":{"current":"katherine-kwon-md","_type":"slug"},"profileImage":null},{"displayName":"Rohit Sharma, MD","firstName":"Rohit","lastName":"Sharma","url":{"current":"rohit-sharma-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Nirav","lastName":"Vakharia","url":{"current":"nirav-vakharia-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Nirav Vakharia, MD"}]},{"_id":"5a821cca-ecbc-492b-b96a-f79fac509885","url":"uptake-of-rituximab-biosimilars-in-medicare-and-medicaid-in-2019-2022","published":"2024-12-16T17:00:00.000Z","authorDetails":[{"lastName":"Qian","url":{"current":"jingjing-qian-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jingjing Qian, PhD","firstName":"Jingjing"}],"factCheckBy":[{"lastName":"Qian","url":{"current":"jingjing-qian-phd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Jingjing Qian, PhD","firstName":"Jingjing"}],"issueGroup":{"_ref":"336c2bd9-8d6c-4558-8bd3-24df074cf426","_type":"reference"},"title":"Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022","summary":"Significant uptake of rituximab biosimilars in Medicare and Medicaid occurred within the first 4 years of marketing in the US.","thumbnail":{"_type":"mainImage","alt":"AJMC","asset":{"uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","metadata":{"lqip":"data:image/png;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch"},"vibrant":{"population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26,"background":"#9bb7cc"},"_type":"sanity.imagePalette","darkMuted":{"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.71},"muted":{"title":"#fff","population":0.38,"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93}},"hasAlpha":true},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","size":203185,"extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png"}}},{"_id":"a4a004f4-c13e-4e82-9b80-c57f6a1b3bfd","title":"Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond","thumbnail":{"_type":"mainImage","asset":{"_id":"image-5421358c8f117ee86126333e135f08cf1e61ded6-778x382-png","uploadId":"HVdJn1r9v3RWlQCGbYP2dDQdFL6PajVT","sha1hash":"5421358c8f117ee86126333e135f08cf1e61ded6","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","size":203185,"metadata":{"lqip":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAKCAYAAAC0VX7mAAAACXBIWXMAABYlAAAWJQFJUiTwAAABxklEQVQoka2STW/aQBCG+f/qLZdeqkrpoQqpWiIlCk2BhKCEErAxRXGMnQ8wJoAxGMyX7fX6rWbSpqXnWlrN7M7sszPvOAMAaZrif32Z3zCySSKRSIlYJFhtQgTrLVbbCNsohpQSUqYIY8ErigU2YYxNGPGe7hHjFUiHjutj6C0w8ZfQLAeK0UPTtKF2bEwXK8yCNZ+3LAd6d4iOPcbjYIKB63MBO0BvvkSxYaDctHDvuCg0DJzd3OHsRsd+voaG0UP7YYAP+Rren1RxVGnxfjDxMZousN5GL0CCiSRhSLakIFtU0DT7DL9QTVy1HxiQLan4WtPxNlfBm48FHBQVPHtzloIkIvsLmMIP1tzWafUWh+cqCnUD+e+3KCkd1PQnfC5reHd8zRCye58u+IHucMoaU7ukP7EyJHR/PENd76J173CrhyUVuUsN52oH1fYjyk2TK6b1pazhqPKDH9OsPkx7zPfDKH6ZMpVK+tnjGVw/YGjusoVv9TsYvRG6Q48vTOZL1srqu1wZ+aQfDZKGRbJxhdS3SCSESFiL0TRgsZ+ePRaaziiZ8qgbyqP2yCdLMfIpvjPl139RSkRCcPK/sT/7v/3d+E98j+pE3hWucAAAAABJRU5ErkJggg==","dimensions":{"_type":"sanity.imageDimensions","width":778,"aspectRatio":2.0366492146596857,"height":382},"exif":{"PixelXDimension":778,"PixelYDimension":382,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MQRfnMfl?Ht7%LxvofofWBWC~pofE1t6Rj","_type":"sanity.imageMetadata","palette":{"muted":{"background":"#628cad","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.38},"lightVibrant":{"background":"#cae1f2","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.93},"darkVibrant":{"foreground":"#fff","title":"#fff","population":0.09,"background":"#044679","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"title":"#fff","population":1.26,"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"title":"#fff","population":0.52,"background":"#18568d","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"dominant":{"background":"#9bb7cc","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.26},"_type":"sanity.imagePalette","darkMuted":{"population":0.71,"background":"#37536a","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":true},"_rev":"hiKH9HIKxNVM35TxYdonKh","_type":"sanity.imageAsset","extension":"png","mimeType":"image/png","_createdAt":"2023-07-11T20:45:56Z","originalFilename":"AJMC_logo_NEW.png","path":"images/0vv8moc6/ajmc/5421358c8f117ee86126333e135f08cf1e61ded6-778x382.png","assetId":"5421358c8f117ee86126333e135f08cf1e61ded6","_updatedAt":"2023-07-11T20:45:56Z"}},"url":"addressing-stis-through-managed-care-opportunities-in-medicaid-and-beyond","published":"2024-12-16T14:00:00.000Z","issueGroup":{"_ref":"336c2bd9-8d6c-4558-8bd3-24df074cf426","_type":"reference"},"summary":"Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.","authorDetails":[{"displayName":"Naomi Seiler, JD","firstName":"Naomi","lastName":"Seiler","url":{"current":"naomi-seiler-jd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Katie Horton, JD, RN, MPH","firstName":"Katie","lastName":"Horton","url":{"current":"katie-horton-jd-rn-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Paige Organick-Lee, MPH","firstName":"Paige","lastName":"Organick-Lee","url":{"current":"paige-organick-lee-mph","_type":"slug"}},{"displayName":"Mekhi Washington, BS","firstName":"Mekhi","lastName":"Washington","url":{"_type":"slug","current":"mekhi-washington-bs"},"profileImage":null,"biography":null,"showSocialShare":null},{"firstName":"Taylor","lastName":"Turner","url":{"current":"taylor-turner-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Taylor Turner, MPH"},{"lastName":"Pearson","url":{"current":"william-s-pearson-phd-mha","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"William S. Pearson, PhD, MHA","firstName":"William"}],"factCheckBy":[{"url":{"current":"naomi-seiler-jd","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Naomi Seiler, JD","firstName":"Naomi","lastName":"Seiler"},{"biography":null,"showSocialShare":null,"displayName":"Katie Horton, JD, RN, MPH","firstName":"Katie","lastName":"Horton","url":{"current":"katie-horton-jd-rn-mph","_type":"slug"},"profileImage":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Paige Organick-Lee, MPH","firstName":"Paige","lastName":"Organick-Lee","url":{"current":"paige-organick-lee-mph","_type":"slug"}},{"displayName":"Mekhi Washington, BS","firstName":"Mekhi","lastName":"Washington","url":{"current":"mekhi-washington-bs","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Taylor Turner, MPH","firstName":"Taylor","lastName":"Turner","url":{"current":"taylor-turner-mph","_type":"slug"}},{"showSocialShare":null,"displayName":"William S. Pearson, PhD, MHA","firstName":"William","lastName":"Pearson","url":{"current":"william-s-pearson-phd-mha","_type":"slug"},"profileImage":null,"biography":null}]},{"_id":"1b2f775c-eb1e-4c9d-aab4-b9c0796cb0e2","summary":"Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes. ","thumbnail":{"alt":"Park City Utah | Image Credit: © SeanPavonePhoto - stock.adobe.com","asset":{"extension":"jpg","mimeType":"image/jpeg","sha1hash":"d79c993ad4d9e3983bc0d532aad3e304b33becd6","path":"images/0vv8moc6/ajmc/d79c993ad4d9e3983bc0d532aad3e304b33becd6-1200x800.jpg","uploadId":"HbuqVrHWM61ym51aODEQvln7RdZOo3Y9","assetId":"d79c993ad4d9e3983bc0d532aad3e304b33becd6","_createdAt":"2024-12-09T16:14:43Z","metadata":{"blurHash":"VbGt,K%NbvogW;-@o~s;xFofxbSiR*s9jvRjNIR*R*bI","_type":"sanity.imageMetadata","palette":{"muted":{"population":6.15,"background":"#8c7298","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightVibrant":{"background":"#db8a8b","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":5.57},"darkVibrant":{"population":0.09,"background":"#531914","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"lightMuted":{"population":1.88,"background":"#baacda","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"background":"#ce742b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.86},"dominant":{"background":"#55402b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.52},"_type":"sanity.imagePalette","darkMuted":{"background":"#55402b","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.52}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.5,"height":800},"exif":{"_type":"sanity.imageExifMetadata","FocalLengthIn35mmFormat":70,"DateTimeOriginal":"2019-09-30T07:53:48.000Z","Saturation":0,"ExposureBiasValue":0,"Sharpness":1,"PixelYDimension":800,"SubSecTimeDigitized":"72","ExposureMode":1,"LensSpecification":[70,200,2.8,2.8],"ApertureValue":6.9188632619439865,"SceneCaptureType":0,"PixelXDimension":1200,"FNumber":11,"Contrast":0,"ISO":64,"DateTimeDigitized":"2019-09-30T07:53:48.000Z","ExposureProgram":1,"LensModel":"70.0-200.0 mm f/2.8","SensitivityType":2,"FocalPlaneResolutionUnit":3,"BodySerialNumber":"3009697","ShutterSpeedValue":-6.169924996926103,"ExposureTime":72,"FocalLength":70,"SubSecTimeOriginal":"72","FocalPlaneYResolution":2301.324607329843,"SubjectDistanceRange":0,"CustomRendered":0,"MaxApertureValue":2.9708536585365852,"GainControl":0,"FocalPlaneXResolution":2301.324607329843,"WhiteBalance":1,"RecommendedExposureIndex":64,"ColorSpace":1,"MeteringMode":5,"LightSource":9,"SensingMethod":2},"isOpaque":true},"_type":"sanity.imageAsset","size":684667,"originalFilename":"Park City Utah - SeanPavonePhoto - stock.adobe.com.jpeg","_rev":"NpDlOLwo2XgOWDaMKGnmaJ","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/d79c993ad4d9e3983bc0d532aad3e304b33becd6-1200x800.jpg","_id":"image-d79c993ad4d9e3983bc0d532aad3e304b33becd6-1200x800-jpg","_updatedAt":"2024-12-09T16:14:43Z"},"_type":"mainImage"},"url":"transforming-kidney-care-policy-risk-stratification-and-collaborative-models","authorDetails":[{"url":{"current":"kyle-munz","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Kyle Munz","asset":{"_ref":"image-afb5da0a933e7f6f632d76cd52a5bc1c1243fb36-430x430-png","_type":"reference"}},"biography":null,"showSocialShare":null,"displayName":"Kyle Munz","firstName":"Kyle","lastName":"Munz"}],"factCheckBy":[{"lastName":"Munz","url":{"current":"kyle-munz","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Kyle Munz","asset":{"_ref":"image-afb5da0a933e7f6f632d76cd52a5bc1c1243fb36-430x430-png","_type":"reference"}},"biography":null,"showSocialShare":null,"displayName":"Kyle Munz","firstName":"Kyle"}],"issueGroup":{"_ref":"5c3d9b93-74e5-4e58-915c-ae8f5885c9b7","_type":"reference"},"title":"Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models","published":"2024-12-12T18:00:00.000Z"},{"_id":"f802c956-5821-427f-8529-cd5ac1bf6b46","title":"From Approval to Practice: Addressing the Hurdles in Biosimilar Integration","published":"2024-12-12T17:00:00.000Z","authorDetails":[{"displayName":"Skylar Jeremias","firstName":null,"lastName":null,"url":{"_type":"slug","current":"skylar-jeremias"},"profileImage":{"_type":"mainImage","asset":{"_type":"reference","_ref":"image-eca9090f66344b90a493123dfc0035ae7b6b1976-800x800-jpg"}},"biography":[{"style":"normal","_key":"f73a10e9267d","markDefs":[],"children":[{"_type":"span","marks":[],"text":"Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders.","_key":"6fba991875ae0"}],"_type":"block"},{"markDefs":[{"_key":"510f2efa56c7","nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/skylar-jeremias-0b8879116/"}],"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on ","_key":"8bc8c321c24e"},{"marks":["510f2efa56c7"],"text":"LinkedIn","_key":"6fba991875ae1","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"6fba991875ae2"}],"_type":"block","style":"normal","_key":"95aad26356ef"}],"showSocialShare":null}],"factCheckBy":[{"profileImage":{"_type":"mainImage","asset":{"_ref":"image-eca9090f66344b90a493123dfc0035ae7b6b1976-800x800-jpg","_type":"reference"}},"biography":[{"children":[{"_key":"6fba991875ae0","_type":"span","marks":[],"text":"Skylar is an associate editor for The American Journal of Managed Care® (AJMC®) and The Center for Biosimilars®, and joined AJMC® in 2020. She is responsible for covering all aspects of the ever-changing global biosimilar industry and produces content that is accessible and informative for all health care stakeholders."}],"_type":"block","style":"normal","_key":"f73a10e9267d","markDefs":[]},{"children":[{"_type":"span","marks":[],"text":"She has a BA in journalism and media studies from Rutgers University. You can connect with Skylar on ","_key":"8bc8c321c24e"},{"_type":"span","marks":["510f2efa56c7"],"text":"LinkedIn","_key":"6fba991875ae1"},{"_type":"span","marks":[],"text":".","_key":"6fba991875ae2"}],"_type":"block","style":"normal","_key":"95aad26356ef","markDefs":[{"nofollow":true,"blank":true,"_type":"link","href":"https://www.linkedin.com/in/skylar-jeremias-0b8879116/","_key":"510f2efa56c7"}]}],"showSocialShare":null,"displayName":"Skylar Jeremias","firstName":null,"lastName":null,"url":{"current":"skylar-jeremias","_type":"slug"}}],"issueGroup":{"_ref":"5c3d9b93-74e5-4e58-915c-ae8f5885c9b7","_type":"reference"},"summary":"Recent discussions at an Institute for Value-Based Medicine event highlighted the significant potential of biosimilars in reshaping the health care landscape, despite facing considerable barriers to adoption.","thumbnail":{"_type":"mainImage","alt":"Seattle Washington skyline | Image Credit: © espiegle - stock.adobe.com","asset":{"_rev":"Wk5bXdTaWvRA2U061yIUpH","sha1hash":"50d700b88aa9af2c75864177d43c5651d055284b","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/50d700b88aa9af2c75864177d43c5651d055284b-1200x697.jpg","_createdAt":"2024-12-09T16:08:58Z","_updatedAt":"2024-12-09T16:08:58Z","_type":"sanity.imageAsset","assetId":"50d700b88aa9af2c75864177d43c5651d055284b","_id":"image-50d700b88aa9af2c75864177d43c5651d055284b-1200x697-jpg","originalFilename":"Seattle Washington skyline - espiegle - stock.adobe.com.jpeg","size":691007,"extension":"jpg","metadata":{"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.721664275466284,"height":697},"isOpaque":true,"blurHash":"M%DAo?fkWBofWBTOj]j?WWj?IXa~oKayj[","_type":"sanity.imageMetadata","palette":{"dominant":{"foreground":"#fff","title":"#fff","population":8.35,"background":"#565e2e","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"background":"#565e2e","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":8.35},"muted":{"background":"#92ac4f","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.04},"lightVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":0.07,"background":"#8fb9e4"},"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":1.59,"background":"#53590e"},"lightMuted":{"title":"#fff","population":8.22,"background":"#d1c4b3","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":4.04,"background":"#1775d9"}}},"uploadId":"720OvtZqjd5bfGGG0HMUoxl39Z5gnaIE","mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/50d700b88aa9af2c75864177d43c5651d055284b-1200x697.jpg"}},"url":"from-approval-to-practice-addressing-the-hurdles-in-biosimilar-integration"},{"url":"navigating-the-complexities-of-neurological-drug-access","published":"2024-12-12T16:00:00.000Z","title":"Navigating the Complexities of Neurological Drug Access","summary":"At an Institute for Value-Based Medicine® event held in Aurora, Colorado, experts discussed strategies to improve patient outcomes and manage health care costs in neurological diseases. ","thumbnail":{"alt":"Aurora Colorado aerial | Image Credit: © Jacob - stock.adobe.com","asset":{"path":"images/0vv8moc6/ajmc/e795e86678821e21c6aef5cf087bc961b2661488-1200x799.jpg","sha1hash":"e795e86678821e21c6aef5cf087bc961b2661488","metadata":{"_type":"sanity.imageMetadata","location":{"_type":"geopoint","alt":1846,"lat":39.63568055555555,"lng":-104.88007777777777},"dimensions":{"width":1200,"aspectRatio":1.5018773466833542,"height":799,"_type":"sanity.imageDimensions"},"blurHash":"VtBzqmogR*a}aypMofaxa#ayS+j[jZj[ayRkfkj?fPjs","exif":{"PixelYDimension":799,"Flash":0,"DateTimeDigitized":"2021-10-22T12:38:25.000Z","GainControl":0,"PixelXDimension":1200,"ExposureTime":0.01,"FNumber":11,"Sharpness":0,"ApertureValue":6.9188632619439865,"Contrast":0,"ShutterSpeedValue":6.643856143856143,"WhiteBalance":0,"LightSource":1,"FocalLength":10.3,"ExposureMode":1,"DateTimeOriginal":"2021-10-22T12:38:25.000Z","LensSpecification":[28,28,2.8,11],"_type":"sanity.imageExifMetadata","MeteringMode":2,"SceneCaptureType":0,"ExposureBiasValue":0,"ColorSpace":1,"BodySerialNumber":"0K8TFB50024243","Saturation":0,"ISO":100,"DigitalZoomRatio":1,"FocalLengthIn35mmFormat":28,"ExposureProgram":1,"MaxApertureValue":2.9708536585365852},"isOpaque":true,"palette":{"vibrant":{"background":"#0a71c4","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":3.59},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.03,"background":"#938a66"},"_type":"sanity.imagePalette","darkMuted":{"population":0.95,"background":"#343f53","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"muted":{"foreground":"#fff","title":"#fff","population":5.03,"background":"#938a66","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"foreground":"#000","title":"#fff","population":0.11,"background":"#7da9ec","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"background":"#054cac","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.03},"lightMuted":{"title":"#fff","population":0.11,"background":"#ada8bc","_type":"sanity.imagePaletteSwatch","foreground":"#000"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAANABQDASIAAhEBAxEB/8QAFwAAAwEAAAAAAAAAAAAAAAAAAAQGBf/EACIQAAIBBAEEAwAAAAAAAAAAAAECAAMEBREhBhIUMUFRYv/EABYBAQEBAAAAAAAAAAAAAAAAAAMAAv/EABwRAAEFAAMAAAAAAAAAAAAAAAEAAgQFIRVRUv/aAAwDAQACEQMRAD8AWt+ocWQKb4s7+uIvd5XC1A2scQR+pBWV1UYM5PK+o75BentlBJ59ydcSmnChFfGcNat0nHVj3pbKoPwX1CStdy9ViCVA40DCMLmZ2scXG8r/2Q=="},"originalFilename":"Aurora Colorado aerial - Jacob - stock.adobe.com.jpeg","extension":"jpg","_rev":"Wk5bXdTaWvRA2U061yEwr7","_type":"sanity.imageAsset","mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/e795e86678821e21c6aef5cf087bc961b2661488-1200x799.jpg","size":792084,"_id":"image-e795e86678821e21c6aef5cf087bc961b2661488-1200x799-jpg","uploadId":"hDCo0dHvoUsJtwqc6XFChcP57mr0GYWo","_createdAt":"2024-12-09T16:01:02Z","_updatedAt":"2024-12-09T16:01:02Z","assetId":"e795e86678821e21c6aef5cf087bc961b2661488"},"_type":"mainImage"},"factCheckBy":[{"profileImage":{"_type":"mainImage","alt":"Pearl Steinzor","asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"}},"biography":null,"showSocialShare":null,"displayName":"Pearl Steinzor","firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"}}],"_id":"07739c7a-2ab2-4136-9387-b461d01ee7d6","issueGroup":{"_ref":"5c3d9b93-74e5-4e58-915c-ae8f5885c9b7","_type":"reference"},"authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Pearl Steinzor","firstName":"Pearl ","lastName":"Steinzor","url":{"current":"pearl-steinzor","_type":"slug"},"profileImage":{"asset":{"_ref":"image-aaad3972f041cf080c4994a923d62017c74f0ac3-512x512-jpg","_type":"reference"},"_type":"mainImage","alt":"Pearl Steinzor"}}]},{"issueGroup":{"_ref":"73c988a3-a73b-49fa-af49-dce7e755e713","_type":"reference"},"thumbnail":{"asset":{"extension":"jpg","metadata":{"dimensions":{"height":1867,"_type":"sanity.imageDimensions","width":2800,"aspectRatio":1.4997321906802357},"exif":{"CustomRendered":0,"SensitivityType":2,"BrightnessValue":-0.89296875,"ExposureBiasValue":0,"MeteringMode":5,"Saturation":2,"LensSpecification":[16,35,4,4],"LightSource":0,"FocalLengthIn35mmFormat":42,"DigitalZoomRatio":1,"ExposureTime":2,"ExposureProgram":1,"FNumber":5.6,"FocalPlaneXResolution":2164.4328018223237,"Sharpness":0,"PixelXDimension":2800,"FocalPlaneResolutionUnit":3,"PixelYDimension":1867,"LensModel":"16-35mm F4 G SSM OSS","_type":"sanity.imageExifMetadata","ApertureValue":4.970853658536585,"Contrast":0,"SceneCaptureType":0,"ExposureMode":1,"ISO":100,"ShutterSpeedValue":-1,"FocalLength":28,"RecommendedExposureIndex":100,"ColorSpace":1,"MaxApertureValue":4,"DateTimeDigitized":null,"WhiteBalance":0,"FocalPlaneYResolution":2164.4328018223237,"DateTimeOriginal":"2016-11-15T06:32:19.000Z"},"isOpaque":true,"blurHash":"VLKJoRB?^vPDoi765Ev|$*$x~W-poztRR-%#x]SxNyt7","_type":"sanity.imageMetadata","palette":{"darkVibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.13,"background":"#935917"},"lightMuted":{"population":0.06,"background":"#b6a9cd","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"vibrant":{"population":5.95,"background":"#efa11f","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.13,"background":"#f6d770"},"_type":"sanity.imagePalette","darkMuted":{"background":"#2e3d58","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.99},"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":5.22,"background":"#976e64"},"lightVibrant":{"background":"#f6d770","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":6.13}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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"},"description":null,"mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867.jpg","_id":"image-29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867-jpg","size":4265557,"_updatedAt":"2024-08-28T16:07:46Z","altText":null,"_rev":"LtkInV1jlQdtEIFjVqjDMg","sha1hash":"29b0fbb8f7b48c24276a1a8a300c1168e50e8707","title":null,"url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/29b0fbb8f7b48c24276a1a8a300c1168e50e8707-2800x1867.jpg","_createdAt":"2024-08-28T16:07:24Z","originalFilename":"New Orleans Bourbon Street - f11photo - AdobeStock_169182961.jpeg","uploadId":"kH1bS8OTS7iWFNmOt3qixxFUDmuSmj11","_type":"sanity.imageAsset","opt":{"media":{"tags":null}},"assetId":"29b0fbb8f7b48c24276a1a8a300c1168e50e8707"},"_type":"mainImage","alt":"New Orleans Bourbon Street | Image Credit: © f11photo - stock.adobe.com"},"authorDetails":[{"profileImage":{"alt":"Mary K. Caffrey","asset":{"_ref":"image-ed06a2c91900970a850116ba649d9f9b4a954ca5-430x430-png","_type":"reference"},"default":false,"_type":"mainImage"},"biography":null,"showSocialShare":null,"displayName":"Mary K. Caffrey","firstName":null,"lastName":null,"url":{"current":"mary-k-caffrey","_type":"slug"}}],"factCheckBy":[{"firstName":null,"lastName":null,"url":{"current":"mary-k-caffrey","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Mary K. Caffrey","asset":{"_ref":"image-ed06a2c91900970a850116ba649d9f9b4a954ca5-430x430-png","_type":"reference"},"default":false},"biography":null,"showSocialShare":null,"displayName":"Mary K. Caffrey"}],"_id":"04159ba8-44f9-40b5-b25f-0ae627881e39","title":"Healthy State: Practicing What They Preach in Louisiana","summary":"An IVBM event cohosted by The American Journal of Managed Care focused on Healthy State, a multiyear, multistakeholder commitment to moving Louisiana ahead in America’s Health Rankings.","url":"healthy-state-practicing-what-they-preach-in-louisiana","published":"2024-09-16T16:31:55.211Z"},{"_id":"2a95bae0-0c9f-4bc1-8e7d-3602ac803646","issueGroup":{"_ref":"73c988a3-a73b-49fa-af49-dce7e755e713","_type":"reference"},"summary":"Clinicians, researchers, and payer experts convened in Aurora, Colorado, on August 13, 2024, for discussions on ensuring that the recent advancements in lipid management are making their way to patients.","thumbnail":{"_type":"mainImage","alt":"Denver Colorado | Image Credit: © f11photo - stock.adobe.com","asset":{"metadata":{"palette":{"lightMuted":{"background":"#a2a7c8","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":2.17},"vibrant":{"population":1.42,"background":"#ca762d","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.64,"background":"#4f4e2c"},"_type":"sanity.imagePalette","darkMuted":{"background":"#4f4e2c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":6.64},"muted":{"foreground":"#fff","title":"#fff","population":4.67,"background":"#50659b","_type":"sanity.imagePaletteSwatch"},"lightVibrant":{"background":"#e9cf8d","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":0.31},"darkVibrant":{"background":"#544d07","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.56}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,/9j/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAAMABQDASIAAhEBAxEB/8QAGAAAAgMAAAAAAAAAAAAAAAAAAAcCBAX/xAAfEAACAgICAwEAAAAAAAAAAAABAgADBBEGEiExYQX/xAAWAQEBAQAAAAAAAAAAAAAAAAACAwT/xAAdEQABBAIDAAAAAAAAAAAAAAADAAECEQQxBRJB/9oADAMBAAIRAxEAPwCeBhfnUkd7arNe+reptUZ/HVcV2voiKx8m2mtTWQCfgly3NtZEdhWWHgHqJI3InaVstA4C6aTkqyOIJWvfKRSRvREImxc7gMx8n5CBs83qLxhel//Z","dimensions":{"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.7142857142857142,"height":700},"exif":{"DateTimeDigitized":"2014-09-12T07:37:33.000Z","ColorSpace":1,"PixelXDimension":1200,"PixelYDimension":700,"_type":"sanity.imageExifMetadata"},"isOpaque":true,"blurHash":"MjHx1~IoS$S4oL%QRijZWrbH9vocWAoffP","_type":"sanity.imageMetadata"},"_type":"sanity.imageAsset","path":"images/0vv8moc6/ajmc/c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700.jpg","_updatedAt":"2024-09-13T18:14:54Z","originalFilename":"Denver Colorado - f11photo - stock.adobe.com.jpeg","uploadId":"H7WTao1JKvhWv1JBicLCJENbGPV6jpQH","mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700.jpg","_rev":"WVB52uR738qojYGNKmrerb","sha1hash":"c2b2ded664a1fbdc0483dd96d0b7deae84831a7b","size":584915,"_createdAt":"2024-09-13T18:14:54Z","_id":"image-c2b2ded664a1fbdc0483dd96d0b7deae84831a7b-1200x700-jpg","extension":"jpg","assetId":"c2b2ded664a1fbdc0483dd96d0b7deae84831a7b"}},"title":"Institute for Value-Based Medicine®: Multifaceted Approach Can Help Patients Benefit From the Expanded Lipid-Lowering Toolbox","url":"multifaceted-approach-can-help-patients-benefit-from-the-expanded-lipid-lowering-toolbox","published":"2024-09-16T16:31:18.436Z","authorDetails":[{"firstName":"Christina","lastName":"Mattina","url":{"current":"christina-mattina","_type":"slug"},"profileImage":{"alt":"Christina Mattina","asset":{"_ref":"image-6304e08858dcb7b689cd8fa5703c926a96ecdb48-512x492-jpg","_type":"reference"},"_type":"mainImage"},"biography":[{"_key":"9271b97a8f45","markDefs":[],"children":[{"text":"Christina is the associate editorial director of ","_key":"ffac76b64934","_type":"span","marks":[]},{"marks":["em"],"text":"The American Journal of Managed Care","_key":"4eac35f29678","_type":"span"},{"marks":["superscript"],"text":"®","_key":"b16316585120","_type":"span"},{"text":" (","_key":"ed200dc9139a","_type":"span","marks":[]},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b773bee92455"},{"_type":"span","marks":["superscript"],"text":"®","_key":"1f9bb13b24fa"},{"_type":"span","marks":[],"text":") and ","_key":"b9461d308bc8"},{"text":"The American Journal of Accountable Care","_key":"f235dc7df490","_type":"span","marks":["em"]},{"_type":"span","marks":["superscript"],"text":"®","_key":"14118ee858d3"},{"_type":"span","marks":[],"text":" (","_key":"a25757970c62"},{"_key":"6353c3a02e0f","_type":"span","marks":["em"],"text":"AJAC"},{"_type":"span","marks":[],"text":"), and joined ","_key":"7f777b20be12"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"682a0f2ea0d4"},{"_type":"span","marks":[],"text":" in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.","_key":"8b1f00d70d7f"}],"_type":"block","style":"normal"},{"_type":"block","style":"normal","_key":"a90d7ab4c801","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/christinamattina/","_key":"c281c6aba22d","nofollow":true,"blank":true}],"children":[{"text":"She has a BS in public health from Rutgers University. You can connect with Christina on ","_key":"6d8dca7834cc","_type":"span","marks":[]},{"_type":"span","marks":["c281c6aba22d"],"text":"LinkedIn","_key":"e23534b48658"},{"_type":"span","marks":[],"text":".","_key":"83d100c64d0e"}]}],"showSocialShare":null,"displayName":"Christina Mattina"}],"factCheckBy":[{"lastName":"Mattina","url":{"current":"christina-mattina","_type":"slug"},"profileImage":{"alt":"Christina Mattina","asset":{"_ref":"image-6304e08858dcb7b689cd8fa5703c926a96ecdb48-512x492-jpg","_type":"reference"},"_type":"mainImage"},"biography":[{"_type":"block","style":"normal","_key":"9271b97a8f45","markDefs":[],"children":[{"marks":[],"text":"Christina is the associate editorial director of ","_key":"ffac76b64934","_type":"span"},{"_type":"span","marks":["em"],"text":"The American Journal of Managed Care","_key":"4eac35f29678"},{"_key":"b16316585120","_type":"span","marks":["superscript"],"text":"®"},{"_type":"span","marks":[],"text":" (","_key":"ed200dc9139a"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"b773bee92455"},{"_type":"span","marks":["superscript"],"text":"®","_key":"1f9bb13b24fa"},{"_key":"b9461d308bc8","_type":"span","marks":[],"text":") and "},{"_type":"span","marks":["em"],"text":"The American Journal of Accountable Care","_key":"f235dc7df490"},{"_type":"span","marks":["superscript"],"text":"®","_key":"14118ee858d3"},{"_key":"a25757970c62","_type":"span","marks":[],"text":" ("},{"marks":["em"],"text":"AJAC","_key":"6353c3a02e0f","_type":"span"},{"_type":"span","marks":[],"text":"), and joined ","_key":"7f777b20be12"},{"_type":"span","marks":["em"],"text":"AJMC","_key":"682a0f2ea0d4"},{"text":" in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.","_key":"8b1f00d70d7f","_type":"span","marks":[]}]},{"style":"normal","_key":"a90d7ab4c801","markDefs":[{"blank":true,"_type":"link","href":"https://www.linkedin.com/in/christinamattina/","_key":"c281c6aba22d","nofollow":true}],"children":[{"_type":"span","marks":[],"text":"She has a BS in public health from Rutgers University. You can connect with Christina on ","_key":"6d8dca7834cc"},{"_type":"span","marks":["c281c6aba22d"],"text":"LinkedIn","_key":"e23534b48658"},{"_key":"83d100c64d0e","_type":"span","marks":[],"text":"."}],"_type":"block"}],"showSocialShare":null,"displayName":"Christina Mattina","firstName":"Christina"}]},{"issueGroup":{"_ref":"73c988a3-a73b-49fa-af49-dce7e755e713","_type":"reference"},"summary":"Experiences from a large, integrated, value-based health system suggest that telehealth can be an effective care delivery approach. Public policies can improve telehealth access and care.","thumbnail":{"_type":"mainImage","alt":"telemedicine | Image Credit: © rh2010 - stock.adobe.com","asset":{"_type":"sanity.imageAsset","assetId":"aa55cba013e542363db5e3021a7d049b005c0d44","_updatedAt":"2023-12-05T16:28:07Z","mimeType":"image/jpeg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912.jpg","_createdAt":"2023-12-05T16:28:07Z","_id":"image-aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912-jpg","extension":"jpg","metadata":{"isOpaque":true,"blurHash":"VEDl=,D%4n?c-;_N%M-pD%xvM{-;_3DiWBt7xax]t7M{","_type":"sanity.imageMetadata","palette":{"muted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0,"background":"#b4745c"},"lightVibrant":{"title":"#000","population":0.05,"background":"#e7d1c6","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"title":"#fff","population":6.07,"background":"#493a1a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":6.95,"background":"#bbbcbe"},"vibrant":{"population":0.01,"background":"#ba825c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"title":"#fff","population":6.95,"background":"#bbbcbe","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"_type":"sanity.imagePalette","darkMuted":{"population":6.82,"background":"#61553c","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"_type":"sanity.imageDimensions","width":7360,"aspectRatio":1.498371335504886,"height":4912}},"uploadId":"ueKegQc9OLg07IP1riXXhgBAywYfiVMU","sha1hash":"aa55cba013e542363db5e3021a7d049b005c0d44","path":"images/0vv8moc6/ajmc/aa55cba013e542363db5e3021a7d049b005c0d44-7360x4912.jpg","size":10640408,"_rev":"yLkPQ1Yunv4gUqVh5QBQaa","originalFilename":"telemedicine - rh2010.jpeg"}},"published":"2024-09-16T16:29:41.215Z","authorDetails":[{"biography":null,"showSocialShare":null,"displayName":"Rebecca Flournoy, MPH","firstName":"Rebecca","lastName":"Flournoy","url":{"current":"rebecca-flournoy-mph","_type":"slug"},"profileImage":null},{"displayName":"Reema Shah, MPH","firstName":"Reema","lastName":"Shah","url":{"_type":"slug","current":"reema-shah-mph"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Elizabeth Moisan, MS","firstName":"Elizabeth","lastName":"Moisan","url":{"current":"elizabeth-moisan-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"displayName":"Cecilia Oregón, MPP, MPH","firstName":"Cecilia","lastName":"Oregón","url":{"current":"cecilia-oreg-n-mpp-mph","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null}],"factCheckBy":[{"biography":null,"showSocialShare":null,"displayName":"Rebecca Flournoy, MPH","firstName":"Rebecca","lastName":"Flournoy","url":{"current":"rebecca-flournoy-mph","_type":"slug"},"profileImage":null},{"biography":null,"showSocialShare":null,"displayName":"Reema Shah, MPH","firstName":"Reema","lastName":"Shah","url":{"current":"reema-shah-mph","_type":"slug"},"profileImage":null},{"firstName":"Elizabeth","lastName":"Moisan","url":{"current":"elizabeth-moisan-ms","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Elizabeth Moisan, MS"},{"url":{"_type":"slug","current":"cecilia-oreg-n-mpp-mph"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Cecilia Oregón, MPP, MPH","firstName":"Cecilia","lastName":"Oregón"}],"_id":"336a74f6-937d-40c6-a94c-b14c26f025f6","title":"Telehealth Insights From an Integrated Care System","url":"telehealth-insights-from-an-integrated-care-system"},{"_id":"1472df1f-ab77-4b68-8ced-12ff81256022","authorDetails":[{"firstName":"Giuliana","lastName":"Grossi","url":{"current":"giuliana-grossi","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Giuliana Grossi","asset":{"_ref":"image-5dc1da24786c43a7f87e4ea0a7ae3880e6cee39f-430x430-png","_type":"reference"}},"biography":null,"showSocialShare":null,"displayName":"Giuliana Grossi"}],"url":"cardiometabolic-interventions-focus-on-accessibility-evidence-based-medicine","published":"2024-06-14T13:00:00.000Z","factCheckBy":[{"lastName":"Grossi","url":{"current":"giuliana-grossi","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Giuliana Grossi","asset":{"_ref":"image-5dc1da24786c43a7f87e4ea0a7ae3880e6cee39f-430x430-png","_type":"reference"}},"biography":null,"showSocialShare":null,"displayName":"Giuliana Grossi","firstName":"Giuliana"}],"issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"title":"Cardiometabolic Interventions Focus on Accessibility, Evidence-Based Medicine","summary":"At an Institute for Value-Based Medicine® (IVBM) event cohosted by The American Journal of Managed Care® and Sutter Health, experts illuminated the current state of cardiometabolic health care and offered a glimpse into the future.","thumbnail":{"asset":{"uploadId":"O5nnIZFuz4knEBd9QmteN8nCCmR8xh2K","_type":"sanity.imageAsset","assetId":"1f3095024fd984fa3a60b43c4cf33663635bcaf7","_id":"image-1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800-jpg","metadata":{"lqip":"data:image/jpeg;base64,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","dimensions":{"aspectRatio":1.5,"height":800,"_type":"sanity.imageDimensions","width":1200},"exif":{"LensSpecification":[70,300,4.5,5.6],"MeteringMode":5,"SensitivityType":2,"MaxApertureValue":4.970853658536585,"BrightnessValue":-0.44765625,"FocalLength":220,"ExposureProgram":3,"Sharpness":0,"_type":"sanity.imageExifMetadata","DateTimeDigitized":"2016-06-04T04:25:41.000Z","CustomRendered":0,"FocalPlaneXResolution":2164.4328018223237,"ExposureTime":3.2,"SceneCaptureType":0,"PixelXDimension":1200,"ApertureValue":6.9188632619439865,"RecommendedExposureIndex":200,"DateTimeOriginal":"2016-06-04T04:25:41.000Z","PixelYDimension":800,"ColorSpace":1,"DigitalZoomRatio":1,"ShutterSpeedValue":-1.6780719083366258,"LensModel":"FE 70-300mm F4.5-5.6 G OSS","ExposureBiasValue":0,"ISO":200,"Saturation":0,"FNumber":11,"FocalLengthIn35mmFormat":220,"FocalPlaneResolutionUnit":3,"Contrast":0,"LightSource":14,"WhiteBalance":1,"ExposureMode":0,"FocalPlaneYResolution":2164.4328018223237},"isOpaque":true,"blurHash":"VuJ@2qs:WCjYbb}%soahbIjs-:R*WBoJW:I.W=WEoLj[","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"foreground":"#000","title":"#000","population":4.62,"background":"#fbe182","_type":"sanity.imagePaletteSwatch"},"darkVibrant":{"title":"#fff","population":3.69,"background":"#6f2c2a","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":8.5,"background":"#9099c0"},"vibrant":{"background":"#f2a973","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":7.2},"dominant":{"background":"#9099c0","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":8.5},"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":7.93,"background":"#2e3250"},"muted":{"title":"#fff","population":0.47,"background":"#9c5c58","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":false},"mimeType":"image/jpeg","sha1hash":"1f3095024fd984fa3a60b43c4cf33663635bcaf7","path":"images/0vv8moc6/ajmc/1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800.jpg","size":416089,"_rev":"SWZtARO2mf3vRstToueLld","_updatedAt":"2024-06-07T15:30:01Z","originalFilename":"San Francisco Golden Gate Bridge - phitha - stock.adobe.com.jpeg","extension":"jpg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1f3095024fd984fa3a60b43c4cf33663635bcaf7-1200x800.jpg","_createdAt":"2024-06-07T15:30:01Z"},"_type":"mainImage","alt":"San Francisco's Golden Gate Bridge | Image Credit: © phitha - stock.adobe.com"}},{"issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"title":"Experts Highlight How GLP-1s Have Revolutionized Management of T2D and Obesity ","url":"experts-highlight-how-glp-1s-have-revolutionized-management-of-t2d-and-obesity","published":"2024-06-13T19:00:00.000Z","authorDetails":[{"url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"_type":"block","style":"normal","_key":"4a950aea97b3","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}],"children":[{"_type":"span","marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00"}]},{"style":"normal","_key":"b28d8058b3d8","markDefs":[{"href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true,"blank":true,"_type":"link"},{"href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link"}],"children":[{"_key":"48d199d8ecd5","_type":"span","marks":[],"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on "},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"_type":"span","marks":[],"text":" or ","_key":"67a67d3764f02"},{"marks":["c419f18a7ffe"],"text":"Twitter","_key":"67a67d3764f03","_type":"span"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block"}],"showSocialShare":true,"displayName":"Laura Joszt, MA","firstName":"Laura","lastName":"Joszt"}],"_id":"4d553701-915f-4873-8b9f-4f53893d6561","summary":"The number of Americans with type 2 diabetes and/or obesity is rising, and the entry of therapies such as glucagon-like peptide-1 (GLP-1) receptor agonists has been revolutionary.","thumbnail":{"_type":"mainImage","alt":"Cleveland Ohio | Image Credit: © Ai - stock.adobe.com.jpeg","asset":{"_updatedAt":"2024-06-07T15:42:37Z","mimeType":"image/jpeg","path":"images/0vv8moc6/ajmc/264df279db594adda69bc3737a08c6773f27a6ef-1200x800.jpg","assetId":"264df279db594adda69bc3737a08c6773f27a6ef","_createdAt":"2024-06-07T15:42:37Z","metadata":{"dimensions":{"_type":"sanity.imageDimensions","width":1200,"aspectRatio":1.5,"height":800},"exif":{"DateTimeOriginal":"2016-07-24T18:28:07.000Z","BrightnessValue":5.84,"FocalPlaneYResolution":2083.4231274638632,"ExposureTime":0.08333333333333333,"LensModel":"XF18-55mmF2.8-4 R LM OIS","ShutterSpeedValue":3.584962502403692,"PixelYDimension":800,"CustomRendered":0,"_type":"sanity.imageExifMetadata","FocalPlaneResolutionUnit":3,"ColorSpace":1,"SceneCaptureType":0,"LensSerialNumber":"48A03748","SensitivityType":1,"ApertureValue":8.643856143856144,"ExposureMode":0,"SensingMethod":2,"ISO":500,"LensMake":"FUJIFILM","MeteringMode":5,"LightSource":11,"FocalPlaneXResolution":2083.4231274638632,"PixelXDimension":1200,"MaxApertureValue":2.9708536585365852,"ExposureBiasValue":0.33,"Sharpness":0,"ExposureProgram":3,"FNumber":20,"DateTimeDigitized":"2016-07-24T00:00:00.000Z","LensSpecification":[18,55,2.8,4],"FocalLength":18,"Saturation":1,"SubjectDistanceRange":0,"FocalLengthIn35mmFormat":27,"WhiteBalance":1},"isOpaque":true,"blurHash":"VwHx:8$xRit5WA_4$~jEaej[T1oMWEa}axENR-f6bIWC","_type":"sanity.imageMetadata","palette":{"lightVibrant":{"background":"#efc989","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#000","population":2.52},"darkVibrant":{"title":"#fff","population":0,"background":"#043484","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightMuted":{"background":"#8897be","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":2.56},"vibrant":{"population":5.13,"background":"#0d90d3","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff"},"dominant":{"foreground":"#fff","title":"#fff","population":6.22,"background":"#677397","_type":"sanity.imagePaletteSwatch"},"_type":"sanity.imagePalette","darkMuted":{"background":"#30384f","_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":2.79},"muted":{"foreground":"#fff","title":"#fff","population":6.22,"background":"#677397","_type":"sanity.imagePaletteSwatch"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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"},"uploadId":"gcL2RcGUNOwVnVWGsh0ao9mQiEvDHrKK","_type":"sanity.imageAsset","sha1hash":"264df279db594adda69bc3737a08c6773f27a6ef","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/264df279db594adda69bc3737a08c6773f27a6ef-1200x800.jpg","_id":"image-264df279db594adda69bc3737a08c6773f27a6ef-1200x800-jpg","extension":"jpg","size":501001,"originalFilename":"Cleveland Ohio - Ai - stock.adobe.com.jpeg","_rev":"FTf7O3KU2GxuMy4tElpSB4"}},"factCheckBy":[{"showSocialShare":true,"displayName":"Laura Joszt, MA","firstName":"Laura","lastName":"Joszt","url":{"current":"laura-joszt","_type":"slug"},"profileImage":{"_type":"mainImage","alt":"Laura Joszt headshot","asset":{"_ref":"image-93ea362164e769dfd84dca31a8b2670a1dd9092b-512x512-jpg","_type":"reference"}},"biography":[{"children":[{"marks":[],"text":"Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.","_key":"67a67d3764f00","_type":"span"}],"_type":"block","style":"normal","_key":"4a950aea97b3","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d"},{"_type":"link","href":"https://twitter.com/joszt","_key":"c419f18a7ffe"}]},{"_key":"b28d8058b3d8","markDefs":[{"_type":"link","href":"https://www.linkedin.com/in/laura-joszt-05ba7116/","_key":"f77b28536a8d","nofollow":true,"blank":true},{"href":"https://twitter.com/joszt","_key":"c419f18a7ffe","nofollow":true,"blank":true,"_type":"link"}],"children":[{"text":"She has an MA in business and economic reporting from New York University. You can connect with Laura on ","_key":"48d199d8ecd5","_type":"span","marks":[]},{"_type":"span","marks":["f77b28536a8d"],"text":"LinkedIn","_key":"67a67d3764f01"},{"marks":[],"text":" or ","_key":"67a67d3764f02","_type":"span"},{"_key":"67a67d3764f03","_type":"span","marks":["c419f18a7ffe"],"text":"Twitter"},{"_type":"span","marks":[],"text":".","_key":"67a67d3764f04"}],"_type":"block","style":"normal"}]}]},{"title":"Reducing Delays in Breast Cancer Care Using an Innovative Digital Health Platform","summary":"The use of a novel digital health platform achieved a 55% reduction in time to treatment among women with a new diagnosis of breast cancer.","thumbnail":{"asset":{"originalFilename":"Medicine doctor hold icon health and electronic medical record on interface. Digital healthcare and network connection on hologram virtual screen, insurance. medical technology and network concept - ipopba - stock.adobe.com.jpeg","extension":"jpg","url":"https://cdn.sanity.io/images/0vv8moc6/ajmc/1e602bba35858bd62230432132517d1d42061e3d-1280x800.jpg","path":"images/0vv8moc6/ajmc/1e602bba35858bd62230432132517d1d42061e3d-1280x800.jpg","_createdAt":"2023-09-25T20:33:46Z","_updatedAt":"2023-09-25T20:33:46Z","_type":"sanity.imageAsset","size":323017,"assetId":"1e602bba35858bd62230432132517d1d42061e3d","_id":"image-1e602bba35858bd62230432132517d1d42061e3d-1280x800-jpg","uploadId":"hTRTLrPbL2uAPSQkjvmAG41W4tGru8UX","_rev":"pEhoUqandJkxjPidorVwRV","sha1hash":"1e602bba35858bd62230432132517d1d42061e3d","metadata":{"palette":{"_type":"sanity.imagePalette","darkMuted":{"_type":"sanity.imagePaletteSwatch","foreground":"#fff","title":"#fff","population":0.14,"background":"#655176"},"muted":{"title":"#fff","population":7.54,"background":"#629eb9","_type":"sanity.imagePaletteSwatch","foreground":"#fff"},"lightVibrant":{"title":"#000","population":3.38,"background":"#badff5","_type":"sanity.imagePaletteSwatch","foreground":"#000"},"darkVibrant":{"foreground":"#fff","title":"#fff","population":8.47,"background":"#205a7b","_type":"sanity.imagePaletteSwatch"},"lightMuted":{"background":"#a4c2d3","_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":4.58},"vibrant":{"_type":"sanity.imagePaletteSwatch","foreground":"#000","title":"#fff","population":1.22,"background":"#2bc4d6"},"dominant":{"title":"#fff","population":8.47,"background":"#205a7b","_type":"sanity.imagePaletteSwatch","foreground":"#fff"}},"hasAlpha":false,"lqip":"data:image/jpeg;base64,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","dimensions":{"aspectRatio":1.6,"height":800,"_type":"sanity.imageDimensions","width":1280},"isOpaque":true,"blurHash":"VKJ01o~pIBTJo#K6MxxuRjs:R6xuNGxuRORi-;IUSexb","_type":"sanity.imageMetadata"},"mimeType":"image/jpeg"},"_type":"mainImage","alt":"Medical technology and digital health network concept | Image Credit: © ipopba - stock.adobe.com"},"authorDetails":[{"showSocialShare":null,"displayName":"Dennis R. Holmes, MD","firstName":"Dennis","lastName":"Holmes","url":{"current":"dennis-r-holmes-md","_type":"slug"},"profileImage":null,"biography":null},{"biography":null,"showSocialShare":null,"displayName":"Steven D. Evans, MD","firstName":"Steven","lastName":"Evans","url":{"current":"steven-d-evans-md","_type":"slug"},"profileImage":null},{"showSocialShare":null,"displayName":"Warren Fisher, DO","firstName":"Warren","lastName":"Fisher","url":{"current":"warren-fisher-do","_type":"slug"},"profileImage":null,"biography":null},{"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Darren Wheeler, MD","firstName":"Darren","lastName":"Wheeler","url":{"current":"darren-wheeler-md","_type":"slug"}},{"lastName":"Pulicharam","url":{"_type":"slug","current":"riya-pulicharam-md-cpi"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Riya Pulicharam, MD, CPI","firstName":"Riya"}],"_id":"e881417a-9e64-48ca-9b72-7daafa2dd9c4","issueGroup":{"_ref":"c6747bef-322f-4aa5-bf20-1af9d678cde0","_type":"reference"},"factCheckBy":[{"url":{"current":"dennis-r-holmes-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Dennis R. Holmes, MD","firstName":"Dennis","lastName":"Holmes"},{"lastName":"Evans","url":{"current":"steven-d-evans-md","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Steven D. Evans, MD","firstName":"Steven"},{"displayName":"Warren Fisher, DO","firstName":"Warren","lastName":"Fisher","url":{"current":"warren-fisher-do","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null},{"biography":null,"showSocialShare":null,"displayName":"Darren Wheeler, MD","firstName":"Darren","lastName":"Wheeler","url":{"current":"darren-wheeler-md","_type":"slug"},"profileImage":null},{"lastName":"Pulicharam","url":{"current":"riya-pulicharam-md-cpi","_type":"slug"},"profileImage":null,"biography":null,"showSocialShare":null,"displayName":"Riya Pulicharam, MD, CPI","firstName":"Riya"}],"url":"reducing-delays-in-breast-cancer-care-using-an-innovative-digital-health-platform","published":"2024-06-13T13:00:00.000Z"}],"isLiveSite":true,"host":"www.ajmc.com","settings":{"title":"AJMC","networkID":"4688","adUnit":"ajmc.com","liveDomain":"www.ajmc.com","publicationName":"AJMC","logo":"/ajmc_logo_inverted.png","white_logo":"/ajmc_logo_inverted.png","logoHeight":"50px","enableEdgeCache":true,"sMaxAge":300,"staleWhileRevalidate":359,"clinicalTopicTopLatestNews":true,"megaMenuTaxName":"topic","megaMenuChildren":true,"sharingImageUrl":"https://s3.amazonaws.com/mjhlifesciences.com/sitelogos/AJMC_1200x637.png","twitterHandle":"@AJMC_Journal","publicationMapping":"publications","useNewSubNavMegaMenu":true,"redesignDetail":true,"redesignSAP":true,"useNewFooter":true,"newFooterLogos":[{"img":"/CHA_Logo.png","alt":"CH Logo","mobileWidth":"158px","mobileHeight":"42px","link":"/topic/center-on-health-equity-and-access","target":"_self"},{"img":"/CB.png","alt":"Center for Biosimilars Logo","mobileWidth":"170px","mobileHeight":"42px","link":"https://www.centerforbiosimilars.com/","target":"_blank"}],"useV3Components":true,"useAuthorRedesign":true,"navigationOptions":{"version":"2","variant":"4","customSpecialtyText":"Speciality Area"},"gateEnabled":"modal"},"homepage_creative_layout":{"creativeLayout":null}},"targeting":{"content_placement":["fda-approvals"],"document_url":["approvals-launches"],"document_group":[],"rootDocumentGroup":[],"hostname":"www.ajmc.com"},"statusCode":200,"data":{"page":{"contentCategory":null,"styling":{"divider":{"_type":"divider","dividerSize":1},"titleOptions":{"_type":"titleOptions","titleSize":"1rem"},"border":{"borderRadius":{"topLeft":"0rem","topRight":"0rem","bottomLeft":"0rem","bottomRight":"0rem"},"_type":"border","borderSize":1},"contentControl":{"showSummary":true,"_type":"contentControl","showPublished":true,"readMore":true,"showAuthor":true},"imageControl":{"_type":"imageControl","showImage":true,"thumbnailRadius":{"bottomLeft":"0rem","bottomRight":"0rem","topLeft":"0rem","topRight":"0rem"}}},"isDsoGated":null,"contentCategories":null,"filters":null,"cmeConfig":null,"searchConfig":{"baseUrl":"/view/"},"fixIdentifier":null,"title":"Product Approvals and Launches","url":{"current":"/approvals-launches","_type":"slug"},"docGroup":null,"content":null,"franchise":null,"label":null,"articleDetailConfig":{"issueMapping":"/publications","enableSegmentRecommend":true,"brightcoveAccountID":"10203567001","disqusShortName":"www-ajmc-com","downloadCitation":true,"shareOptions":{"SocialIconSize":32,"twitterSiteName":"@AJMC_Journal","hidePinterest":false,"shareSubject":"Check out this article!","twitterHandle":"AJMC","siteName":"ajmc","hideFacebook":false},"brightcovePlayerID":"pbDmfQhRw","drupalleadBaseURL":"https://drupalleads.mjh.group/injectablewebform/output/"},"pageSliders":null,"videoPlayerConfig":null,"identifier":null,"parent":null,"creativeLayout":null,"archived":false,"externalLinks":null,"intro":null,"hasSubCategory":false,"labelRequired":false,"pages":null,"useV3":null,"linkedPage":null,"gateCode":null,"excludeFromSitemap":false,"disableEpisode":null,"orderDesc":null,"pageType":"General Taxonomy","creativeLayoutLatestNews":null,"creativeLayoutDetail":null,"taxonomy":{"summary":[{"style":"normal","_key":"a08634bd8b5b","markDefs":[],"children":[{"_type":"span","marks":[],"text":"The ","_key":"53357d6c1d10"},{"marks":["em"],"text":"AJMC","_key":"122b18d05e3c","_type":"span"},{"_type":"span","marks":["superscript"],"text":"® ","_key":"461dab9da6c6"},{"_type":"span","marks":[],"text":"Product Approvals and Launches page will cover the latest FDA product approvals, as well as product launches in the United States.","_key":"e9256ecb5332"}],"_type":"block"}],"_createdAt":"2021-07-20T15:08:02Z","_rev":"LrtUTIK6MzyeYqVxGijM86","pixelTrackingCode":null,"identifier":"fda-approvals","_type":"taxonomy","name":"Approvals Launches","_id":"a39b59ec-5475-424a-b270-06d6cc201842","_updatedAt":"2022-02-18T12:15:33Z"},"filterRequired":false,"theme":"default","relatedMegaMenu":null,"featureContent":null},"pageData":{"pageSize":30,"data":[{"_id":"1cd4e738-c3bd-469d-bf18-cc5143f53ef8","title":"Risdiplam Tablet for Spinal Muscular Atrophy Receives FDA Approval","author":null,"updatedOn":null,"url":"risdiplam-tablet-for-spinal-muscular-atropy-receives-fda-approval","authors":[{"displayName":"Giuliana Grossi","url":"giuliana-grossi"}],"summary":"The 5 mg risdiplam tablet provides the same efficacy and safety for spinal muscular atrophy as the currently available oral solution.","contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"thumbnail":{"_type":"mainImage","alt":"FDA approval. | Image Credit: syahrir - stock.adobe.com","asset":{"_ref":"image-2f366a4ab7421a6a697b539c22b8aedf46713899-6000x4000-jpg","_type":"reference"}},"published":"2025-02-12T21:11:59.815Z","source":null,"documentGroupMapping":null,"factCheckAuthors":null},{"thumbnail":{"_type":"mainImage","alt":"FDA approved. | Image Credit: Pawel - stock.adobe.com","asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"}},"author":null,"source":null,"url":"fda-approves-mirdametinib-for-neurofibromatosis-type-1-with-plexiform-neurofibromas","authors":[{"displayName":"Giuliana Grossi","url":"giuliana-grossi"}],"_id":"91be9df4-5cb5-4b34-bd22-fcdb3f471310","summary":"Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas that are not amenable to complete surgical resection are indicated in the approval.","published":"2025-02-12T15:32:27.122Z","updatedOn":null,"documentGroupMapping":null,"factCheckAuthors":null,"title":"FDA Approves Mirdametinib for Neurofibromatosis Type 1 With Plexiform Neurofibromas","contentCategory":{"_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles"}},{"title":"FDA Approves Brentuximab Vedotin, Lenalidomide, Rituximab Triplet for R/R LBCL","contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"thumbnail":{"alt":"FDA approval | Image Credit: © wladimir1804 - stock.adobe.com","asset":{"_ref":"image-ff9ffbca858fbb2833bf65b18c99e5a9c74b8707-1200x738-jpg","_type":"reference"},"_type":"mainImage"},"published":"2025-02-12T15:27:00.000Z","updatedOn":"2025-02-12T18:10:46.624Z","factCheckAuthors":null,"_id":"a1f50515-283d-45c7-bf51-cafe087ac04b","author":null,"source":null,"url":"fda-approves-brentuximab-vedotin-lenalidomide-rituximab-triplet-for-r-r-lbcl","documentGroupMapping":null,"authors":[{"displayName":"Maggie L. Shaw","url":"maggie-l-shaw"}],"summary":"Interim data from the ECHELON-3 trial previously showed that adding brentuximab vedotin to lenalidomide and rituximab improved overall survival among patients who have relapsed or refractory large B-cell lymphoma (R/R LBCL)."},{"updatedOn":null,"url":"bimzelx-expands-treatment-options-for-inflammatory-conditions","documentGroupMapping":null,"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"},{"displayName":"Maggie L. Shaw","url":"maggie-l-shaw"},{"displayName":"Jeffrey Stark, MD","url":"jeffrey-stark-md"}],"title":"Bimekizumab-bkzx Expands Treatment Options for Inflammatory Conditions","summary":"Jeffrey Stark, MD, vice president and head of medical immunology at UCB, discusses tailored dosing of bimekizumab-bkzx (Bimzelx) for various inflammatory conditions, highlighting its 5 FDA approvals and the remaining challenges.","contentCategory":{"_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z"},"author":null,"factCheckAuthors":null,"_id":"3bf1fb25-cdd9-4f7b-a094-c5dead6fb6b8","thumbnail":{"_type":"mainImage","alt":"Jeff Stark, MD, vice president, head of medical immunology, UCB.","caption":"Jeff Stark, MD, vice president, head of medical immunology, UCB.","asset":{"_ref":"image-6423a9f30c8bc429e9005755f0b06b2c4bd99078-1893x986-png","_type":"reference"}},"published":"2025-02-10T14:00:00.000Z","source":null},{"updatedOn":null,"source":null,"documentGroupMapping":null,"thumbnail":{"_type":"mainImage","alt":"Terra Wonsettler, PharmD, MBA | Image credit: Evolent","caption":"Terra Wonsettler, PharmD, MBA | Image credit: Evolent","asset":{"_ref":"image-8aa43400435897ab5bb0a33acb12825a618857bf-323x323-jpg","_type":"reference"}},"author":null,"published":"2025-02-07T23:23:31.198Z","url":"evolent-s-wonsettler-sees-outcomes-based-reimbursement-as-a-healthy-tool-","_id":"82a56aca-fca8-4960-8d0f-cbeff844f335","title":"Evolent’s Wonsettler Sees Outcomes-Based Reimbursement as “A Healthy Tool”","summary":"Terra Wonsettler, PharmD, MBA, vice president of pharmacy for Evolent, discusses the recent HHS OIG report that stemmed from the 2021 FDA approval of aducanumab (Aduhelm) and use of the accelerated approval pathway.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"authors":[{"displayName":"Interview by Mary Caffrey","url":"interview-by-mary-caffrey"},{"displayName":"Terra Wonsettler, PharmD, MBA","url":"terra-wonsettler-pharmd-mba"}],"factCheckAuthors":null},{"contentCategory":{"_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory","name":"Videos"},"published":"2025-02-07T21:53:28.655Z","url":"treosulfan-approval-offers-novel-option-for-allo-hsct-conditioning-in-aml-mds","documentGroupMapping":null,"factCheckAuthors":null,"_id":"0fc84d24-dede-4c63-bfd2-f2e86c68995d","summary":"Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT) conditioning in acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). ","thumbnail":{"_type":"mainImage","alt":"Mikkael Sekeres, MD","asset":{"_type":"reference","_ref":"image-b60f4e85aeb9d33a7da0658f96541e8b5373838c-1032x574-png"}},"author":null,"updatedOn":null,"source":null,"authors":[{"displayName":"Rose McNulty","url":"rose-mcnulty"},{"displayName":"Mikkael A. Sekeres, MD","url":"mikkael-a-sekeres-md"}],"title":"Treosulfan Approval Offers Novel Option for Allo-HSCT Conditioning in AML/MDS"},{"authors":[{"displayName":"Mikkael A. Sekeres, MD","url":"mikkael-a-sekeres-md"},{"displayName":"Rose McNulty","url":"rose-mcnulty"}],"title":"Treosulfan Shown Effective, Safe as Conditioning for Allo-HSCT in AML/MDS","summary":"Mikkael A. Sekeres, MD, of Sylvester Comprehensive Cancer Center, University of Miami, discussed data supporting the FDA approval of treosulfan as part of conditioning for allogeneic hematopoeitic stem cell transplantation (allo-HSCT). ","source":null,"author":null,"published":"2025-02-06T22:00:00.000Z","updatedOn":null,"url":"treosulfan-shown-effective-safe-as-conditioning-for-allo-hsct-in-aml-mds","documentGroupMapping":null,"_id":"136603a7-b9f4-4310-a0aa-8827944ec34d","contentCategory":{"_type":"contentCategory","name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB"},"thumbnail":{"_type":"mainImage","alt":"Mikkael Sekeres, MD","asset":{"_ref":"image-10bc2cb3804d6a94f413d9a5cb8071be332f7ad5-724x404-png","_type":"reference"}},"factCheckAuthors":null},{"authors":[{"displayName":"Maggie L. Shaw","url":"maggie-l-shaw"},{"displayName":"Jeff Stark, MD","url":"jeff-stark-md"}],"_id":"2a1ed783-5f61-4149-9910-ce9a6ebd527f","title":"Dr Jeff Stark: New Bimzelx Dose Offers Simplicity and Choice","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"_type":"mainImage","alt":"Jeff Stark, MD, UCB","asset":{"_ref":"image-893e836b204582bb2c27b9679b0ceab9e719963e-1200x675-jpg","_type":"reference"}},"author":null,"updatedOn":null,"url":"dr-jeff-stark-new-bimzelx-dose-offers-simplicity-and-choice","summary":"On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.","published":"2025-02-06T14:53:32.603Z","source":null,"documentGroupMapping":null,"factCheckAuthors":null},{"authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"title":"FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease","thumbnail":{"asset":{"_ref":"image-8f653113486fc52cd1daac9f7124732eb4da7809-1200x800-jpg","_type":"reference"},"_type":"mainImage","alt":"Parkinson disease | Image credit: wladimir1804 - stock.adobe.com"},"documentGroupMapping":null,"author":null,"published":"2025-02-04T21:11:42.913Z","updatedOn":null,"source":null,"url":"fda-approves-first-subcutaneous-apomorphine-device-for-parkinson-disease","_id":"01d56971-fa9f-43e1-8819-fc2e6a49a52a","summary":"The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo), for the treatment of adults with advanced Parkinson disease.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"factCheckAuthors":null},{"url":"fda-approves-ranibizumab-injection-in-treatment-of-dme","documentGroupMapping":null,"_id":"0c080946-5775-4544-9bee-6cecfed79337","title":"FDA Approves Ranibizumab Implant in Treatment of DME","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"published":"2025-02-04T17:37:18.009Z","source":null,"authors":[{"displayName":"Julia Bonavitacola","url":"julia-bonavitacola"}],"factCheckAuthors":null,"summary":"The ranibizumab injection delivered through an implant device could be administered in a convenient schedule twice per year for the treatment of diabetic macular edema (DME).","thumbnail":{"_type":"mainImage","alt":"FDA approved. | Image Credit: Pawel - stock.adobe.com","asset":{"_type":"reference","_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg"}},"author":null,"updatedOn":"2025-02-04T19:24:12.808Z"},{"published":"2025-01-31T06:45:00.000Z","url":"fda-approves-celltrion-s-tocilizumab-anoh-biosimilar-to-actemra","documentGroupMapping":null,"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}],"_id":"c1ee57b7-5303-4b5b-b488-9499039385ee","title":"FDA Approves Celltrion’s Tocilizumab-anoh, Biosimilar to Actemra","summary":"Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients. ","author":null,"factCheckAuthors":null,"contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"thumbnail":{"caption":"Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients. | Image Credit: Olivier Le Moal - stock.adobe.com","asset":{"_ref":"image-a0cb6495daeaee9e3fb7822d0e083c4ace68041e-6000x4000-jpg","_type":"reference"},"_type":"mainImage","alt":"FDA approved. | Image Credit: Olivier Le Moal - stock.adobe.com "},"updatedOn":null,"source":null},{"source":null,"url":"suzetrigine-the-first-non-opiate-pain-therapy-is-fda-approved","documentGroupMapping":null,"_id":"ace3691e-1e86-4f16-a635-351c4aca7ba3","title":"Suzetrigine: First-in-Class Nonopioid Pain Therapy Is Approved by FDA","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"published":"2025-01-31T01:05:19.300Z","updatedOn":null,"authors":[{"displayName":"Giuliana Grossi","url":"giuliana-grossi"}],"summary":"Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as a selective NaV1.8 pain signal inhibitor, an alternative to opiates.","thumbnail":{"_type":"mainImage","alt":"Image Credit: Image Credit: syahrir - stock.adobe.com","asset":{"_ref":"image-2f366a4ab7421a6a697b539c22b8aedf46713899-6000x4000-jpg","_type":"reference"}},"author":null,"factCheckAuthors":null},{"factCheckAuthors":null,"contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"thumbnail":{"asset":{"_ref":"image-d7d2fd821f87077daeef38311eebbe230514ccf3-1200x738-jpg","_type":"reference"},"_type":"mainImage","alt":"FDA Approval | Image credit: wladimir1804 - stock.adobe.com"},"source":null,"documentGroupMapping":null,"authors":[{"displayName":"Ashling Wahner","url":"ashling-wahner"}],"updatedOn":null,"url":"fda-approves-companion-diagnostic-for-tovorafenib-in-braf-altered-pediatric-low-grade-glioma","_id":"23e89a07-0da2-4514-91fa-e900b3ac87fe","title":"FDA Approves Companion Diagnostic for Tovorafenib in BRAF-Altered Pediatric Low-Grade Glioma","summary":"Tovorafenib generated durable drug holiday responses in pediatric patients with BRAF-altered relapsed/refractory low-grade glioma.","author":null,"published":"2025-01-29T14:53:37.497Z"},{"title":"FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD","thumbnail":{"_type":"mainImage","alt":"FDA approval | image credit: Aquir - stock.adobe.com","caption":"FDA approval | image credit: Aquir - stock.adobe.com","asset":{"_ref":"image-a5d351e64efb13433b50de220709d3d9d11705d2-4610x3254-jpg","_type":"reference"}},"author":null,"updatedOn":null,"authors":[{"displayName":"Kyle Munz","url":"kyle-munz"}],"factCheckAuthors":null,"_id":"1498ccc5-1537-4744-88fb-dd039ecfda63","contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"published":"2025-01-28T22:48:50.506Z","source":null,"url":"fda-expands-semaglutide-use-for-cv-kidney-risks-in-t2d-ckd","documentGroupMapping":null,"summary":"The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes (T2D) and chronic kidney disease (CKD), addressing their cardiovascular (CV) and kidney disease risks. "},{"factCheckAuthors":null,"title":"Treosulfan Regimen Approved for Allo-HSCT Conditioning in AML/MDS","author":null,"documentGroupMapping":null,"thumbnail":{"alt":"FDA approved. | Image Credit: Pawel - stock.adobe.com","asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"},"_type":"mainImage"},"published":"2025-01-23T14:09:00.109Z","updatedOn":null,"source":null,"url":"treosulfan-regimen-approved-for-allohsct-conditioning-in-aml-mds","_id":"c11e086c-6e2e-4b1f-b99b-0da9f5266312","summary":"The FDA approved treosulfan in combination with fludarabine as preparation for allogeneic hematopoietic stem cell transplantation (allo-HSCT) in adult and pediatric patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). ","contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"authors":[{"displayName":"Rose McNulty","url":"rose-mcnulty"}]},{"thumbnail":{"_type":"mainImage","alt":"FDA approved. | Image Credit: Pawel - stock.adobe.com","asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"}},"author":null,"published":"2025-01-21T15:57:36.207Z","url":"esketamine-approved-by-fda-as-first-monotherapy-for-treatment-resistent-depression","_id":"10e6a5d5-80c9-4ced-a976-95e11904aa5a","title":"Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression","summary":"Esketamine (Spravato; Johnson \u0026 Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD) with inadequate response to at least 2 oral antidepressants.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"documentGroupMapping":null,"updatedOn":null,"source":null,"authors":[{"displayName":"Giuliana Grossi","url":"giuliana-grossi"}],"factCheckAuthors":null},{"summary":"The Bruton tyrosine kinase inhibitor was approved in combination with bendamustine and rituximab in previously untreated mantle cell lymphoma (MCL) ineligible for autologous hematopoietic stem cell transplantation and as monotherapy in previously treated MCL.","thumbnail":{"_type":"mainImage","alt":"FDA approval | Image Credit: © wladimir1804 - stock.adobe.com","asset":{"_ref":"image-d7d2fd821f87077daeef38311eebbe230514ccf3-1200x738-jpg","_type":"reference"}},"updatedOn":null,"source":null,"url":"fda-grants-2-traditional-approvals-for-acalabrutinib","documentGroupMapping":null,"factCheckAuthors":null,"_id":"a61574e2-d3c5-486e-b847-361c2574aed5","title":"FDA Grants 2 Traditional Approvals for Acalabrutinib","contentCategory":{"_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z"},"author":null,"published":"2025-01-17T15:54:49.297Z","authors":[{"displayName":"Maggie L. Shaw","url":"maggie-l-shaw"}]},{"source":null,"url":"fda-approves-sotorasib-plus-panitumumab-for-kras-g12c-mutated-metastatic-crc","documentGroupMapping":null,"factCheckAuthors":null,"summary":"The combination treatment specifically targets KRAS-mutated metastatic colorectal cancer (CRC) to improve progression-free survival.","author":null,"published":"2025-01-17T14:06:52.286Z","thumbnail":{"_type":"mainImage","alt":"FDA Approved","caption":"FDA Approved","asset":{"_ref":"image-407d27c5fd74836a18293620e5dbacab64d631cd-2000x2000-jpg","_type":"reference"}},"updatedOn":null,"authors":[{"displayName":"Julia Bonavitacola","url":"julia-bonavitacola"}],"_id":"350fe973-dd41-4046-ba08-8c51e8d164d3","title":"FDA Approves Sotorasib Plus Panitumumab for KRAS G12C-Mutated Metastatic CRC","contentCategory":{"_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2"}},{"author":null,"url":"fda-approves-tislelizumab-jsgr-as-first-line-therapy-for-her2-gastric-cancers","authors":[{"displayName":"Skylar Jeremias","url":"skylar-jeremias"}],"_id":"cbca2311-a3c6-4c80-b821-71122f61cff1","title":"FDA Approves Tislelizumab-jsgr as First-Line Therapy for HER2– Gastric Cancers","summary":"Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic HER2-negative (HER–) gastric or gastroesophageal junction adenocarcinoma (G/GEJ) in adults whose tumors express PD-L1.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"alt":"gastric cancer | Image credit: Crystal light - stock.adobe.com","asset":{"_ref":"image-504d2d94cf61879727ad2313dbe018741c0aef00-3600x2400-jpg","_type":"reference"},"_type":"mainImage"},"published":"2025-01-02T16:24:00.803Z","updatedOn":null,"source":null,"documentGroupMapping":null,"factCheckAuthors":null},{"published":"2024-12-27T13:20:00.000Z","source":null,"url":"5-key-drug-approvals-and-crls-in-2024","_id":"54e84f07-56e9-4743-b862-aa803084d27d","summary":"In 2024, multiple drugs received complete response letters (CRLs), sometimes unrelated to the safety and efficacy of the drug, but patients with schizophrenia gained the first new treatment with a new mechanism of action in decades.","contentCategory":{"name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory"},"thumbnail":{"asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"},"_type":"mainImage","alt":"Paper with FDA approved on top of a magnifying glass and a keyboard | Image Credit: Pawel - stock.adobe.com"},"author":null,"documentGroupMapping":null,"authors":[{"displayName":"Laura Joszt, MA","url":"laura-joszt"}],"factCheckAuthors":null,"title":"5 Key Drug Approvals and CRLs in 2024","updatedOn":null},{"authors":[{"displayName":"Giuliana Grossi","url":"giuliana-grossi"}],"_id":"dd7a2659-613f-4a10-b6df-e7e5c8fb7862","summary":"The approval of concizumab-mtci (Alhemo) injection marks a significant milestone in managing hemophilia A and B with inhibitors by preventing or reducing bleeding episodes in adults and children 12 years and older.","contentCategory":{"_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh"},"thumbnail":{"alt":"FDA-Deni-stock.adobe.com","asset":{"_ref":"image-9218bd8ec17bcbd1f819d87da6b7afbff7b24fdf-1200x738-jpg","_type":"reference"},"_type":"mainImage"},"updatedOn":null,"source":null,"url":"first-subcutaneous-prophylaxis-for-hemophilia-a-and-b-with-inhibitors-approved-by-fda","factCheckAuthors":null,"title":"First Subcutaneous Prophylaxis for Hemophilia A and B With Inhibitors Approved by FDA","author":null,"published":"2024-12-23T21:32:10.901Z","documentGroupMapping":null},{"documentGroupMapping":null,"authors":[{"displayName":"Rose McNulty","url":"rose-mcnulty"}],"title":"FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes","summary":"The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise.","contentCategory":{"name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory"},"author":null,"source":null,"url":"fda-approves-first-generic-daily-glp-1-injection-for-type-2-diabetes","factCheckAuthors":null,"_id":"9264035e-f063-437a-abfc-73d0985fc340","thumbnail":{"_type":"mainImage","asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"}},"published":"2024-12-23T18:26:00.122Z","updatedOn":null},{"title":"FDA Rejects Sotagliflozin for Type 1 Diabetes; Lexicon Shifts Focus","thumbnail":{"_type":"mainImage","alt":"FDA website | Image credit: Postmodern Studio – stock.adobe.com","asset":{"_ref":"image-ebfb40d061db8cb94776018fe5f4c50f7871539b-5293x3529-jpg","_type":"reference"}},"documentGroupMapping":null,"_id":"77fa93df-8bab-4156-929b-5913b0eb4648","summary":"The FDA issued a complete response letter for sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"author":null,"published":"2024-12-20T22:37:45.251Z","updatedOn":null,"source":null,"url":"fda-rejects-sotagliflozin-for-type-1-diabetes-lexicon-shifts-focus","authors":[{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"factCheckAuthors":null},{"authors":[{"displayName":"Julia Bonavitacola","url":"julia-bonavitacola"}],"factCheckAuthors":null,"_id":"f4b1fb1f-3972-479a-ab7f-cc95ebdf46ed","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"_type":"mainImage","alt":"FDA Approved","caption":"FDA Approved","asset":{"_ref":"image-407d27c5fd74836a18293620e5dbacab64d631cd-2000x2000-jpg","_type":"reference"}},"author":null,"documentGroupMapping":null,"url":"fda-approves-encorafenib-with-cetuximab-and-mfolfox6-for-metastatic-crc","title":"FDA Approves Encorafenib With Cetuximab and mFOLFOX6 for Metastatic CRC","summary":"Patients with the BRAF V600E mutation and metastatic colorectal cancer (CRC) can be treated with a combination of encorafenib with cetuximab and mFOLFOX6.","published":"2024-12-20T22:02:38.246Z","updatedOn":null,"source":null},{"author":null,"url":"fda-approves-seventh-ustekinumab-biosimilar-to-reference-stelara","factCheckAuthors":null,"title":"FDA Approves Seventh Ustekinumab Biosimilar to Reference Stelara","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"_type":"mainImage","alt":"FDA approval with stamp. | Image Credit: Surendra - stock.adobe.com","caption":"The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to reference Stelara after a year of multiple ustekinumab biosimilar approvals. | Image Credit: Surendra - stock.adobe.com\n","asset":{"_ref":"image-ca845f7e6dfc35ab2f006b74744bb6c3a34fff11-5500x4093-jpg","_type":"reference"}},"published":"2024-12-20T17:39:00.000Z","updatedOn":null,"source":null,"documentGroupMapping":null,"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}],"_id":"93b03420-da7e-4db0-b339-9c6cf70d6c8a","summary":"The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to reference Stelara after a year of multiple ustekinumab biosimilar approvals."},{"thumbnail":{"_type":"mainImage","alt":"FDA approval. | Image Credit: Pawel - stock.adobe.com","caption":"The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naïve to ALK treatment. | Image Credit: Pawel - stock.adobe.com","asset":{"_ref":"image-b0002ea79080e3493345e3c993b00be4690f0087-4279x2706-jpg","_type":"reference"}},"author":null,"url":"ensartinib-receives-fda-approval-for-alk-positive-locally-advanced-or-metastatic-nsclc","documentGroupMapping":null,"_id":"32cad189-eb47-45e8-a79d-ce9175485cf4","title":"Ensartinib Receives FDA Approval for ALK-Positive Locally Advanced or Metastatic NSCLC","summary":"The FDA has approved ensartinib in adult patients with anaplastic lymphoma kinase (ALK)–positive locally advanced or metastatic non–small cell lung cancer (NSCLC) naive to ALK treatment.","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"factCheckAuthors":null,"published":"2024-12-19T16:57:09.414Z","updatedOn":null,"source":null,"authors":[{"displayName":"Cameron Santoro","url":"cameron-santoro"}]},{"author":null,"published":"2024-12-17T22:05:38.892Z","updatedOn":null,"source":null,"url":"fda-rejects-subcutaneous-amivantamab-for-nsclc-over-manufacturing-concerns","factCheckAuthors":null,"contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"_type":"mainImage","alt":"Syringe and vials | Image credit: Aliaksandr Marko – stock.adobe.com","asset":{"_ref":"image-1b0ea624bff10262e2da3d5ec75d235207a08adc-1200x630-jpg","_type":"reference"}},"summary":"Subcutaneous amivantamab joins a growing list of drugs receiving complete response letters due to manufacturing facility issues.","documentGroupMapping":null,"authors":[{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"_id":"9a55a571-89b9-4221-a202-c0f92efa2519","title":"FDA Rejects Subcutaneous Amivantamab for NSCLC Over Manufacturing Concerns"},{"published":"2024-12-16T18:27:15.828Z","source":null,"documentGroupMapping":null,"authors":[{"displayName":"Kristi Rosa","url":"kristi-rosa"}],"_id":"dadde280-b31d-40e8-bdb1-7de0b6ff2ece","thumbnail":{"_type":"mainImage","alt":"FDA approved stamp in black with a red ribbon across it | Image credit: BHM - stock.adobe.com","asset":{"_type":"reference","_ref":"image-3deabc81aa93f0e49190012e256a274872b958e8-4363x3438-jpg"}},"author":null,"updatedOn":null,"url":"cosibelimab-approved-for-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma","factCheckAuthors":null,"title":"Cosibelimab Approved for Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma","summary":"The FDA has approved cosibelimab-ipdl for the treatment of adults with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or radiation.","contentCategory":{"name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z","_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory"}},{"updatedOn":null,"documentGroupMapping":[{"thumbnail":{"blank":true,"_type":"mainImage","link":"https://usoncology.com/","asset":{"_ref":"image-4c487c84faffb9c415baa61497e29cc2d9b429d4-926x180-jpg","_type":"reference"}},"facebook":"https://www.facebook.com/theusoncologynetwork","linkedin":"https://www.linkedin.com/company/us-oncology/","twitter":"https://twitter.com/TheUSONetwork","name":"US Oncology Network","_rev":"Yi2bn4k8OtohOHqwyL1yb1","_type":"documentGroup","_updatedAt":"2021-11-15T14:30:11Z","youtube":"https://www.youtube.com/channel/UCllQZ0OLFbed9P7JVVQKQmw","_createdAt":"2021-11-15T14:28:45Z","_id":"3b34ebd7-d5ae-4f77-913d-2860ae97e8ec","identifier":{"current":"us-oncology-network","_type":"slug"},"parent":{"isShow":true,"identifier":{"current":"partners","_type":"slug"},"_createdAt":"2020-04-23T14:18:14Z","_rev":"BQFrvRf4X3oJFULv3BebwA","_type":"documentGroup","name":"SAP Partners","_id":"fe99fa76-7982-425c-96bb-30c90951f3b1","_updatedAt":"2023-01-16T18:39:02Z"}}],"authors":[{"displayName":"Hayden E. Klein","url":"hayden-e-klein"}],"factCheckAuthors":null,"title":"Durvalumab Approval Redefines Resectable NSCLC Treatment Strategies","summary":"Martin Dietrich, MD, PhD, discusses how the FDA-approved combination therapy is transforming care for resectable early-stage non–small cell lung cancer (NSCLC).","author":null,"published":"2024-12-13T22:07:46.821Z","source":null,"url":"durvalumab-approval-redefines-resectable-nsclc-treatment-strategies","_id":"08678ca2-275d-42e2-8bfc-48689e122d28","contentCategory":{"_createdAt":"2020-04-03T20:03:53Z","_rev":"Q2ZL7ihdIB33NiMMcGccmh","_type":"contentCategory","name":"Articles","_id":"3f4b3ced-7c9d-4fc4-967f-fe993087cce2","_updatedAt":"2023-09-29T14:32:27Z"},"thumbnail":{"asset":{"_ref":"image-1ec091ec5293e43b6addd5389b5c28855d74083a-2549x1426-png","_type":"reference"},"_type":"mainImage","alt":"Martin Dietrich, MD, PhD"}},{"title":"Next-Gen Strategies for Resistance in EGFR-Mutated Lung Cancer","summary":"To conclude our interview with Joshua K. Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses that could help to overcome treatment resistance in non–small cell lung cancer.","updatedOn":null,"authors":[{"displayName":"Maggie L. Shaw","url":"maggie-l-shaw"}],"url":"next-gen-strategies-for-resistance-in-egfr-mutated-lung-cancer","documentGroupMapping":[{"twitter":"https://twitter.com/nyulangone","_rev":"bpAXDOWYlyN1gnXD97ocLp","_type":"documentGroup","_id":"partners_635","parent":{"_rev":"BQFrvRf4X3oJFULv3BebwA","_type":"documentGroup","name":"SAP Partners","_id":"fe99fa76-7982-425c-96bb-30c90951f3b1","_updatedAt":"2023-01-16T18:39:02Z","isShow":true,"identifier":{"current":"partners","_type":"slug"},"_createdAt":"2020-04-23T14:18:14Z"},"thumbnail":{"blank":true,"_type":"mainImage","link":"https://nyulangone.org/","asset":{"_ref":"image-53296f75dec063bcfef5d910f1d0ea0c8f11246e-2657x1427-jpg","_type":"reference"}},"identifier":{"current":"nyu-langone","_type":"slug"},"name":"NYU Langone Health","_updatedAt":"2020-09-21T19:45:11Z","_createdAt":"2020-04-23T14:21:22Z"}],"_id":"76d1639e-176a-48db-9209-d9938920ea98","contentCategory":{"name":"Videos","_id":"ee14ccb3-3542-4414-9046-927be1198c76","_updatedAt":"2020-04-03T20:03:44Z","_createdAt":"2020-04-03T20:03:44Z","_rev":"Yw6MEKZDMdk6hC2JCPjfiB","_type":"contentCategory"},"thumbnail":{"alt":"Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center","asset":{"_ref":"image-398f81181f2692ac562b24bc01c26f9ba8dd0284-1200x675-jpg","_type":"reference"},"_type":"mainImage"},"author":null,"published":"2024-12-13T12:00:00.000Z","source":null,"factCheckAuthors":null}],"pageNumber":1,"totalCount":321,"filterData":[],"filterRequired":false,"targeting":{"content_placement":["fda-approvals"],"document_url":["approvals-launches"],"document_group":[],"rootDocumentGroup":[],"hostname":"www.ajmc.com"},"videoData":{}},"queryString":{"slug":["approvals-launches"]}},"host":"www.ajmc.com"},"__N_SSP":true},"page":"/[...slug]","query":{"slug":["approvals-launches"]},"buildId":"IRrGcHGbYOSE-7JrEGg8a","isFallback":false,"gssp":true,"appGip":true,"scriptLoader":[]}</script></body></html>